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Abstract 
The aim of this thesis is to investigate the role of fast protein dynamics (pico-
second timescale) in enzyme activity and stability, and specifically to test the 
hypothesis that enzyme activity and stability are inversely related by their internal 
dynamics. 
Activity ∝ Dynamics (flexibility) ∝ 1/Stability 
 
In order to test this hypothesis, the well known anti-cancer drug: methotrexate 
was used as an informative ligand in the network established between these 
properties. A multidisciplinary approach combining neutron scattering, circular 
dichroism, UV absorption, isothermal titration calorimetry and X-ray crystallography 
was undertaken to examine the current paradigm using the enzyme: dihydrofolate 
reductase as a model.  
As inferred by neutron spectroscopy, the binding of MTX influences the 
dynamical behavior of DHFR. Macromolecular dynamics such as the resilience: <k> 
(i.e. structural rigidity) was found to be increased and, inversely, the flexibility 
decreased upon MTX binding. In addition, as revealed by circular dichroism, this 
dynamical dependency upon MTX binding was correlated with an enhanced thermal 
stability. Compared to the free enzyme, the melting temperature was found to be 
increased by 13.8 °C in the presence of MTX. The inhibitory power of MTX was also 
examined by steady state kinetics and isothermal titration calorimetry. The Ki for 
MTX was found to be in the nanomolar range Ki= 10.9 nM. Using isothermal 
titration calorimetry, the binding thermodynamic signature between MTX and DHFR 
was characterized. The binding event was found to be largely favourable (∆Gb=-12.1 
Kcal mol-1), enthalpy driven (∆Hb= -16.8 Kcal mol-1) with an unfavourable entropy 
∆Sb=-15.6 cal K-1mol-1.  
In conclusion, the modulation of the macromolecular dynamics may reflect 
how specific conformations are favoured for subsequent protein function in response 
of the binding of specific ligand and how conformational substates approach to 
protein function. In this context the unprecedented power of transition state analogs 
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such as MTX on protein function might therefore be dependent on fast protein 
dynamics. 
 
Keywords: Incoherent neutron scattering, circular dichroism, isothermal titration 
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Fast proteins dynamics and its correlation to activity and stability 
 
1. Protein dynamics and function: A moving story 
1.1. Molecular flexibility and protein function 
 
Proteins are the tools of the living; they participate or perform all the reactions 
within the cell. They are noticeably important in cell signaling, cell adhesion or 
immune responses. Because their role is very versatile, they are classified in families. 
One particular class of proteins, namely enzyme, often called “life catalysts” lie at the 
interface between the energies of the living and protein function. These biocatalysts 
enhance chemical reaction over 5 to 10 orders of magnitude by lowering the 
activation barrier. They ultimately ease reactions to occur on a life time scale but 
paradoxically to their biological relevance, the origin of their prodigious power is 
unknown. In this respect, a considerable effort and theories were developed to 
unravel the origin of enzymatic catalysis but none succeed to establish a general 
consensus [1]. The concept of transition state or activated complex first developed in 
the 1940s was reformulated by Pauling: ‘The activation barrier must be lowered to 
speed the reaction’[2-4]. According to the postulate, enzymatic catalysis must pass 
through a critical and fleeting state: the transition state corresponding to the 
maximum energy state along the reaction coordinate. Although, this postulate 
originally focuses on the chemical reaction itself, it also strongly suggests the need of 
a structural flexibility in the architecture of the enzyme. In other words, the enzyme 
might also experiences structural changes in order to guide the reactant in the proper 
orientation for the reaction to occur. Indirectly, this statement was introducing the 
premise of a new era in enzymology: conformational functionality [5]. 
The earliest indication of this structural flexibility came from crystallographic 
investigations, which was at first glance surprising since the crystallization process 
implies a structural homogeneity. Indeed, when the first two structures were solved 
by X-ray crystallography, lysozyme and ribonuclease respectively, small 
conformational changes were found between the structure in the presence and in the 
absence of substrate [6-8]. Daniel Koshland (who passed away in July 2007) was 
very surprised that these small changes were discarded and not being addressed as  
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evidence of a new theory: induced fit (1958) [9]. This particular mechanistic model 
supposes that the protein structure changes upon ligand binding. This view was 
therefore prompting the first challenging points to the traditional paradigm, ’one 
sequence, one structure, one function’. The magnitude of conformational diversity 
observed in proteins was just emerging and was later confirmed by several techniques 
such as Nuclear Magnetic Resonance (NMR) [5]. Nowadays with many structures 
from NMR and X-ray crystallography, structural changes are widely accepted as an 
intrinsic property of proteins. Consequently, there is good evidence that most, if not 
all proteins require molecular flexibility for function. These fluctuations range from 
side chain motions to loop or sub-domain movement or even tertiary structure 
rearrangement [10]. A growing and important collection of molecular motions is 
depicted in a specific database: The Database of Macromolecular Movements 
(http://molmovdb.org/) which could be considered as the dynamic counterpart of the 
Protein data bank (PDB) [11, 12]. The movements are identified and classified 
according to their nature and geometry. Overall, the most intriguing consequence of 
conformational diversity is that it provides a structural mechanism for protein 
function. A fine-tuning is operating between the architecture and the chemical 
process. However, if the structures of the reaction intermediates are sometimes well 
defined, the frequencies of the conformational changes and their biological 
importance remain largely unknown. 
Pre-steady state kinetics and NMR studies have shed light on this fundamental 
question [13, 14]. They have given a picture of both kinetic and structural details of 
the catalysis mechanism of various enzymes such as cyclophilin A [15]. In most 
cases, a direct relationship can be established between the turnover number and the 
frequencies of specific motions. In other words, milli to micro second motions are the 
‘key stones’ in protein activity since most enzyme catalysed reactions occur on these 
specific timescales [16]. Nonetheless, if these studies have contributed to improve our 
understanding of protein function, they have assumed that ‘functional dynamics’ 
must be restricted to this particular time window. Though this assumption can be 
applied to many proteins, some proteins do not exhibit such dynamics changes to 
perform their biological function but on the other hand, we cannot consider them as 
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rigid elements. Indeed, the hierarchy of protein dynamics spans over at least 15 
orders of magnitude, some proteins fluctuate with speeds ranging from femto-seconds 
to minutes (table 1.). Clearly, the various classes of motions extending over multiple 
timescales throughout the protein might potentially play a role in protein activity 
and/or stability. However, as reviewed by Daniel et al, the role of dynamics in 
enzymatic activity is very versatile: different protein functions may have different 
dynamical dependencies. Conformational dynamics are likely to be dependent on the 
nature of enzyme and its catalytic mechanism [17]. For instance, quantum/classical 
molecular dynamics with site directed mutagenesis approaches have correlated 
femto-pico second timescale conformational changes with kinetic motions in the 
DHFR kinetic cycle (millisecond) [18]: suggesting that motions can be coupled to 
each other in a specific network throughout the protein. It also suggests that fast 
conformational fluctuation might be channelled into productive events for protein 
function, which is intriguing since their frequencies do not match the kinetically 
relevant motions [19]. On the other hand, protein stability is also dependent on 
dynamics, in the sense that native proteins are flexible within much narrower limits 
than their denatured form [20]. This has given rise to the paradigm that activity and 
stability are inversely related by internal dynamics; i.e.  
 
Activity ∝ Dynamics (flexibility) ∝ 1/Stability 
 
Consequently, proteins need to be sufficiently flexible to be catalytically 
active, but not so flexible that they readily denature. However, the nature of the 
dynamic requirements for activity and stability and in particular whether they are the 
same are unclear. Protein dynamics and how dynamical fluctuations are coupled to 
each others is still a paradigm of complexity. Various methods have been used to 
address this problem representing a gap in our understanding of protein function. A 
number of concepts have been advanced to rationalise their precise role but the basis 
of this inter-relationship still remains uncertain... 
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1.2. Fast motions for slow action? Fast swings for slow steps? 
In the literature devoted to protein dynamics fast protein dynamics lie at the 
border of the spectrum with time scale ranging from the nanosecond to the femto 
second. The role of these motions that constantly fluctuate along the protein 
backbone and side chains is still a matter of controversy. A number of studies have 
clearly identified these motions as ‘random’ vibrations not necessary for protein 
function [22-24]. On the other hand, in the recent years, these ultra fast fluctuations 
have gained popularity in view of enzymology and protein evolution [5, 19, 25-28]. 
In fact, there is much evidence indicating, that many fluctuations can be coupled 
together to greatly enhance the catalytic power of enzyme or participate in protein 
stability [19, 29]. 
 
 Are these motions simply inherent properties of proteins or have they 
been harnessed to enhance the functional efficiency? 
 
Motions Amplitude (nm) 
Approximate time 
scale Log (s) 
 
Electronic rearrangement 
 
0.001 to 0.01 -15 to -14 
 
Atomic vibrations 
 
0.001 to 0.01 -14 to -9 
 
 
Loop motions 
 
0.05 -11 to -6 
 
Domain motions 
 
0.1 to 0.5 -11 to -6 
 
Allosteric transitions 
 
0.1 to 0.5 -6 to 0 
 
Folding and unfolding transitions 
 
0.5 to 1 -3 to 1 
Table 1. The timescale and amplitude of various dynamic events that can occur in 
proteins [21]. 
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A number of concepts have also emerged to rationalise the role of fast protein 
dynamics in terms of protein action. If proteins have a hierarchical spatial 
organization, which is naturally mapped onto the spectrum of their motions, we 
would in principle assume that the protein conformation adopted must be functionally 
relevant. NMR was used to test this determinist hypothesis in order to depict the 
‘true’ number of alternative conformations of a single protein in solution. This 
number was exceeding largely what was expected to be the catalytically active 
conformations [30]. Interestingly, these findings have confirmed the postulate of 
Landsteiner and Pauling in 1930, suggesting that immunoglobulins can exist as an 
ensemble of isomers with different structures but with a similar free energy. The 
Monod-Wyman-Changeux (MWC, 1965), model of allosteric regulation was actually 
reformulating this concept of conformational diversity in view of enzymology [31]. 
The simple rigid scaffold of a protein was replaced by a more modern view: a 
dynamic equilibrium of pre-existing conformations. This idea although considered 
outlandish for decades is now elegantly presented in energy diagrams such as folding 
funnels found in Dill’s theory [32]. This ‘new view’ of protein as inferred for instance 
by James et al depicts proteins using a rugged energy landscape [5] (figure 1). 
 
Figure 1. Two dimensional energy landscape of a protein. The energy minima 
correspond to the different conformational substates (CS) explored by the protein. 
CS 
Free  
energy 
Conformational coordinate 
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 This theory was originally formulated by the Frauenfelder’s group 20 years ago [33]. 
Indeed, energy landscapes are defined as the potential energy of the system as a 
function of all coordinates. The native folded form of a protein can assume a very 
large number of nearly iso-energetic conformations or conformational substates. The 
hierarchy is organised in tiers which are shifted by the presence a specific ligand [29, 
33-35]. Energy landscapes are therefore important since they help to characterize the 
different possible structures, but also because they determine the dynamics of the 
system. More recently, a number of studies have concurred to build an unifying 
picture, connecting: protein structure, energy landscape, dynamics and enzyme 
catalysis. Free energy landscapes can be viewed as three-dimensional catalytic 
pathway [29, 36]. Enzymes reactions are suggested to operate through “catalytic 
networks” involving multiple energy minima (reaction intermediates) and 
unfavourable energy states (transition states) (figure 2). Thus, this new view is 
stochastic rather than deterministic and emphasises growing evidence for ‘non-
catalytically active’ conformations [19]. In other words, enzymes must be considered 
as existing in an ensemble of coupled conformational states, working in concert to 
achieve their remarkable efficiency [37].  
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Figure 2. Schematic three-dimensional representation of the standard free-energy 
landscape for the catalytic network of an enzyme reaction. G° is the free energy of the 
system, E+S represents the enzyme and its substrate and E+P the enzyme and 
products respectively. This figure illustrates the multiple populations of 
conformations, intermediates (minima) and transitions states (maxima) that may 
facilitate the enzyme catalyzed reaction. This figure was created by Sarah Janes 
Edward and reproduced from reference [36]. 
 
However, we still do not know how the different conformational substates inter-
converse. Fast protein dynamics might promote the vibrational modes necessary for 
the jumps between the various energy levels or conformational substates (CS). 
Intuitively, these ‘promoting motions’ could be coupled to slower motions relevant 
for protein function [38]. In this respect, fast protein dynamics are believed to serve 
as lubricant by enhancing the conformational space sampled by the protein [17]. 
Computational approaches such as molecular dynamic (MD) simulation have 
contributed to bring some insights in this framework [39]. The calculations and 
consequently the timescales accessible from simulation are matching the motion 
frequencies (ps-ns). These approaches have naturally provided an opportunity to 
examine if fast motions were required in energy barrier crossing, which are in 
principle localized and of high frequency. In view of enzymology, fleeting states such 
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as Transition State (TS) or Near Active Conformers (NACs) might require such 
motions to progress along the reaction coordinate [40, 41]. By definition, NACs are a 
ground state of the Michaelis complex which differ slightly in the geometry of the TS 
within 0.4 Å and 15º [42]. The changes in going from the enzyme NAC to enzyme 
TS are therefore very subtle and may therefore link backbone fluctuations among the 
conformational substates population to their functional relevance. A recent MD study 
has examined the negative effect of a site specific mutation in the network of coupled 
motions over different time-scales[18]. A clear connection between backbones 
fluctuations on the ns-ps timescale with the kinetic rate of DHFR [43] was 
established. It seems also that the efficiency of hydrogen tunnelling might depend on 
fast motions. This phenomenon by which a particle ‘digs’ in the reaction barrier 
because of its wavelike property is exquisitely sensitive to the distance or donor and 
acceptor molecule and temperature [44]. The tunnelling effect decreases respectively 
with temperature. It is therefore tempting to assume that these thermally excited 
fluctuations are involved in the hydride transfer reaction. Consequently, if these 
views turn out to be correct, ps to ns motions will be in particular responsible for the 
crossing of activation barriers in protein function. In addition, these fast motions 
would determine the shape of the free-energy landscape of the catalysed reaction [18, 
45]. 
Now the research in these fields has to address these finding on issues relating 
to protein allostery, enzyme evolution and drug design. The implication of fast 
protein dynamics in fundamental sciences might profoundly affect our understanding 
of protein structures. 
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1.3. The dihydrofolate reductase enzyme: A prime model  
1.3.1. Presentation 
DNA is one of the major macromolecules in the cell, it supports the genetic 
information necessary for the cell to produce proteins. The DHFR enzyme, which is 
found in all living organisms is of prime importance in this path. It catalyses the 
reduction of dihydrofolate into tetrahydrofolate and therefore participates in normal 
folate biosynthesis. Consequently, DHFR is a key-stone in nucleic acids and protein 
biosynthesis (figure 3). The biological relevance of this particular enzyme was first 
indirectly highlighted by cancer therapy strategies, which were using inhibition of the 
folate pathway to slow and block the growth of tumors. The discovery in 1957 of the 
dihydrofolate reductase enzyme by Futterman was the starting point of an avalanche 
of studies not only dedicated to its medical application but also in fundamental 
research field [46, 47]. This wealth of information on the DHFR enzyme was taking 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of the folate pathway. 
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advantage of the important number of anti-cancer strategies inhibiting directly the 
DHFR enzyme. For instance, the development of drugs such as methotrexate, which 
is known as a DHFR stoichiometric inhibitor [48], is still one of the most potent 
treatments in certain forms of cancer [49]. The success of this enzyme as a prime 
target in cancer therapy is still not questioned; the recent development drug 
Permetrexed for lung and oesophageal cancer reflects its relevance in drug design 
[50]. Nowadays, this success has expanded beyond the pharmaceutical world, 
extending to a number of research fields, which encompass not only applied science 
but also fundamental research areas such as enzymology and computational science. 
The structure analysis of this small enzyme has revealed an interesting architecture: 
the structure is made of two domains: the adenosine binding domain and the major 
subdomain which are organized in an α/β fold [51]. The β secondary structures forms 
a relatively rigid skeleton counterbalance by an extensive number of loop which 
accounts about 40% of the major subdomain. The loops are believed to control the 
catalytic power of the enzyme by acting as a dynamic gate [51]. This unique 
interrelationship has therefore prompted a growing interest in protein function, 
particularly in enzymology where protein motions i.e. protein dynamics are implicit 
in enzyme action but not completely understood. Overall, the DHFR biological 
relevance in cancer therapy and this unique structure/function relationship have 
promoted the DHFR enzyme as a prime model for an unprecedented number of 
research projects. 
1.3.2. Kinetic mechanism 
 The dihydrofolate reductase first discovered by Futterman in 1957 belongs to 
an ubiquitous pathway found in all living organism. It plays a key role in the normal 
folate pathway enabling nucleic acid and protein synthesis. DHFR catalyses the 
reduction of 7,8-dihydrofolate (H2F) to 5,6,7,8-tetrahydrofolate (H4F) using the 
reduced form of nicotinamide dinucleotide phosphate (NADPH) as a cofactor (figure 
4). In many organisms, the reduction of folate to H2F is also catalysed, although less 
efficiently. 
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The reaction occurs by stereospecific hydride transfer of the pro-R hydrogen of 
NADPH to the C6 atom of the pterin ring of H2F with concomitant protonation at N5 
[45]. However, the protonation mechanism is still a matter of debate. Indeed, for 
hybrid transfer to proceed, the substrate must be protonated at the N5 of the pteridin 
ring but at physiological pH, only a small proportion of the substrate is protonated 
[52]. Hence, numerous experimental and theoretical studies have attempted to 
rationalise a possible mechanistic scheme [47]. However, the complex contribution of 
amino acids distal or proximal to the active site, long-lived water molecules and the 
effect of coenzyme binding still hindered the answer. The main question is how the 
enzyme provides an architecture that complements the chemical reaction resulting in 
the correct ionisation of H2F for hydride transfer to occur. Not surprisingly, site 
directed mutagenesis and sequence alignment has shed the light on a strictly 
conserved carboxy residue in the active site (Aspartate 27 in E. coli, Aspartate 26 in 
L. casei, Glutamate 30 in human DHFR). The interaction of this acidic residue and 
the pteridin fragment was proposed to drive the substrate protonation. In addition, a 
keto-enol tautomerism mechanism, involving long-lived water molecules in the 
vicinity of the active site, was proposed to participate actively in the mechanism. 
However, the position of the water molecules obtained by X-ray crystallography did 
not agree with the model, which finally raised more questions than it answered. 
 
Figure 4. Schematic representation of the reduction of dihydrofolate in 
tetrahydrofolate using NADPH as a cofactor by the enzyme DHFR. This material 
is based upon the review of Benkovic et al [45]. 
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Consequently, in spite of the abundant data, the mechanism of substrate protonation 
is not fully understood [53]. On the other hand, pre-steady and steady state kinetic 
analyses have given a detailed map of E. coli DHFR catalytic scheme Benkovic et al 
[45]. The enzyme is cycling between five kinetically observable intermediates with a 
preferred pathway (figure 5). The cofactor NADPH is believed to initiate the catalysis 
by forming the binary complex E:NADPH. The subsequent binding of H2F leads to 
the fleeting Michaelis complex E:NADPH:H2F, and to the products E:NADP+:H4F, 
E:H4F and E:NADPH:H4F. In this complex mechanism, the association and 
dissociation of the ligand are of primary importance. 
 
It actively modulates the overall rate of the process along a preferred pathway. The 
hydride transfer rate, which is the key stage of the catalytic process, is one of the 
most rapid stages in the catalytic cycle whereas the limiting step is associated with 
the rebinding of a new NADPH molecule. Interestingly, the reaction product H4F is 
not released after hydride transfer. A new NADPH molecule must bind the binary 
complex, E:H4F, for H4F release. A synergistic coordination is therefore achieved 
between product release and cofactor/ substrate binding which plays a key role in the 
regulation of the whole pathway.  
 
 
 
 
 
Figure 5. Kinetic scheme for DHFR catalysis at 25°C. E is DHFR, NH is NADPH; 
N+ is NADP+;H2F is dihydrofolate,H4F is tetrahydrofolate. The preferred pathway 
during multiple turnovers is highlighted in red [45]. 
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1.3.3. Structure  
The pharmaceutical and biological relevance of DHFR have led to a number 
of structural studies. Various techniques such as X-ray crystallography, NMR, and 
neutron crystallography have contributed to a detailed map of the architecture of the 
enzyme in various ligated states. In particular the work of Sawaya and Kraut has 
depicted the reaction intermediates of the kinetic cycle with more than 24 different 
isomorphous crystals [51]. The corresponding number of E. coli structures found in 
the Brookhaven Protein Databank (PDB) now exceeds 80. In fact, E. coli DHFRs 
complexed with small molecules such as drugs have been very popular over the last 
20 years. In addition, despite a low sequence homology between DHFRs isolated 
from various sources (less than 30 %), DHFRs display a high degree of structural 
similarity. Sequence alignment for DHFRs shows a series of strictly conserved 
residues not only at the active site but also in the distal part of the enzyme. 
Consequently, this wealth of structural studies has brought E. coli DHFR a role as a 
prime ‘model’ and the main reference against which other DHFRs sources are 
compared.  
Overall, all chromosomally encoded DHFRs are small (≈18-25 kDa for most 
enzyme species isolated from various sources) single domain proteins organized in 
two subdomains, the adenosine-binding domain and the loop domain also named the 
major subdomain [14, 51]. These two structural motifs are organized in a α/β 
structure consisting of a central eight stranded β-sheet (composed of β-strands A-H) 
and four flanking α-helices (designated αB, αC, αE, and αF) connected by the loops. 
The β-sheet structure is suggested to form a rigid skeleton balancing the flexibility 
from the loop sub-domain [51]. The adenosine binding subdomain (residues 38-88 in 
E. coli DHFR) which is composed of two α-helices is the smaller of the two 
subdomains and provides the binding site for NADPH moiety. On the other hand, the 
major subdomain consists of approximately 100 residues from the N and C termini 
and is dominated by a set of three loops that surround the active site. Interestingly, in 
terms of sequence length, these loops makes up approximately 40 %-50 % of the 
major subdomain; hence it is sometimes called the loop subdomain. This subdomain 
is made of three loops: Met20 loop (residues 9-24), F-G loop (residues 116-132), and 
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G-H loop (residues 142-150) in E.coli DHFR [51]. The Met20 and F-G loops are also 
referred to in the literature as loop 1 and loop 2, respectively.  
At the interface of the two domains, we find a hinge region, which plays a role 
in the access to the active site through bending motions. The adenosine binding 
domain moves relative to the major domain upon binding of various ligands, resulting 
in closure of the active site cleft. The active site cleft lies in the hydrophobic pocket 
surrounded by the α-helix B, the central β –sheets (a, e and b), and the loop I. The 
nicotinamide fragment of the cofactor resides in a deep pocket in the vicinity of the 
substrate whereas the rest of the molecule is positioned at the protein surface. 
Similarly, the pteridin ring of the substrate resides in the centre of the protein with its 
p-aminobenzoylglutamine part at the protein surface (figure 6). This structural 
arrangement provides the environment for hydride transfer to occur. The Met20 loop 
is often depicted in the literature in respect with the catalytic pathway with two 
distinct conformations, closed and occluded and four in the crystalline state open, 
closed, occluded and disordered (figure 9). The conformation of the active site loops 
depends on the ligand bound in the substrate and cofactor binding site. The loop 
adopts the closed conformation when it packs against the nicotinamide ring of the 
cofactor bound in the active site. On the other hand the occluded conformation is 
prompted when substrate site is occupied. The amplitude of variation between closed 
and occluded conformation is up to 9Å. The Met20 loop is therefore an active gate 
controlling the access of the active site. 
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Figure 6 Cartoon representation of the tertiary structure of E. coli DHFR bound to 
the substrate (folate) and the cofactor (NADP+). Secondary structural elements, α-
helices in yellow and β-strands in orange are denoted by capital Latin letters (B, C, E 
and F) and lower-case Latin letters (a-g) respectively. Major loop regions are 
labeled. The active site Asp 27 is labeled in purple. The adenosine-binding loop 
(residues 62-70) is at the top of the structure, linking the c and d β-strands together. 
The coordinate were taken from the X-ray structure of the corresponding ternary 
complex (Brookaven PDB code 1RX2). This figure was made using PyMOL [54, 
55] 
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1.3.4. Bacillus stearothermophilus DHFR structure 
Since our laboratory (Thermophile unit) is interested in the interrelationship 
between activity/stability and protein function under extreme temperature conditions, 
we have used a DHFR from thermophilic organism: Bacillus stearothermophilus (Bs 
DHFR).  
 The X-ray structure of the free form of Bs DHFR (1ZDR) was first determined 
by Klinman et al [56]. This structure is the first monomeric DHFR structure from a 
moderate thermophilic organism. The structure was resolved at a 2 Ångstrom 
resolution and exhibits the common α/β fold organised in two subdomain found in all 
chromosomal DHFRs. Relative to the other known structures of DHFRs, the 
sequence of Bs DHFR shares the greatest sequence identity and similarity with the 
DHFR from E. coli (38 and 58 %, respectively). In comparison, DHFRs from 
Lactobacillus casei or Thermotoga maritima share 35 and 23 % of sequence identity 
and 56 and 40 % of similarity respectively (figure 7) [56]. The superimposition of the 
two structures from E. coli and Bs show a very little deviation in the protein backbone 
(figure 8). The average RMSD/residue was found to be 4.0 and 4.7 Å for the main 
and side chains respectively (table 2). The folding pattern is extremely well 
conserved between the various evolved thermal sources. 
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Figure 7. Structure-based sequence alignment [57] of representative DHFR 
structures: Bs, B. stearothermophilus;Ec, E. coli; Tm, T. maritima; Ca, C. albicans; 
Pc, P .carinii; Hs, H. sapiens; Gg, G. gallus; Hv, H. volcanii; and Lc, L. casei. 
Secondary structures found in Bs DHFR are indicated on the top line. The sequence 
alignment was constructed using the software Multalin [58]. 
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Figure 8. Overlay of three-dimensional structure of Bs DHFR (1ZDR, magenta) and 
E. coli DHFR (1DRA yellow). This figure was made using the program Superpose 
[59] available in the CCP4 package (Collaborative Computational Project, Number 4) 
[60].  
 
Table 2. RMSD values of the main chain (blue) and side chain (red) between Bs 
DHFR and E. coli DHFR. The graph was obtained using the program Superpose [59]. 
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1.3.5. Motions and DHFR catalysis: a synergistic 
mechanism 
 In this picture of catalysis, which takes advantage of the X-ray and NMR 
models, the structure of all the kinetic intermediates or models of the intermediates 
have been solved. The various intermediates have been compiled in a movie to 
highlight the dynamical key elements in view of the kinetic cycle (http://www.chem-
faculty.ucsd.edu/kraut/dhfr.html). This study has unambiguously revealed an 
essential role for substantial backbone and side chains motions in cofactor and 
substrate binding and in the catalytic cycle. Almost 40 % of the major subdomain is 
formed by loops (Met20, F-G and G-H) which potentially implies a high structural 
flexibility. In particular, the Met20 loop is one of the major sites of conformational 
change with the substrate binding pocket. The closed, occluded, and opened 
conformations correlate to the various binding states along the reaction cycle (figure 
9). The loops movements are believed to assist the proper alignment of the reactive 
groups involved in the chemical reaction [47]. The timescale and amplitude of 
backbone motions depend primarily on the conformation of the active site Met20 
loop. For instance conformational changes on the micro-millisecond time-scale 
appear to be related to the structural changes in the occluded-closed transition [61]. 
This is of particular interest since these motions are comparable to the timescale of 
product release (12 s-1), which is the rate-limiting step under conditions of steady 
state turnover [45]. In addition, in the closed conformation, picoseconds-nanoseconds 
timescale motions become attenuated [62]. The various conformations adopted by the 
Met20 loop have therefore specific fluctuations modes over a wide range of 
timescales, from pico to milliseconds. In this respect, the Met20 loop serves as a 
dynamic gate controlling the active site accessibility. These finding are prompting 
strong evidence of a synergistic mechanism between specific motions and catalysis. 
Boehr et al have elegantly deepened our understanding on these so called ‘promoting’ 
dynamics or motions in the DHFR catalytic cycle [37]. Using NMR relaxation 
dispersion they have detected a conformational exchange on a micro to millisecond 
time scale between the ground-state structure and one or two excited states that 
resemble the ground state of the preceding and/or the following intermediate in the 
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catalytic cycle. They suggest that there is an active cycling conformational selection 
during DHFR catalysis. It provides solid evidence that the whole kinetic pathway is 
governed by the dynamics of the conformational fluctuations between the ground and 
excited states of all kinetics intermediates. Consequently, certain enzymes such as 
DHFR combine flexibility and plasticity to achieve their function. The coordination 
of the fluctuations is therefore expected to have a long range impact on the 
performance and the regulation of the enzyme.  
 
 
 
Figure 9. Three main types of the Met20 loop (residues 9-24): open, closed, occluded. 
The picture is based on the atomic coordinates of the X-ray structures of the complexes 
of E. coli DHFR with NADPH (open, gold), with NADPH and MTX (closed, grey), and 
with H2F (occluded, purple) (PDB codes are 1RH3, 1RA1 and 1RX5, respectively). 
This figure was built using PyMOL [54] based on the reference [63]. 
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1.3.6. The transition state analog Methotrexate 
DHFR is a key enzyme in normal folate synthesis. Folate is an essential 
precursor metabolite required for many one-carbon transfer reactions involved in 
purines, pyrimidines synthesis, and amino acids [47]. This particular biochemical 
pathway has therefore gained over the years an important potential for inhibiting 
rapidly dividing or invasive cells. Sidney Farber and coworkers at the Children's 
Hospital Bostonhad used this fact to cure cancers. In the 1940s, they were the first to 
observe the effects of aminopterin, a folate antagonist, on cancer remission. The 
therapeutic potential of the folic acid biosynthesis pathway was just emerging. The 
importance and recognition of this work came in 1988 when Hitchings, Elion and 
Black shared the Physiology and medecine Nobel prize for their joint work on this 
important biosynthetic pathway (http://www.en.wikipedia.org/wiki/Methotrexate). 
Nowadays, the purine and pyrimidine biosynthesis pathways have triggered an 
avalanche of studies which have eventually led to the development of therapeutic 
agents such as trimethoprim, pyrimethamine, methotrexate [49]. These so-called 
antifolate drugs compete with dihydrofolate for the substrate binding site in DHFR. 
Particularly pertinent to our discussion is the impact of MTX on the catalytic 
properties of DHFR. MTX is a folate analog, only differing at position 4 with respect 
to folate competing reversibly with folate. It was developed by Yellapragada 
Subbarao in 1948 and is now used to treat million of patients suffering with both 
malignant and autoimmune diseases.  
To understand the physiological and pharmacologic effects of MTX in the cell, 
we shall see MTX inhibition as a combination of at least two distinct effects: a partial 
depletion of reduced folate substrates but also in a direct enzymatic inhibition of 
various key enzymes involved in the pathway such as DHFR, and thymidylate 
synthase (Ts) [64]. Although MTX is not in the strictest sense a specific inhibitor of 
DHFR, this enzyme has become its prime target [65]. Indeed, overall drug 
effectiveness depends significantly of the strength and selectivity of the inhibitor. In 
this respect the interaction between MTX and DHFR has become a perfect example 
of a high affinity interaction. The dissociation constant of methotrexate for E. coli 
DHFR is about one thousand-fold that of folate (Kd= 10-10 Mol l-1) [65]. MTX has 
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become the ‘DHFR stoichiometric inhibitor’. However one fundamental question 
remains unsettled:  
Why does MTX bind so tightly to DHFR? 
It is undoubtedly due to the structural features shared with H2F. Most potent 
inhibitor of chromosomal DHFR contain N1-2,4-diamino heterocycles. MTX and 
H2F differ noticeably at position 4, where the 4-oxo group of DHF is replaced with a 
4-amino group (please, see figure 10). Numerous crystallographic studies on MTX 
DHFR complexes have revealed a specific geometry of binding [14, 51, 66]. The 
MTX binding site is well defined, a loop that forms the active site, residues 9-24 in 
Lactobacillus. casei closes over MTX when bound to DHFR [51, 66]. On the other 
hand, the interaction of small molecules with DHFR was depicted extensively by 
NMR studies. Interestingly, the pteridin ring of MTX is inverted (180º) in the active 
with respect the natural substrate H2F [67, 68]. This flipped orientation is believed to 
alter the H-bond network favoring a direct interaction between two conserved 
backbone carbonyl oxygen from the highly conserved residu Asp 27 and the 4-amino 
group from MTX (figure 11) [69]. In addition, on going from the free to the bound 
state, the pKa of MTX (complexed with L. casei DHFR) marked an increased, from 
5.3 to 10.5 [70]. It further favors the H-bond formation between the conserved active 
site carboxylate group which is negatively charged and the protonated N1 from MTX. 
This specific architecture contributes actively to the stabilization of the MTX 
heterocycle in the enzyme active site [51]. The total energy of binding of MTX to 
DHFR involves also a significant contribution from hydrophobic interactions [71]. 
The pteridine and benzoyl rings of MTX interact with lipophilic amino acids present 
in the active site of the enzyme. For instance, the key residues ensuring such 
interactions are known in L. casei DHFR: Leu 27, Phe 30, Phe 49 and Leu 54 and 
contribute to a stabilizing energy not lower than 10.5 kJ mol-1[64]. 
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Figure 11. The arrangement of the pteridin ring of MTX (grey) and H2F (light blue) 
with respect of the carboxy group of the aspartic residu 27 (Asp 27). Selected atoms 
are numbered. The atomic coordinate were taken from the structures of the 
complexes E. coli DHFR-MTX NADPH (PDB code 1RX3) and E. coli DHFR H2F 
NADP+ (1RX2) and were superimposed by the protein backbone. The figure was 
made using PyMOL [54] . 
 
 
 
Figure 10. Structure of Dihydrofolate (1) and Methotrexate (2). 
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However, even if it is now clear that these structural factors contribute to the 
extremely high affinity of MTX for the DHFR, it does fully describe the unique 
properties of the inhibitor toward DHFR. Interestingly, the dynamic characteristics of 
the interaction between MTX and E. coli DHFR were studied by stopped-flow 
kinetics and single molecule fluorescence [72]. The binding of MTX is a complex 
process involving multiple enzyme conformations. In particular, a conformational 
change was attributed to the opening and closing of the Met20 loop and later 
confirmed by X-ray and neutron crystallography studies [51, 67, 73]. This 
conformational diversity may underlie the great potency of MTX toward DHFR 
catalysis. One other striking property is the cooperative binding of NADPH when 
MTX is bound to the enzyme [74, 75]. The affinity constant in the binary complex 
NADPH-DHFR is lowered by 100 times when the inhibitor is bound. This 
observation supports interestingly the idea that MTX can favor particular 
conformational state of the enzyme and therefore lowered free energies. Thus, the 
DHFR-MTX complex would represent a favorable energy state of the enzyme 
whereas the transition state marked by the association of NADPH-H2F-DHFR would 
represent the maximal height in the energy profile of the reaction [63, 75]. This 
discrepancy in the binding constant between the two complexes, DHFR MTX 
NADPH and DHFR H2F NADPH might provide the evidence for a synergistic 
arrangement of MTX with enzyme structure, function and dynamics.  
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1.4. How to study fast protein dynamics: Theory of neutron 
scattering 
1.4.1. Basic properties of the neutron 
A number of experimental and theoretical techniques can be used to assess 
protein dynamics. However, the key parameter to choose a particular method is 
invariably dependent of the space and time window of interest. Using a schematic 
energy diagram (figure 12), it is clear that the scope of protein dynamics can not be 
measured by a single method.  
 
Figure 12. Comparison of neutrons with other biophysical methods: time and space 
ranges accessible to different techniques. The different types of neutron 
spectrophotometers are denoted by chopper, backscattering, multi chopper, spin echo. 
Adapted from www.neutron-eu.net. 
 
 
 
 
 
 
Fast proteins dynamics and its correlation to activity and stability 
 
 
 From MD to NMR or fluorescence, several orders of magnitude are covered 
and sometimes overlap. However in most cases, the different methods used to probe 
protein dynamics gives complementary information based on the radiation-sample 
interactions. To a certain extent the method of choice depends of the advantages and 
disadvantages which can be obtained. Our goal on the present work was to focus on 
fast protein dynamics which occurs on the ps-ns timescale with a space window in the 
Ångstrom range. Early experiment in this field used Mossbauer spectroscopy [76] but 
as illustrated, NMR, and neutron scattering, can also provide significant insights in 
these regions. 
1.4.2. A powerful tool for structural biology: neutron 
scattering 
 Neutron spectroscopy was developed after the Second World War, in the late 
fifties, through essentially E. Fermi. and later on by C.G Shull and Brockhouse who 
obtained the Nobel prize in 1994 for their pioneering work. However, the 
establishment of neutron spectroscopy in biology is surprisingly recent, the first 
experiences on DNA fibres were performed by Dahlborg and Rupprecht in 1971 and 
further on membrane proteins in 1972 [77]. Nowadays, neutron spectroscopy has 
gained in popularity with the development of innovative instruments dedicated to 
biological sciences [78]. Techniques such as small angle neutron scattering have 
reinforced the strength of neutrons in biology [79, 80]. The opening of new research 
centres with more powerful sources has also contributed to the rapid development of 
neutron methods in sciences.  
 The unique features of neutron spectroscopy reside in physical properties of 
these subatomic particles. Neutrons were first discovered in 1932 by J Chadwick in 
the nucleus of atoms. Neutrons are either produced in nuclear reactor through the 
fission of uranium-235 or in spallation sources when an accelerated proton beam hits 
a heavy metal target. After moderation, the neutron beam obtained has an energy 
between 0.2 and 500 meV (1 meV=1,602.10-22 J) with wavelength ranging from 2 nm 
to 0.04 nm. The most striking properties of neutrons are their relatively high mass: 
1,675.10-27 kg (i.e. 1836 times the mass of an electron), the absence of electric 
charge, and their spin: 1/2 [81].  
Fast proteins dynamics and its correlation to activity and stability 
 
 
 
The energy of a neutron is related to its speed by the following equation: 
 
                                                
2
2
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mvE =                                                                             Equation 1 
 
 As all subatomic particles, neutrons obey to the laws of quantum mechanics, 
which means they behave like waves as well as particles, therefore we can 
alternatively use a planar wave of wave vector   
r 
k  with a wavelength λ to describe 
neutrons. The module of the wave vector is equal to  
                                                 λpi2=k
r
                                                                            Equation 2 
 
Their energy can be therefore described with the following relations 
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With h  being the Planck constant  
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A neutron of energy of 25 meV, at a temperature of 293 K, has an associated 
wavelength: λ of ~ 1.8 Å with a velocity of ~ 2.2 km/sec. These values clearly 
illustrate the strength of neutron in biology, their wavelength (about tenth of 
nanometers) is comparable to interatomic distances found in proteins and their 
associated energy (meV) are very similar to the forces that maintain biological 
structure such as hydrogen bonding, electrostatic interaction, van der Waals or ones 
arising from the hydrophobic effect [82]. These forces are therefore weak and are in 
the range of a few meV. Neutron spectroscopy therefore matches uniquely the 
amplitude and energies associated with atomic motions found in biological materials. 
Other important advantage of the neutron method is that it can characterize the 
dynamics of any type of biological sample, which not need not to be crystalline [83]. 
Small Angle Neutron Scattering takes advantage of this property and allows the 
exploration of ‘soft’ matter structures with length between 0.5 and 500 nm [79, 84]. 
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As C.G Shull and Brockhouse summed up elegantly in their Nobel citation, neutrons 
enable us to know ’where atoms are and what atoms do’. 
 
 
1.4.3. Interaction between neutrons and matter 
Neutrons interact with atoms of an element in a manner that does not seem 
correlated with the atomic number of the element (table 3). It varies from one isotope 
to another. Unlike X-rays, neutrons interact with the nucleus of atoms with an order 
of 10-15 m. The nucleus can therefore be considered a point-like scatterer, since the 
neutron wavelength is five orders of magnitude larger, implying that the waves 
scattered are isotropic [81]. The scattering of neutron by a single nucleus is described 
in terms of a cross section σ measured in barns (1 barn=10-28 square meter). It is 
equivalent to the effective area presented by the nucleus to the passing neutron. The 
strength of the interaction is denoted by the scattering length: b and related to the 
cross section σ = 4πb2 [85].  
 
Atomic 
number 
Z 
 
Element 
 
Scattering length (10-14 m) 
Scattering 
length 
X-ray* 
(10-14 m) 
 
 Coherent 
Diffusion 
bcoh 
Incoherent 
Diffusion 
binc 
 
1 H D 
-0.374 
0.667 
2.530 
0.404 0.282 
6 C C13 
-0.665 
0.619 
0.005 
-0.05 1.69 
7 N 0.937 0.198 7.05 
8 O 0.581 0.004 7.33 
Table 3. Neutron scattering lengths for studying organic molecules [86]. bcoh is the 
coherent scattering length and binc is the incoherent scattering length. 
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This isotopic difference is of particular interest for instance for hydrogen and 
deuterium which both interact weakly with X-rays but have neutron scattering 
lengths, binc and bcoh that are relatively large and quite different. P. Schoenborn 
exquisitely highlighted the strength of the neutron techniques in biology, ‘The 
strength of neutron scattering remains principally in the manipulation of scattering 
density through hydrogen and deuterium’ [87]. The difference between the scattering 
lengths of hydrogen and deuterium is the basis of an isotopic-labelling technique, 
called contrast matching.  
1.4.4. Scattering law 
 As displayed pictorially in the so-called scattering triangle (figure 13), a 
neutron scattering experiment consists to measure the exchange of momentum (Q) 
and energy ( ωh ) between the neutron and the sample. The scattering can be either 
elastic when there is no change in the energy ( ωh =0) of the incident neutron or 
inelastic when the magnitude of the neutron wave vector k1 change ( ωh ≠0). 
 
 
Figure 13. Schematic representation of a scattering event (scattering triangle). 
 
 
 
 
 
 
Q 
E’ 
E 
 
k2 
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θ 
The process can be describe using the following relationships 
2k1kQ −=       Momentum transfer 
'EE −=ωh     Energy transfer 
 
Fast proteins dynamics and its correlation to activity and stability 
 
 
The incoming neutron wave is characterized by a wavevector k1 and energy E.  
During the scattering event between, some neutrons are scattered in a certain solid 
angle dΩ
 , in the direction of the wavevector k2 with a final energy E’ along the 
diffusion angle θ. This quantity is called the double differential cross section  
 
     
ω
σ
dd
d
Ω
2
                           Equation 5 
 
It can be shown that for a system of N identical atoms of equal scattering length b:  
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Where S(Q,ω) is called the neutron scattering function. 
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The Fourier transform of S(Q, ω) equation introduce the intermediate time dependent 
function S (Q, t). 
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The intermediate scattering function S(Q, t) can be written in terms of time-
dependent correlations between the position of pairs of atoms and the autocorrelation 
of the same atom in the sample [81]. 
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                                 Equation 9 
 
The intermediate scattering function denotes the position of the atom i at time t, ri(t), 
in a system of N atoms with i=1,….,N. 
The brackets reflect the average of all enclosed states. 
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1.4.5. Instruments 
As implied by figure 12, neutron spectroscopy used a number of instruments 
and strategies to explore matter. 
Spin echo is primarily used to study slow relaxation phenomena in polymers, 
glasses or magnetic materials [81]. It exploits one neutron’s intrinsic angular 
momentum or spin to access slow relaxation processes (~101ns). This kind of 
spectrometer allows studies of dynamic processes in macromolecular systems that are 
relevant to, polymer [88] and biological sciences [89]. Neutron diffractometers and 
small angle neutron scattering instruments essentially count neutrons as a function of 
the scattering angle, and display few particularities compared to X-ray diffraction 
[87]. D11 and D22 at the ILL, Grenoble, are neutron diffractometers where small 
angle measurements are performed. They are often used to resolve the structure of 
large scale molecules (10 to 1000 nm) such as macromolecular complexes or 
polymers [90]. 
Some instruments such as neutron spectrophotometers measure not only the 
scattering angle but also the neutron’s energy. Neutron detectors are devices that can 
‘count’ neutrons but not resolve their energies. The incident and scattered energies 
must be known, so the beam must first be ‘prepared’ for the measurement by 
selecting a particular wavelength or energy. After, the energy of the scattered neutron 
is measured. Different methods exist to determine neutron energies, the main being: 
the time of flight and the backscattering (diffraction off crystals).  
The time of flight technique uses choppers (rotating disks with slits) to select 
neutrons depending on their velocities. A first chopper with a slit will sends a pulse of 
neutrons at different speeds. A second chopper turning at a certain speed will only let 
through neutrons of a certain wavelength. Knowing the time of flight of the neutrons 
and the distance between the sample and the detectors, it is possible to calculate the 
neutron outgoing energy. Examples of these types of spectrometers are IN5 and IN6 
at the ILL, Grenoble. On the other hand, crystals can be used to select a particular 
wavelength and therefore neutron’s energy. The so-called backscattering 
spectrometers use this method. Indeed, it is based on the Bragg’s law, which is 
extremely wavelength selective when the scattering angle is equal to 180°. To select a 
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specific wavelength the monochromating crystal is simply heated. IN13, IN10 and 
IN16 at the ILL, Grenoble used this strategy. Since IN13 has been used in the present 
study, a detailed description will be given but more information can be easily 
obtained at (http://www.ill.fr/YellowBookCDrom). 
1.4.6. Dynamic studies using neutron scattering  
Equation 9 is fundamental in neutron spectroscopy. Neutrons are somehow 
‘schizophrenic’ particles, behaving either as a coherent and incoherent wavelike 
function. The first term found in the intermediate scattering function S (Q, t) is the 
intermediate coherent scattering function, which describes the relative position of all 
the atoms present in the system. This type of scattering depends on the relative 
distances between the constituent atoms and thus gives information about the 
structure of the materials. In the next part of the equation, a second type of scattering: 
incoherent scattering is depicted. The neutron wave interacts independently with each 
nucleus in the sample so that the scattered waves from different nuclei do not 
interfere. This scattering gives information about the interaction of a neutron wave 
with the same atom but at different positions and different times, thus providing 
information about atom diffusive motions involved in dynamic studies [87]. 
Macromolecular dynamics are essentially followed by incoherent neutron 
scattering (INS). The scattering intensity can be described with the relation: 
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                                 Equation 10 
 
This relation denotes the motions of the same atom over time. Since, Sinc(Q, ω) is 
proportional to the square of binc, the incoherent signal is highly dominated by the 
scattering of hydrogen atoms reflect the dynamics. Protons are therefore an exquisite 
probe to investigate dynamic motions of the groups to which they are attached. This 
is of particular interest for biological materials such as protein which contains 
predominantly hydrogen atoms uniformly distributed in the structure. In the 
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frequency range examined, pico to nano-second, protein dynamics can be therefore 
studied with incoherent neutron scattering. A schematic picture of the theoretical 
spectrum obtained from INS is given in figure 14. It depicts the three main 
components: elastic, quasi-elastic and inelastic scattering. These correspond to the 
energy resolved when neutrons interact with atoms. Different cases are possible. A 
peak centred at zero energy transfer over all Q values signs an elastic scattering. The 
momentum may change but its energy is conserved ( ωh =0). For an ideal 
spectrophotometer, the elastic peak is a Dirac function, however in practise, the form 
and the width of this peak represents the instrument resolution. At higher 
temperatures, atoms begin to move, the elastic peak begins to diminish in height as a 
function of the wavevector Q. Two other types of scattering are now observed when 
( ωh ≠0): quasi-elastic and inelastic centered on ωh =0 and ωh ≠0 respectively. 
Quasi-elastic broadening is rich in information. It reflects how diffusive processes 
such as translations or rotations occur in the sample. On the other hand, inelastic 
scattering arises from energy transitions from the high frequency vibration of 
individual atoms. 
 
 
 
 
 
Figure 14. Scattering dependency over temperature with T>T1>T2. Adapted from 
[91]. 
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Hence, the variation of the intensity of the elastic peak as a function of temperature 
reflects various motions modes within the sample. However, what can be gleaned 
from these three types of scattering?  
Different models are used to interpret and rationalise the spectra. However, it 
is worth noting, that the weight given to these scattering modes depends primarily on 
the energy resolution of the instrument. The energy and Q-values accessible to a 
spectrophotometer correspond in a reciprocal fashion to a window in space and time. 
For instance, a backscattering and a time-of flight spectrophotometer have very 
different time and space dependencies. Typically, vibrational modes are analysed 
within an energy range from 20 to 125 meV whereas rotational and translational 
motions occurs at lower energy levels from 10-2 meV to 30 meV. The selection of the 
time and space window and therefore the instrument is crucial to follow in a 
satisfactory manner a specific type of motions. In addition, there are number of 
models to describe and interpret macromolecular dynamics [85, 92]. Since, it was not 
the aim of this work to focus on this issue, only one particular model is described in 
chapter two. 
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1.5. Aim and objectives 
 
The aim of this research is to increase the understanding of the role of fast 
protein dynamics in enzyme activity and stability, and specifically to test the 
hypothesis that enzyme activity and stability are inversely related by their internal 
dynamics. 
 
Activity ∝ Dynamics (flexibility) ∝ 1/Stability 
 
The specific objectives if we redefine more narrowly the interrelationship 
between enzyme activity stability and dynamics are to improve our fundamental 
understanding of protein dynamics to protein function. The idea that enzymes might 
have evolved not just structurally but also dynamically to optimize their function in 
intriguing but not proven [93]. We seek an improvement in this fundamental issue. 
To address this problem, we have embarked a multidisciplinary project using 
the technique of neutron scattering as the main probe to depict fast protein dynamics 
on the ps-ns time scales. Our strategy was to perturb simultaneously activity, stability 
and dynamics and to cross-correlate these findings. We have performed this work 
using a particular enzyme, the Dihydrofolate Reductase (DHFR) from a moderate 
thermophilic organism, bacillus stearothermophilus (Bs DHFR). We have also taken 
advantage of the pharmacological relevance of DHFR in cancer therapy for the 
extensive structural information and the number of specific inhibitors available. The 
anti-cancer drug methotrexate was of particular interest since it could impact not only 
on activity, but potentially also on stability, structure and protein dynamics. We have 
therefore used MTX as an informative probe in this network of pairs of properties and 
examined dynamics/stability/structure relationships. The thermodynamic analysis 
combines both, circular dichroism and isothermal calorimetry in order to assess the 
effect of MTX on DHFR thermal stability and its binding ‘signature’ respectively. 
Classical kinetic measurements were performed to examine the potency of the 
inhibitor on DHFR catalysis. The cross correlation of the various results is therefore 
expected to provide the framework for shedding the light on our current paradigm. 
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2. Effect of Methotrexate on DHFR fast protein 
dynamics: a neutron scattering study 
2.1. Introduction 
The dependence of the catalytic action of DHFR on dynamics has already been 
demonstrated using a combination of techniques such as NMR and steady state 
kinetics [37, 45]. Motions concomitant with the rate of catalysis have been often 
highlighted as the driving force, but little is known of the role of faster motions 
occurring on the ps-ns timescales. In this context, it is important to distinguish which 
motions are required for enzyme function and conceptually for protein function. 
The aim of my work is to further the understanding of the role of fast protein 
dynamics in the activity and stability of this specific system. A key element in protein 
function is molecular flexibility without which enzymes for example cannot function 
or fold correctly [93]. A key point in enzymology is the binding of specific ligands 
which can selectively (or not) modify the dynamical behavior of such biocatalysts [5]. 
We have taken advantage of the tight binding inhibitor: methotrexate to examine the 
interrelationship between dynamics/activity and stability. In our dynamical map, 
MTX is an informative ligand in this network of properties since it can impact not 
only on activity and stability but potentially on all these parameters. 
As presented in the introduction, neutron scattering is particularly well-suited to 
study protein dynamics on the pico and nano-seconds time-scale. We have therefore 
examined the effect of the anti-cancer drug MTX on the dynamical behavior of the 
enzyme DHFR and correlated these findings with activity and stability measurements 
under the same conditions. 
 
2.2. Technique overview: Neutron scattering 
As mentioned in the introduction, there are a few ways to characterize the 
dynamical properties of biological materials using the technique of neutron scattering. 
A relatively fast and simple way is to measure the elastic intensity as a function of 
temperature. During the experiment the energy of the scattered neutron is only 
recorded at the elastic peak. If the atomic displacements within the sample are 
confined within the space-time window of the spectrophotometer, their displacements 
can be described by the Gaussian approximation. In this case the measured elastic 
intensity (at zero energy transfer) is related to the mean square displacement as shown 
in equation 10 (a full development is given in Gabel et al [94]). 
. 
A simple way to describe the incoherent scattering function Sinc is possible.  
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where <u 2> is the mean square displacement 
The expression is valid for small Q values, where <u 2>Q2 is smaller than 2. 
The mean square displacement is therefore calculated from the slope of the natural 
logarithm of the elastic intensity as a function of Q2. 
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It is to be noted that different authors use either a factor 1/6 or 1/3 in the previous 
expression. If a motion is a fluctuation around equilibrium position, the <u 2> values 
is given by three times the slope. On the other hand, the factor 6 derives to an extent 
from molecular dynamics calculations which are though to better approximate this 
factor. The physical reason also derives from the fact that the displacement is not 
necessarily around an equilibrium position. 
 It is possible to extract, from the way the logarithm of the elastic intensity 
decreases as a function of Q2, a root mean square displacement (RMSD). The RMSD 
corresponds to the mean fluctuation of an atom around its equilibrium position in the 
space and time window defined by the instrument resolution. The RMSD describes 
the overall flexibility of the system, it is often noted as <u2> and given in Å2. An 
independent parameter, postulated by Zaccai et al [95], is also commonly used: the 
mean resilience <k>. This force constant introduces in a more quantative way the 
‘stiffness’ of biological molecules. This parameter is proportional to the inverse of the 
slope of the mean square displacement as a function of temperature. The mean 
resilience is given in N.m-1. The higher the slope, the smaller the force constant and 
the softer the environment can be considered to be, and inversely. An interesting way 
to describe the flexibility, resilience and energy potential landscape was first 
proposed by Doster et al [92]. In this model, the RMSD can be assumed as the 
conformational space that can be explored by the atoms in single energy well and the 
resilience as the energy barrier between the various conformational substates. In the 
present work, the model of force constants was used to describe macromolecular 
dynamics. 
2.3. The backscattering spectrometer: IN13 
The backscattering spectrometer IN13 at the ILL was used during this work 
(figure 15). The principle of backscattering is an inverse spectroscopy where the 
energy of the scattered neutrons remains fixed and only the incident particle energy is 
varied. The energy of the incident neutrons is defined by the backscattering 
conditions by the Bragg relation: 
θλ sin2d=             Equation 13 
 
The energy resolution, which is one of the fundamental instrument characteristics, is 
given by the differentiation of the Bragg equation: 
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The backscattering condition on IN13 permits a very good energy resolution [96] as 
can be seen by the latter equation and takes its value when θ = 0. The energy 
resolution depends on the quality of the crystal and takes crystal imperfections and 
impurities into account (∆d/d~5*10-5). The factor θ is the angular divergence of the 
beam and depends on the wavelength and the monochromator crystal. The last factor, 
cot θ, shows the advantage of the backscattering instrument. The best energy 
resolution is achieved when the neutron are backscattered from the monchromator 
when θ is close to π/2. 
 
 
Figure 15. Thermal neutron backscattering spectrometer IN13 layout 
 
When neutrons have left the monochromator they are reflected on a deflector. Then, 
they pass through a chopper and a monitor before reaching the sample. Scattered 
neutrons are first analyzed by another set of crystals, which reflect only neutrons 
fulfilling the Bragg condition into the 3He detectors ( situated on the opposite side of 
the sample). The basic principle of a neutron detector is to convert the neutral neutron 
to a charged particle. There are a number of neutron detectors [97] but the most 
common gas is 3He. The underlying equation is given below: 
3He+n                       3H+1H+0.765 MeV          Equation 15 
  
The energy released by the reaction between 3He gas and the neutron (n) produces a 
current. This current, which is proportional to the number of neutron hitting the 
detector, gets record by the electronics. The incident wavelength is varied via heating 
and cooling of the monochromator. Indeed, the lattice of the monchromator changes 
upon heating and cooling, which results in neutron of different wavelength being 
reflected. The role of the choppers is to phase the electronic circuit of the 3He 
detectors in a way that only backscattered neutrons are counted and neutrons directly 
scattered into the detector are ignored. The monitor counts a fraction of the incident 
beam and is used for normalisation of the different measurements. 
2.4. Material and methods 
2.4.1. Chemicals 
Deuterium oxide (D2O, 99.9 % and 98 %) was purchased from Minipul, 
Norell Inc. (Landisville, NJ., USA). Methotrexate (MTX) was purchased from 
Sigma-Aldrich Inc (St.Louis, MO., USA). Reagents and medium components for the 
purification and the analysis of Bs DHFR were purchased from Sigma-Aldrich Inc 
(St.Louis, MO., USA) and Merck KgaA (Darmstadt, Germany). 
2.4.2. Over expression and purification of recombinant 
Bacillus stearothermophilus DHFR 
 Bacillus stearothermophilus DHFR clone was a kind gift of Judith Klinman, 
(University of California at Berkeley, US). The recombinant protein was purified 
from transformant E. coli cells (BL21/DE3) bearing the plasmid pET-21a-(+) 
encoding for the DHFR gene. The E. coli clone was grown at 37 °C in Luria broth 
media, containing 100 µg/ml ampicillin for the initial inoculum. The cells were 
grown in a bulk growth media pH 7 containing 100 µg/ml ampicillin as a batch-fed 
culture in a 8.5 litres fermenter. Expression of Bs DHFR was induced by addition of 
IPTG at a final concentration of 1 mM at the end of the first logarithmic growth 
phase. The cells were then harvested generally after 11-15 hours of growth and 
concentrated by hollow fiber filtration. The cells were collected by centrifugation at 
8500 rpm for 30 min, washed in 0.9 % NaCl, recentrifuged, and then resuspended in 
40 mM Hepes pH 6.8 before being lysed by sonication (5 cycles of 5 minutes each). 
The cell debris were removed by centrifugation at 8500 rpm for 30 min and the 
resulting supernatant was heat treated at 55 °C for 20 min and centrifuged at 10000 
rpm for 20 min. The protein solution was then loaded on a SP-Sepharose XK 50 
cation exchange column (Amersham Biosciences) pre-equilibrated in 40mM Hepes at 
pH 6.8 and then eluted with a linear gradient of 0-500 mM NaCl. Fraction showing 
DHFR activity were pooled and then concentrated by ultrafiltration using an Amicon 
concentrator (YM-10 membrane). The concentrated fractions were then dialyzed 
extensively (molecular cut off: 6000-8000), freeze-dried and stored at 4 °C until use. 
The purity was assessed by SDS-PAGE (Sodium-Dodecyl Sulfate Polyacrylamide 
Gel Electrophoresis) and size exclusion HPLC (High Performance Liquid 
Chromatography) analysis. 
2.4.3. SDS-PAGE gel 
SDS-PAGE gels were prepared according to Laemmli [98]. The gels were 
constituted of a 15 % polyacrylamide separating gel layered with a 5 % stacking gel. 
Gel preparation was performed with a concentrated 30 % (w/v) acrylamide solution 
containing 3 % methylene bis-acrylamide (ProtoGel™, National Diagnostics). All 
solutions are stored at 4 ○C. The electrophoresis was performed in a Mini-Protean III 
dual slab cell (Bio-Rad Laboratories, Watford, UK). The separating gel was first 
gently poured in the casting module. Isopropanol was added on the top to avoid the 
formation of air bubbles. After complete polymerization (20 to 30 min), isopropanol 
was removed and the stacking gel was layered on the top of the separating gel. After 
polymerization of the stacking gel, the wells were washed with the cathodic buffer. 
Samples were prepared by dissolving 10 µl of sample with 10 µl of double 
concentrated sample loading buffer (125 mM Tris-HCl, pH 6.8, 4 % SDS, 10 % β-
mercaptoethanol, 0.4 % bromophenol blue and 20 % glycerol). The mixture was 
heated for 2 min at 95 ○C and centrifuge 1 min at 13200 rpm. The samples and 
molecular weight standard (Roche) are then applied to the gel (typically 10 µl per 
well) with a Hamilton micrometer syringe. Electrophoresis was performed at room 
temperature using a voltage stepped procedure: the voltage was kept constant at 80 
volts until the samples have reached the separating gel. The voltage was then, raised 
to 120 volts for approximately 20 min until the tracking dye reached the bottom of 
the gel. Immediately after ending electrophoresis, the proteins embedded in the gel 
were stained by Coomassie brilliant blue R-250 (Roche) for 30 min at room 
temperature under gentle shaking. Destaining was applied for 10 min at room 
temperature and stopped with water when the bands were well defined. Finally, the 
gels were photographed and conserved if necessary in a solution of 10 % glycerol, 5 
% acetic acid in 100 mM Tris-HCl pH 8.8 and dried under vacuum between sheets of 
transparent foil.  
 
Separating gels (15  %) :  
43% (v/v) Protogel™ 
    358 mM Tris-HCL, pH 8.8 
    0.1 % (w/v) SDS 
    0.1 % (w/v) TEMED 
    0.1 % (w/v) APS 
 
Stacking gel (5 %):   
18.2 % (v/v) Protogel™ 
    220 mM Tris-HCL, pH 6.8 
    1.8 % (w/v) SDS 
    0.1 % (w/v) TEMED 
    0.1 % (w/v) APS 
 
Running buffer:   
25 mM  Tris base 
    250 mM  Glycine 
    0.2 % (w/v) SDS 
    pH adjusted to 8.3 
 
Staining solution (Coomassie):   
0.1 % (w/v) Coomassie Brilliant Blue R-250 
450 ml (v/v) Methanol 
100 ml (v/v) Acetic acid 
Adjusted to 1 l with distilled water 
 
Destaining solution:    
450 ml  Methanol 
    150 ml Acetic acid 
Adjusted to 1 l with distilled water 
 
 
2.4.4. Neutron scattering sample preparation 
 To minimize the contribution of hydrogen scattering, the labile hydrogen 
atoms from the protein and/or the ligand have to be exchanged with deuterium oxide 
(D2O). For the ligand MTX, a single deuterium exchange of 4 hours at 6-7 °C was 
carried out before freeze-drying. As MTX is highly insoluble in acidic condition, the 
‘pH’ of the solution was adjusted to pD = 7.5, using the relationship pD= pHmeter+0.4 
unit with ammonium bicarbonate 100 mM. 
 The purified protein was dissolved in D2O (10 mg/ml), gently stirred 12 hours 
at 4 °C and then freeze-dried. The operation was repeated two more times with higher 
grade D2O (purity 99.9 %), freeze-dried, and then stored at 4 °C until use. Activity 
was checked and less than 10 % of the original activity was lost during the process. 
The DHFR-MTX complex was prepared in a similar manner. Since MTX is a tight 
(Kd value is approximately 10-9 M) and specific inhibitor of DHFR with a binding 
stoichiometry of 1:1, we saturated the enzyme preparation with a 2/1 mole ratio 
(MTX to respect to DHFR) during the final deuterium exchange. After lyophilisation, 
both enzyme preparations (100 mg) were dried over phosphorus pentoxide. To reach 
a higher hydration level, the proteins were equilibrated in a desiccator over a 
saturated solution of NaBr (which gives a relative humidity of 50 % at 20 °C). After 
exposure at this relative humidity (for two days), the D2O content was shown to be 20     
%, (i.e. 25 mg of D2O per 100 mg of dry weight protein). At this hydration level the 
sample holder was quickly sealed and stored at 4 °C until use. The NaBr salt was 
rotary evaporated before use to near dryness in order to remove as much as possible 
any remaining water molecules and then dissolved in high grade D2O (99.9 %). 
2.4.5. Neutron scattering and Macromolecular Dynamics 
Results described in this work are from experiments performed on the 
backscattering spectrometer IN13 at the Institute Laue Langevin Grenoble, France 
(information on the Institute and the instrument is available on the web at 
(www.ill.fr). The instrument allows the examination of atomic motions in the space 
and time window of about 1 Å in 0.1 ns. In this space-time window and according to 
a Gaussian approximation, the incoherent elastic scattered intensity can be analysed 
as [39]:  
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where Q is 4pisinθ/λ, 2θ is the scattering angle and λ the incident neutron wavelength, 
<u2> values include all contributions to motions in the accessible space and time 
windows, from vibrational fluctuations (usually expressed as a Debye-Waller factor) 
as well as from diffusive motions. The validity of the Gaussian approximation for the 
mean square fluctuation <u2> and its analogy to the Guinier formalism for small 
angle scattering by particles in solution has been discussed by Réat et al. [99] and 
more recently by Gabel et al [100]. In the Guinier formalism a radius of gyration Rg2 
of a particles in solution is calculated [101]. The particle equivalent is the volume 
swept out by a single proton during the time scale of the experiment (∼ 100 ps). The 
analogy holds if the motion is localized well within the space-time window defined 
by the Q and energy transfer ranges, respectively. The Guinier approximation is valid 
if Rg
2
*Q2 ≈ 1
. Following our definition of <u2>, Rg2 = 1/2*<u2>. As a 
consequence, the Gaussian approximation is valid in the domain where 
< u2 > *Q2 ≈ 2
. Data were normalized, at each Q-value, by the lowest 
temperature (20 K) data point (figure 16). The mean square fluctuations <u2> at a 
given temperature T were calculated according to the Gaussian approximation as: 
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The mean square fluctuations were therefore calculated as: 
 
A6u2 −=
                                                                                                                       Equation 18 
 
Elastic incoherent scattering data were collected in a scattering vector range of 0.52 
Å-1 ≤ Q ≤ 1.58 Å-1. The <u2> values were then plotted as a function of absolute 
temperature T (figure. 17). An effective mean force constant <k’>, defining mean 
resilience, can be calculated from the derivative of <u2> plotted versus temperature, T 
[95, 102] (figure. 17): 
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The numerical constants are chosen to express <k’> in Newtons/metre (N/m) when 
<u2> is in Å2 and T in Kelvin. 
 
2.5. Results 
 Our experiments were performed on the IN13 backscattering spectrometer 
which allows the study of protein backbone motions in a typical space-time window 
in the range of ~1 Å in 0.1 ns. The elastic incoherent scattering intensities obtained on 
IN13 for a range of temperature are shown in figure 16. The fitted straight lines were 
used to plot <u2> versus temperature for the free and MTX complexed enzyme 
(figure 17). The mean square displacement <u2> attributed to both enzymes increases 
with temperature with a constant slope between 50 and 250 K with a sharp change 
above 220 K. This deviation has been previously identified as the dynamical 
transition. It is generally attributed to the onset of thermally excited inharmonic 
motions [103], but maybe due to the speeding of such motions until they are 
observable within the instrumental timescale, rather than their onset [96]. In the 
harmonic region T=50-230 K, the temperature dependence of <u2> measured from 
the uncomplexed state behaves differently in comparison to the complexed state. The 
presence of MTX seems to systemically lower the mean square displacement 
amplitude by 15 % with a maximum up to 50 % around the dynamical transition. It is 
clear, that MTX significantly alters the structural flexibility of the protein by 
confining the atoms in a narrow energy well. Additionally, the mean environmental 
force <k’>, calculated from the slope of the straight-line part of the scan indicates a 
two fold increase <k’>= 3.3 N/m and <k’>= 1.4 N/m in presence of MTX for the 
complexed and uncomplexed enzyme respectively (inset, figure 17). However, above 
the dynamical transition, in contrast with the flexibility, which holds a significant 
difference over the anharmonic regime i.e lower values in the presence of MTX, we 
did not observe any significant effect of MTX on the resilience of the system. It 
remains essentially unchanged from 250 K to 320 K for both samples.  
This is at first glance surprising, however because neutron scattering 
experiment depends of the time and space resolution given by the instrument, other 
energy conformations of the ensemble might be hindered. Indeed, there might be 
additional contribution from exited states not accessible to the technique. In addition 
results must be interpreted with the greatest care because the conformational 
landscape of macromolecules is, to some extent temperature dependent. For example, 
‘cryo structures’ (below the dynamical transition) may correspond predominantly to a 
structural state weakly populated at room temperature [104]. 
        
  
Figure 16. Variation of ln [ I (Q, 0±∆ω) ] as a function of Q2 for the un-complexed 
DHFR (A) and complexed DHFR with methotrexate (B) at 100 K (×), 230 K (), 
270 K () and 320 K (G), from which mean mean square fluctuations <u 2> were 
calculated.  
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Mean square fluctuation < u 2 > were plotted against absolute temperature 
for the un-complexed DHFR () and complexed DHFR with methotrexate (). In 
the inset mean macromolecular force constant values < k’ > measured for the MTX 
complexed DHFR (blank) and the un-complexed DHFR (hatched) are plotted versus 
below (A) and above (B) the dynamical temperature transition (230 K). 
 2.6. Discussion 
 In conclusion, the data obtained by elastic neutron scattering in the harmonic 
region shows that the free DHFR presents a larger <u2> and lower <k> compared to 
the MTX-DHFR complex. Using the theory of energy landscape and assuming that 
the protein can execute harmonic motions along each local minimum from the energy 
landscape, the binding of MTX must be accompanied by the reduction of the 
conformational freedom. As elegantly suggested by Zaccai et al <u2> and <k> can be 
easily represented with an energy well [105]. Following this graphical interpretation 
of macromolecular dynamics, the energy barrier between the various conformational 
substates must be increased and the relative flexibility which is reflected by the width 
of the energy well must be somehow decreased. It clearly shows that the relative 
plasticity of the energy landscape is modulated by the precise binding event of MTX. 
An alternative way to present these results is to suggest that the various 
conformational substates ‘melt’ to favor particular conformations (figure 18). The 
number of CS is reduced and the shape of the energy well is remodeled. Possibly, the 
well might harbor a funnel shape i.e. deeper with a restricted space in presence of 
MTX.  
                
Figure 18. Schematic representation of the possible rearrangement of the free energy 
landscape of DHFR upon MTX binding. 
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 Interestingly, it is therefore possible to observe such dynamical ‘groups’ and their 
properties with neutron scattering. For instance, the pseudo force <k>, i.e. protein 
resilience is often associated with structural rigidity and is one of the observed 
properties of the new conformational substates. It has been observed that under 
thermal denaturation MTX acts as a protective agent [106]. A recent study using 
atomic force microscopy has also correlated an increase in the mechanical stability of 
DHFR upon the binding of MTX [107]. It is therefore very tempting to suggest that 
MTX can modify the energy landscape of Bs DHFR by guiding the protein toward a 
particular folded state which is less susceptible to unfolding. 
Relatively few studies have investigated the effect of ligand binding on 
internal protein dynamic using the technique of neutron scattering [102, 108]. Using 
this particular technique, most studies have focused on the effect of hydration and/or 
unspecific molecules such as sugars on internal proteins dynamics [17, 109]. The first 
lines of evidence investigating the effect of a small, specific non-covalently bound 
molecule were brought by Balog et al (2006) [110]. Performing an inelastic approach 
on the Time of Flight (TOF) spectrophotometer IN6, they have associated a softening 
effect, entropically driven upon the binding of MTX/NADPH on the E. coli DHFR 
internal dynamics. These findings are therefore in opposition with our results which 
tend to demonstrate a stiffening effect on both the flexibility and resilience. There are 
a few possible reasons for this discrepancy. The instrument resolution is of particular 
importance. We recall that TOF instrument such as the IN6 spectrophotometer detects 
motions over a wide energy shell (i.e. 10 ps-100 ps) but with a limited space window 
which is appropriated for pure vibrational analysis (i.e. backbone motions). On the 
other hand, backscattering spectrophotometers such as IN13 monitor motions on the 
pico-second time scale (100 ps) over a relatively wide space window which matches 
perfectly side chains motions [96]. From X-ray structures and particularly during the 
refinement process, it well known that amino acid side chains present a larger number 
of accessible conformations or rotamers. On the other hand, structural constraints do 
not allow this plasticity for backbone atoms. In other words, the potential changes 
observed in neutron spectroscopy might be more significant when observing side 
chains than backbone nuclei. It is therefore not surprising that IN13 and IN6 reveal 
very different motional frequencies and modes but the question remains the same; 
which ones are the more relevant to unravel the interrelationship between protein 
dynamics and protein function? 
 A specific asset derived from the observation of side chains is highlighted by 
the technique of site directed mutagenesis. Beyond the simple deletion of key amino 
acids, the single replacement of a side chain can have a deleterious effect on protein 
function. Briefly, backbone nuclei can be depicted as the protein skeleton whereas 
side chains hold the chemical reactivity necessary for protein to function. However, 
even if the correlation between fast protein dynamics and function is not completely 
understood, the observation of side chain nuclei instead of backbone motions might 
in the first place be a better approximation to encompass such inter-correlation. In the 
future, it will be possible to depict the relevance of side chain motions and their 
contribution in internal dynamics with the increasing development of specific 
labeling (personal discussion with Dr. M. Haertlein, Deuteration laboratory, ILL, 
Grenoble). 
 
 
3. Binding energetics and effect of Methotrexate on      
dihydrofolate reductase activity 
3.1. Introduction 
 Proteins interact with a variety of ligand to perform a myriad of function in the 
cell. Through these interactions, they control a wide range of biological processes 
including protein synthesis, receptor signaling or signal transduction. A crucial part 
of this process is the modulation of protein dynamics upon ligand binding. Numerous 
studies have observed a structural functionality along preferred enzymatic pathway 
but the modulation of protein motions upon ligand binding remained elusive. 
An understanding of how enzymes distinguish between closely related ligands 
on the molecular level might shed the light on this interrelationship. To gain insight 
into the factors that are most important for enzyme-ligand interactions and dynamics, 
the binding of closely related molecules having distinct effect on enzyme activity has 
been examined. This chapter will assess the inhibitory mode mediated by the 
substrate analog MTX and its binding energetic toward DHFR. We will rationalize 
these findings against the parameters obtained with the natural substrate H2F.  
Different techniques can be used to fulfill these goals. Here, Isothermal 
Titration Calorimetry (ITC) was used to compare the thermodynamic signature of 
these two structurally related molecules, and steady state kinetics were used to 
characterize the MTX inhibitory pattern. 
 
3.2. Steady state kinetics 
3.2.1. Technique overview 
3.2.1.1.The Michaelis-Menten equation 
 Enzyme kinetics is a conceptual tool that allows us to interpret quantitatively 
and measure enzyme activity under variant parameters such as substrate 
concentration, temperature, pH, etc. It explains how enzymes work and behave in 
living organisms. In 1913 Leonor Michaelis and Maud Menten suggested that an 
enzyme catalysed reaction can be described by the following scheme 
 
 
where E is the enzyme, S the substrate, ES the complex enzyme substrate, P the 
product and k1,2,3 the rate constants. The overall reaction rate can be described using 
the Michaelis-Menten’s postulate. This postulate makes the assumption that 
enzymatic reaction can be divided into two discrete parts, the binding of the enzyme 
and the substrate (ES formation and breakdown) and the catalytic step concurring in 
product formation. The concept of steady state corresponds to a particular case where 
the concentration of the ES complex is constant. Mathematically, the reaction rate V 
can be measured with the universally known Michaelis-Menten equation: 
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        with Km= (k2+k3)/k1        
 
Note that this equation introduces a number of parameters such as Km and Vmax.  
These kinetic parameters are critical
 
to attempt to rationalized enzyme action. The 
k1 
k2 
k3 
E+S ES E+P 
                            Diagram 1 
new constant Km has the form of a dissociation constant. Indeed, it is an apparent 
equilibrium constant which measures the affinity of the enzyme for the substrate. 
The Vmax is the maximum velocity when the enzyme is saturated by the substrate. The 
meaning of Vmax is also apparent from inspection of the Michaelis-Menten equation. 
At very high [S], the quantity of: 
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And thus, V=Vmax so the reaction rate V is independent of the substrate concentration. 
For a more detailed description and complete derivation of the Michaelis-Menten 
equation see [111]. We should also see that a number of methods are available to 
determine these valuable parameters (direct linear, Lineweaver-Burk as seen in figure 
19, computer least-square fit method, etc). They all transform the Michaelis-Menten 
equation and gives alternative statistical criteria to estimate the goodness value [111]. 
 
 
 
Figure 19. Lineweaver-Burk plot (or double reciprocal plot) of a typical enzyme 
catalysed reaction. The y-intercept of the graph is equivalent to the inverse of Vmax 
and the x-intercept of the graph represents -1/Km.  
 
 
3.2.1.2.Competitive inhibition 
 Inhibitors can interact with an enzyme in different ways. In this respect a 
number of inhibition models have been described and extensively studied using 
enzyme kinetics. Accordingly, inhibitors are often divided into three classes, 
competitive, mixed (non-competitive), or uncompetitive [111]. If a reversible 
inhibitor can bind to the enzyme active site in place of the substrate, it is described as 
a "competitive inhibitor." In pure competitive inhibition, the inhibitor is assumed to 
bind to the free enzyme but not to the enzyme-substrate (ES) complex. The binding is 
described as shown below: 
 
here Ki is the dissociation constant for the enzyme inhibitor complex (EI). EI does not 
react to form E + P, and the enzyme is unable to bind both S and I at the same time. 
In this specific case, the mathematical treatment derived from the Michaelis-Menten 
equation is modified and the Michaelis-Menten equation for competitive inhibition is 
now: 
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where [I] is the concentration of the inhibitor and Ki the inhibition dissociation 
constant. The bracket denotes the concentration of the enclosed molecule. appmK  is 
the apparent Km for the substrate when the inhibitor I is present. As inferred 
previously, there are several graphical methods for detecting and analyzing 
competitive inhibition. For instance the Lineweaver-Burk equation [112] for 
competitive inhibition is: 
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                             Diagram 2 
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This unweighted fit double reciprocal plot is the least appropriate to use for 
determination of kinetic values but it is the most employed method in the peer 
reviewed literature since it is one of the better methods for display, and convenient to 
differentiate graphically the different inhibitory patterns. A secondary plot is 
therefore necessary to obtain Ki, Km and Vmax and their standard deviations (a more 
detailed description is given in the following section). 
3.2.1.3.Slow binding inhibition 
Slow-binding inhibitors are compounds that inhibit their target in a time-
dependent manner. Slow binding inhibition is a phenomenon in which equilibrium 
between enzyme, inhibitor, and the enzyme-inhibitor complex is established slowly 
on a time scale of seconds to minutes. In the literature, three main mechanisms are 
proposed [113], the first one is very similar to the scheme presented in diagram 2. It 
assumes that the formation of the enzyme-inhibitor complex is a single slow step 
relative to the Michaelis complex formation. This mechanism will be referred as 
mechanism A. The second mechanism is more general and includes an extra step. It 
assumes the rapid formation of the EI complex but it suggests a slow and favorable 
isomerization of this EI complex to an EI* complex with an equilibrium constant Ki* 
(diagram 3). This mechanism will be referred as mechanism B. 
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In a third variant, the enzyme itself must slowly isomerize before it can bind to the 
inhibitor. These mechanisms can be distinguished by the careful analysis of the 
reaction progress curves. In the presence of a classical inhibitor, product formation 
remains constant over the reaction unless substrate depletion. With slow binding 
inhibitors, progress curves show clearly two phases, an initial burst of reaction which 
is relatively linear with an initial velocity V0 and a second phase corresponding to a 
steady state with a velocity VS (with often V0〉 VS) [114]. Classically, the initial rate 
(V0) and steady state velocity (Vs) can be estimated graphically from the slope given 
by the tangent at time zero and at steady state. Such time-dependent inhibitions were 
observed between MTX and various sources of DHFR such as E. coli [65], L. casei 
[115], and N. gonorrhoea [48]. We have in this respect approach the operating 
mechanism and work out the parameters relative to the inhibition mediated by MTX. 
3.2.2. Material and methods 
 Bacillus stearothermophilus dihydrofolate reductase activity was measured 
continuously by following the decrease in absorbance at 340 nm using a molar 
extinction coefficient of ε340= 12300 M -1 L cm-1 [116]. The standard assay mixtures 
contains sodium phosphate buffer 100 mM at pH 8, at a fixed concentration of 
NADPH (100 µM) at variant concentration of H2F (3 µM-200 µM). The final enzyme 
concentration was typically ~ 0.3 nM. The reaction was initiated by the addition of 1 
µL of enzyme to the reaction mixture (469 µL), pre-incubated 2 min at a temperature 
of 30 °C. Assays were run for 60 seconds using a thermospectronic helios γ-
spectrophotometer interfaced with the Vision™ 32 software (version 1.25, Unicam 
Ltd.). Reaction progress curves were recorded in triplicate and repeated if the data 
deviated by more than 10 %. The Michaelis-Menten parameters: Km, Vmax, were 
determined by using the Enzpack software version 3.0 (Biosoft, Cambridge, U.K) 
with the appropriate kinetic model. This software uses a least-square fit regression 
analysis to fit the experimental data to the selected kinetic model. 
 
The inhibition constant: Ki for MTX was determined using essentially the same 
protocol as described above with the specified variable H2F concentrations at 
different fixed concentration of the inhibitor: 5, 20, 50 nM. The enzyme was pre-
incubated 2 min at a temperature of 30 °C in the reaction mixture containing, MTX, 
NADPH. The reaction was initiated by the addition of H2F. To avoid substrate 
depletion, we followed the linearity of the progress curves in the absence of the 
inhibitor. Data collection and further analysis were performed using the software 
Vision™ 32 (version 1.25, Unicam Ltd.). Reaction progress curves were recorded in 
triplicate and repeated if the data deviate by more than 10 %. The inhibition constant 
Ki, was determined graphically and computer assisted by using the Enzpack software 
version 3.0 (Biosoft, Cambridge, U.K) with a competitive model using a least-square 
fit regression analysis.  
3.2.3. Results 
 Kinetic profile: Bs DHFR is a ternary complex mechanism enzyme. Previous 
kinetics studies have indicated an ordered kinetic mechanism with NADPH binding 
first to the enzyme [56]. The reaction progress curves (substrate breakdown Vs 
substrate concentration) in absence of the inhibitor were linear. From their slopes 
representing the initial rates V0, the two kinetic parameters Vmax and Km were 
evaluated using one of the linearized form of the Michaelis-Menten equation 
(Lineweaver-Burk) [112]. From the double reciprocal plots, the Vmax value was 0.178 
± 0.022 µmole/min. The Michaelis constant for the natural substrate H2F was found 
to be 7.5 ± 1.4 µM at 30 °C. This value is in good agreement with Kim et al who 
have determined a Km of the same order of magnitude. Km=1.5 and 12.5 µM at 20 °C 
and 60 °C respectively [56]. 
 Inhibitor binding profile: When DHFR activity was continuously assayed 
after the addition of the enzyme to assay mixture containing MTX, NADPH and H2F, 
the resulting progress curves displayed a time dependent decrease in the reaction rate 
before substrate depletion. This suggests the slow establishment of an equilibrium 
between the enzyme, inhibitor and or enzyme-inhibitor complex. We also observed a 
time dependent inhibition when the reaction was initiated by the addition of NADPH. 
These observations clearly outline the slow acting inhibition of MTX and 
consequently, MTX can be classified as a slow binder. The first step of our analysis 
was to find out the appropriate inhibition mechanism for data processing. 
As inferred previously, the possible mechanisms can be discriminated rapidly 
from the inspection of the initial rate and steady state rate. Under our experimental 
conditions, the initial velocities V0 were dependent on MTX concentration; their rates 
were decreasing with increasing concentration of MTX. Moreover, a similar trend 
was observed with the steady state velocity. In consequence, the diagnostic plots were 
in favor of mechanism B. The determination of the equilibrium constant Ki was 
possible using the initial rate of the reaction as given by the relationship: 
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Graphically, the primary plot 1/Velocity versus 1/[H2F] (figure 20) shows the 
common characteristic of a classical competitive inhibition. The Vmax values are 
almost equivalent, 0.166 µM min-1 and 0.178 µM min-1 in the presence and absence 
of MTX respectively whereas the apparent Km increases with inhibitor concentration. 
An apparent Km of 14.3 µM was estimated for [MTX] =10 nM. The secondary plot or 
the so-called Dixon plot [117], as shown in figure 21, gives an estimated Ki value of 
approximately 11 nM which in good agreement with the computer least square 
analysis which yielded Ki of 10.9 ± 1.6 nM. The MTX concentration is therefore very 
close to that of enzyme (0.3 nM) therefore MTX behaves as a tight inhibitor. It also 
interesting to note that the inhibitor concentration is not reduced upon enzyme 
binding ([I]>>[E]).  
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Figure 21. Replot of the slope from the double reciprocal plots from 
figure 20 versus methotrexate concentration. 
 
Figure 20. Double reciprocal plot of the competitive inhibition of the Bs 
DHFR by methotrexate. H2F concentration was varied between 3-200 
µM while MTX was at different fixed concentrations: () 0 nM; (X) 5 
nM; (+) 20 nM; (-) 50 nM. The straight lines are the best fit value. 
 
3.2.4. Discussion 
 As often described in the literature from many DHFRs sources, MTX is a 
slow, tight and competitive inhibitor [118]. Our experimental data are consistent with 
this inhibition pattern with respect to H2F. The inhibition constant which is an 
apparent dissociation constant is three orders of magnitude lower than the natural 
substrate H2F. However MTX is not an exceptionally tight binding inhibitor of Bs 
DHFR. The Ki value is substantially greater than various bacterial and mammalian 
enzymes: Homo sapiens Ki = 6.1 pM [119], Lactobacillus leichmannii Ki = 7 pM 
[120]. However, as inferred by Baccanari et al a number of studies have over or 
under-estimated numerous Ki values [118]. They noticeably neglect the enzyme 
ligand equilibrium time dependency or the partial depletion of the free inhibitor when 
[I]~[E] and [E]>Ki [121]. An illustration of such discrepancy can be found in enzyme 
database Brenda (http://www.brenda-enzymes.info/): The DHFRs Ki values yielded 
from the same organism: Pneumocystis carinii are over three orders of magnitude, 16 
pM and 20 fM. Consequently, it is not possible to compare in the strictest sense the 
overall MTX potency with previous studies if the assay conditions and data treatment 
are not similar [122]. 
Another point of interest came from the inhibitory pattern. The kinetic data 
presented here clearly show that MTX is an effective inhibitor of Bs DHFR but not 
the origin of its power and mechanism. A complete kinetic analysis for the 
calculation of the kinetic constants would certainly help to draw the complete 
mechanism of the slow-binding inhibition of Bs DHFR by MTX. For instance, the 
second equilibrium constant Ki* relative to the isomerizaton of the enzyme may have 
been evaluated. However the experimental acquisition of V0 is not straightforward 
since it is difficult to measure the initial slope of the progress. Indeed to follow such 
events, a rapid experimental technique is sometimes required with dead times in the 
milli-second time range. Moreover, the analysis must exploit the entire progress 
curves as suggested in [122] with multiple non-linear regressions [123, 124]. The 
mathematical treatment and the powerful computer packages they involved (such as 
DynaFit: www.biokin.com) [125] were beyond the scope of the work proposed in this 
chapter. It is maybe frustrating for a kineticist who knows what is hidden in the 
‘black box’ but to rationalize the enormous power of MTX such analysis is needed. 
This issue is particularly relevant in drug design. The differences in binding affinities 
are currently used to target preferentially either mammalian, prokaryotic or parasite 
cells [126]. The design of new anti-folate drugs such as MTX in cancer 
chemotherapy, bacterial or parasitic infections still requires such efforts. 
 
3.3. Isothermal titration calorimetry 
3.3.1. Technique overview 
 
The aim of this chapter is to determine the binding affinity and the 
thermodynamics parameters associated with the interaction between the enzyme Bs 
DHFR and the anti-cancer drug MTX.  
The recognition of a specific ligand by a protein comes from a delicate 
balance between various factors such as the entropy and enthalpy. The overall change 
in enthalpy and/or entropy is a sum of several contributions that can be either 
favorable or unfavorable. For instance, high specificity can be achieved by the 
formation of optimal contacts such as hydrogen bonds, Van der Waals contacts, 
electrostatic interactions, pKa changes [127] or even conformational changes [128]. 
Due to the many possible contributions to the observed changes in the 
thermodynamic parameters upon binding, assigning the roles of each can be difficult. 
Nevertheless, this knowledge is crucial if we want to understand how specific is a 
protein toward its partner. 
Binding affinities are usually determined by using various techniques: UV-
visible spectroscopy, surface plasmon resonance, ITC, etc. Unlike other techniques, 
ITC allows the complete determination of the thermodynamics signature of the 
interaction between two molecules [129]. The binding association constant Ka, the 
stoichiometry N and the binding enthalpy ∆Hb are available in a single experiment 
[130]. The free energy ∆Gb and entropy ∆Sb of binding are calculated from the 
association binding constant Ka using the equations [131]. 
 
∆Gb =  -RTln(Ka)                                                                Equations 25 
∆Gb =  ∆Hb-T∆Sb.    
 
ITC is a differential technique that measures directly the binding equilibrium 
by determining the heat evolved on association of a ligand with its binding partner 
[129]. For a typical titration, the macromolecule is placed into the sample cell and 
small injections of the ligand are made until all of the binding sites on the 
macromolecules are saturated. The heat released from each injection is recorded and 
integrated yielding a typical sigmoidal curve that can be fitted to a binding model 
[132]. The amount of heat evolved (Q) on addition of ligand can be represented by 
the equation: 
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where V0 is the volume of the cell, ∆Hb is the enthalpy of binding per mole of ligand, 
[M]t is the total macromolecule concentration including bound and free fraction, Ka is 
the association binding constant and [L] is the free ligand concentration. 
In this respect, this technique has been successfully used in drug design [133]. 
Indeed, ITC is particularly useful in the optimization of drugs binding affinities since 
the various forces involved in the equilibrium can be dissected [134]. We have 
therefore used this calorimetry technique for its unique features to characterize our 
enzyme-MTX complex and depict the most important driving forces embedded in the 
equilibrium. ITC can be used to obtain accurate measurements of the binding 
affinities for protein ligand interactions with binding constants between 103 and 108 
M-1 [131]. A common problem with molecules that have a very high affinity (that is, 
nanomolar range or lower) is the difficulty of determining accurately the binding 
affinity. ITC has an upper limit set with a maximum of 108-109 M-1 for the binding 
constant. This restriction is a serious drawback since the reported MTX binding 
affinities (Ka) toward DHFR approach the nanomolar or sub-namolar range [119, 
135, 136]. To circumvent this problem, we have performed a competitive titration as 
described by Sigurskjold [137] and implemented by Velazquez-Campoy et al [131]. 
In this experimental approach, the goal is to lower the affinity of the high affinity 
ligand to a level that can be measured. Three titrations are needed. First a titration 
with the weak ligand (H2F) in order to characterize its binding thermodynamics, 
second, a titration with the high affinity inhibitor (MTX) to measure its binding 
enthalpy and third the displacement titration involving a mixture of both ligands. This 
method has been validated and used successfully to determine the association 
constant between inhibitors, peptides, carbohydrate and nucleotides with proteins 
[131, 133, 137]. 
3.3.2. Material and methods 
3.3.2.1.Sample preparation 
Proper sample preparation is essential for successful ITC testing. In particular 
a minimal number of requirements need to be fulfilled to insure an accurate estimate 
of stoichiometry (N), enthalpy of binding (∆Hb), and binding association (Ka). Beyond 
the technical requirements implied by the machine itself, temperature, stirring speed, 
reference power, particular care has to be given to the macromolecule solutions. For 
all experiments, the protein was dialyzed overnight with the same buffer used for the 
ligand solution to avoid any mismatch between solvent compositions. We have used a 
100 mM sodium phosphate buffer pH 8, 200 mM NaCl, 0.2 mM Tris [2-
carboxyethyl] phosphine (TCEP) for the ligands and the protein. This buffer was 
selected for the optimal stability and solubility of the reactants. The samples were 
filtered and degased prior use. 
The protein, H2F and MTX concentrations were assessed by UV spectroscopy. 
Molar absorption coefficients of 25440 L M-1 cm-1 at 280 nm, 28000 L M-1 cm-1 at 
282 nm and 22100 L M-1 cm-1 at 302 nm were used respectively. 
The thermodynamics binding parameters of MTX to DHFR were measured 
using a Microcal VP-ITC instrument (Microcal. Inc). The setting up of the machine 
was identical for all three experiments. The measurements were done at 25 °C with a 
reference power of 10 µCal/sec with high feedback gain. 
3.3.2.2.Direct titration: MTX and H2F binding. 
The titration of the high inhibitor affinity MTX consisted of 28 injections of 
10 µl each of a 200 µM stock solution of MTX. MTX was injected into the sample 
cell (V= 1.42 ml) containing 33 µM of Bs DHFR (the protein:ligand ratio used was 
1:6). The injections were made over a period of 10 seconds with a 5-min interval 
between subsequent injections. The sample cell was stirred at 286 rpm. 
The calorimetric titration of the natural substrate: H2F was determined with 28 
injections of 10 µl each of a 500 µM stock solution of H2F. The sample cell (V= 1.42 
ml) contained 76 µM of Bs DHFR (the protein:ligand ratio used was 1:7). The 
injections were made over a period of 10 seconds with a 4 min interval. The sample 
cell was stirred at 307 rpm. 
3.3.2.3.Displacement titration experiment 
The displacement titration was set as previously described. The pre-bound 
complex contains 48 µM Bs DHFR with 500 µM H2F (weak ligand: the 
protein:ligand ratio used was 1:10). The solution in the syringe contains 800 µM 
MTX (high affinity ligand: the protein: ligand ratio used was 1:15).A series of 20 
injections over a period 10 s with 4 min interval were made to assess the binding 
thermodynamics. 
3.3.2.4.Data analysis 
The binding thermodynamics parameters: Stoichiometry (N), association 
constant (Ka) and the binding enthalpy (∆Hb) were determined using the Origin 
version 5.0 software from MicroCal interfaced to a Gateway PC for data acquisition 
and analysis. Direct titration of H2F and MTX were performed using a single site 
model. Heat dilutions and baseline correction were carefully subtracted from the raw 
data before analysis. The tail of the titration often includes heats from ligand dilution 
and buffer-buffer interaction, I have performed a titration of the ligand against the 
buffer to determine this heat of dilution, then get the average and subtract from all 
data points. 
For the competitive binding, the mathematics of this method have been presented by 
Wang and Sigurskjold and implemented by a number of groups [137, 138]. In these 
experiments, the observed affinity and enthalpy are made up of two contributions, the 
energetics for the displacement of the primary ligand H2F and the binding energetics 
for the secondary ligand MTX. The observed binding affinity ( obs
aK ) is given as: 
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where Kx is the binding constant for the strong ligand, Ks is the binding constant for 
the weak ligand and [S] the concentration of the free weak ligand in the calorimeter 
cell. The observed binding enthalpy also contains the contribution from both the 
primary and secondary ligand 
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Using the software package from Microcal, the analysis of the displacement 
titration was performed using a competitive binding model. The binding energetics of 
H2F with equation 27 were used to determine the binding energetics of MTX. The 
data correction was performed differently as mentioned previously. The endothermic 
peaks at the end of the titration were average from the stable saturated baseline and 
substracted from all the data points. 
3.3.3. Results 
As previously stated, due to the extremely high affinity of MTX, the binding 
thermodynamic parameters were measured in a competition experiment using H2F as 
a weak ligand. Figure 22 illustrates the three titrations necessary for the complete 
description of the binding signature. 
 Panel (a) from figure 22 shows the direct titration of MTX against the enzyme. 
As inferred by the graph, the characteristic sigmoid shape obtained generally from the 
binding isotherm is not observed [131]. The transition between the non-saturated and 
saturated states is very sharp and approaches nearly linearity. Indeed, if the region of 
the binding isotherm in which the transition takes place contains less than two points, 
the slope of the inflection (which determines the binding constant) can not be 
reasonably determined. Consequently, the equivalence point can not be identified 
accurately which necessarily impairs the accurate determination of the binding 
constant. Nevertheless, using a single site model, the dissociation constant (Kd) which 
is the inverse of Ka value was found to be 1.3 nM with a 1/1 stoichiometry (N= 1.1). 
It clearly demonstrates that the free enzyme binds tightly and selectively MTX at a 
single site. However, this value reflects only a lower limit for the binding affinity 
since we are beyond the limit of the ITC resolution. On the other hand as described 
by Sigurskjold et al [137], this restriction did not impact a precise measurement of 
the binding enthalpy: ∆Hb= -16.8 kcal mol-1. 
The two other experiments consist of the titration of the weak ligand (H2F) 
alone and secondly the displacement reaction (DHFR- H2F against MTX). The 
titration of the natural substrate H2F with DHFR shows the common binding 
isotherm. The transition and therefore the equivalent point are easily fitted with a 
single site model. The binding stoichiometry gives a 1/1 ratio (N= 0.9) with a binding 
constant of 1.8 µM. This value is very close to the Michaelis constant determined by 
steady state kinetics Km= 7.5 µM. The binding enthalpy was found to be favorable 
∆Hb= -12.1 kcal mol-1 and characterized by unfavorable positive entropy change 
∆Sb= -14.3 cal K-1mol-1. The most notable feature of this experiment is that the heat 
effect associated with binding is exothermic. The calculated binding Gibbs energy 
∆Gb= -7.8 kcal mol-1 is therefore enthalpy driven. 
On the other hand the displacement titration can be followed with the heat 
binding isotherm shows in panel (c). The plot has sufficient curvature to allow the 
determination of the apparent binding affinity. Under the conditions of this 
experiment and using a competitive model, the binding constant was Kd= 2.9 nM 
which is surprising since the value was expected to be lower than 1.3 nM as inferred 
previously. However, the error is quite large ± 5 nM so it can explain such 
discrepancy. It also yielded a negative enthalpy which seems to be underestimated 
∆Hb= -11.9 kcal mol-1 with an almost favorable entropy term ∆Sb= -0.7 cal K-1mol-1. 
A second mechanism must contribute to this excessively low value of enthalpy and 
change in entropy. Structural studies have depicted conformational changes in the 
DFHR structure upon ligand binding [51]. However, the competitive binding model 
does not take into account conformational reorganization. This is a serious drawback 
since as inferred by Horn et al, conformational heterogeneity can drastically 
modulates the thermodynamic signature and particularly the enthalpy and entropy 
values [128]. The dynamic nature of proteins and the change in the position of atoms 
could therefore contribute to a significant level in the binding thermodynamics. This 
particular thermodynamic signature could reflect a less synergistic mechanism when 
H2F is bound prior to DHFR. The absence of linear portion in the first injections 
could also derive from this contribution. Unfortunately, it is not possible to determine 
the various factors involved in this specific behavior. Another contribution which is 
scarcely approached in the literature is the statistical analysis. Data fitting using a 
specific model is relatively easy and straightforward with the Microcal package. For 
instance, the stoichiometry values are given with a relative error of 1 % which may be 
far too good for an ITC experiment. On the other end the Kd values are less accurate, 
the relative errors are over 150 % in all tested cases. Therefore, it might be harzadous 
to give a precise statistical meaning of ∆Sb since it is calculated from the enthalpy and 
binding affinities using equation 25. It would in principle include the statistical error 
from both, Kd and ∆Hb. In fact, the statistical deviations from table 4 only reflects 
how good the experimental values agree with the analysis model. What would be 
probably more useful and relevant will imply the repetition of each experiments, at 
least twice to cross correlate the results. Nevertheless, we shall see that an ITC 
experiment is time demanding and only two or three titrations can be made during a 
day work (if everything goes well). Thus, it impairs such analysis. 
 
 
 
Table 4. Thermodynamics of binding of MTX, H2F to Bs DHFR. 
Ligand Kd (µM) 
∆Hb 
(kcal mol-1) 
∆Sb 
(cal K-1 mol-1) N 
 
    
MTX 1.3 10-3± 2.1 10-3 -16.8± 0.4 -15.6 1.14±0.01 
H2F 1.8± 3.3 -12.1± 0.1 -14.3 0.90±0.01 
MTX into  
Bs DHFR-H2F 
2.9 10-3± 5 10-3 -11.9± 0.4 -0.7 0.96±0.01 
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3.3.4. Conclusions and discussion 
The most notable feature of this experiment is that, as expected, MTX binds to 
the enzyme with a higher affinity than H2F (by three orders of magnitude). In 
addition, the thermodynamic profile for both ligands is very similar qualitatively. The 
binding is enthalpically favorable (∆H<0) and entropically unfavorable (∆S<0). The 
reduced affinity for H2F is due to a significantly reduced favorable binding enthalpy 
from ∆Hb= -16.8 kcal mol-1 for MTX to ∆Hb= -12.1 kcal mol-1 for H2F (∆∆Hb= -4.7 
kcal/mol). There is some enthalpy-entropy compensation in that the entropic 
contribution to the binding of H2F is less unfavorable than MTX. However the 
difference is not large enough to counter the magnitude of the favorable enthalpy 
loss. At the thermodynamic level, the binding enthalpy, primarily reflects the strength 
of the interaction of the ligand with the targeted protein (e.g Van der Waals, hydrogen 
bonds, ionic bridge, etc.) relative to those existing with the solvent [139]. A potential 
source of this more favorable accommodation in the case of MTX could reflect the 
better ability of MTX to create additional bonds strengthening its interaction with the 
enzyme. Using the R67 dihydrofolate reductase Jackson et al [140] have pointed out 
that the enthalpic signal arising from folate and antifolate drugs primarily originates 
from the p-aminobenzoylglutamate fragments and not the dihydrobiopterin group. In 
addition, the reduced and keto form (N3 protonated) of folate were found to be the 
preferred binding states. It further supports a strong role for O4 and/ or N3 atoms in 
the interaction. These finding agree well with nearly all available biochemical and 
structural data from E. coli and L. casei DHFR. From these DHFR sources, a 
particular ionic interaction between the Oδ2 of the highly conserved aspartate 27 and 
the N1 atom of MTX has been identified as the main driving force [14, 63, 66, 67, 73, 
141, 142]. It clearly indicates that the replacement of the 4-oxo group of H2F by an 
amino group has a dramatic effect on the binding energetics. It induces a unique 
binding geometry in the enzyme active site. This finding involves the positioning of 
pairwise interactions or counter charges such as that an increase in ligand order or 
rigidity occurs. However, these results are in disagreement with NMR [143] and X-
ray [144] studies which suggest that the MTX high binding energy is due to an 
increase in entropy of the system. These studies noticeably suggest that the binding 
energetics associated with folate and its analogs comes from a disordered segment of 
the molecule. The relative disorder presents in the molecule would help the 
positioning of the negatively charged tail (p-aminobenzoylglutamate). It should be 
emphasized that the entropic term depends primarily on two main forces. An 
unfavorable term, which originates from the loss of conformational degrees of 
freedom from the ligand and from some residues in the protein. Secondly, a favorable 
term, which comes from the release of water molecules upon binding or by a less 
efficient burial of hydrophobic groups from the solvent (solvation effect) [145]. 
Unfortunately, water molecule maps of the free and the various complexed state of 
the enzyme are not available. A recent crystallographic neutron structure has initiated 
such research but more it needed for a complete description of the system [73]. On 
the other hand a number of studies have investigated the conformational dependency 
of the DHFR-MTX complex [14, 67, 146]. Recent H/D exchange studies coupled 
with Mass Spectroscopy (MS) experiments have reported a decrease in structural 
fluctuation upon ligand binding [147]. This effect might shed the light on the 
unfavorable character of the entropy term. The conformational space explore by the 
protein atoms is reduced. However our data set can not explain why the entropy term 
differs between H2F and MTX. The ∆∆Sb= 1.3 cal/K/mol is very low and can not be 
used to draw a direct conclusion. 
Consequently, the main difference between MTX and H2F is its higher affinity 
toward the enzyme and this affinity is achieved by the combination of a strongly 
favorable binding enthalpy and unfavorable entropy. Overall, inhibitors such as 
MTX, displaying favorable binding enthalpies do not require extreme binding 
entropies to achieve high binding affinities. A similar trend was found with HIV-1 
protease inhibitors such as ritonavir and KNI-64 [145]. These findings can be useful 
in drug design since drug screening could be easily achieved and improved by 
introducing flexible segment in the molecules without lowering the affinity toward 
their respective target. 
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4. Effect of methotrexate on the thermal stability of Bs 
DHFR 
4.1. Introduction 
 Binding of an effector molecule is often the primary step in biological 
reactions. For instance, an enzyme must bind to a substrate to initiate its catalytic 
reaction. This association between an enzyme and a ligand is also often accompanied 
with substantial changes in enzyme properties [37]. Such conformational changes 
have been extensively studied and have given rise to an important number of 
concepts. The ‘induced fit’ model suggests the need for functional plasticity for the 
enzyme active site to accommodate the substrate [9]. Since the three-dimensional 
architecture of a protein is often described using a unique model, i.e. static, the spatial 
rearrangement upon ligand binding is very interesting since it must involve a dynamic 
process. It is therefore very tempting to correlate specific movement such as side 
chain rotation or loop reorientation to a binding event. Consequently, if protein 
conformational changes and ligand binding have gained a paramount importance in 
understanding enzyme kinetics and dynamics, it is also relevant in protein stability. 
For example the binding of a cofactor has been directly correlated with an increase of 
protein stability and folding kinetics [148]. Undoubtedly, there is a very subtle and 
narrow boundary between ligand binding and the dynamic processes involved in the 
folding or unfolding pathways. The ligand could be in fact an initiating signal for the 
the onset of original protein properties. Now the question is to understand how the 
nature of the ligand correlates with structural changes and or protein stability.  
 A number of structural techniques are available to unravel this question, such 
as X-ray crystallography, NMR or circular dichroism. In the first place, we have 
assessed the effect of MTX and H2F on the DHFR structure and its thermal stability 
using the well known spectroscopic technique of Circular Dichroism (CD). 
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4.2. Technique overview: circular dichroism 
 As with many biological molecules, proteins possess chiral centers. This 
confers to the protein an optical activity. This property is exploited by spectroscopic 
methods such as CD [149, 150]. Briefly CD is defined as non equivalent absorption 
of the left-handed and right-handed circularly polarized light. When asymmetric 
molecules interact with the beam, they may absorb left circularly polarized (LCP) and 
right circularly polarized light (RCP) to different extents (figure 23). The result of 
this discrepancy is termed circular dichroism and can be measured in terms of 
absorbance: 
 
  ∆A=AL-AR       Equation 28 
 
where AL and AR are the absorbance of the left and right circularly polarized light. 
By applying the Beer’s law, it can be expressed as: 
 
  
( ) l*C*A RL ε−ε=∆      Equation 29 
 
Where εL and εR are the molar extinction coefficient for LCP and RCP light, C the 
molar concentration (in M)and l the path length (in cm). 
Then we can define the molar circular dichroism ∆ε: 
 
  RL ε−ε=ε∆       Equation 30 
 
As shown in figure 23, the ellipticity is defined as the angle θ whose tangent is the 
ratio of the minor and the major axis of the ellipse. 
The ellipticity of polarization is equal to: 
 
  
LR
LR
EE
EE
tan
+
−
=θ       Equation 31 
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where ER and EL are the magnitude of the electric field vectors of the right-and left-
circularly polarized light, respectively. Generally, the circular dichroism effect is 
small, tan θ can be therefore approximated as θ. The ellipticity can be now written as: 
 
  





pi





∆=θ 180
4
10lnA                  Equation 32 
 
The linear dependence of the solute concentration C and pathlength l is removed and 
the molar ellipticity becomes: 
 
  [ ]
Cl
θθ 100=        Equation 33 
 
Then combining the last two equations with Beer’s law, the molar ellipticity becomes 
 
  [ ] 
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
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


ε∆=θ 180
4
10ln100      Equation 34 
 
For illustration of the CD phenomena see this interesting link 
(http://www.enzim.hu/~szia/cddemo/). 
 
 In proteins, CD signal arises from optically active groups such as backbone 
amide bonds, disulfide bonds, aromatic amino acids such as Phenylalanine (Phe), 
Tryptophan (Trp), and Tyrosine (Tyr). In secondary structure conformations, the 
backbone and hence the amide bond chromophores are arranged in regular organized 
patterns. In the far ultraviolet region (<250nm), CD spectroscopy is extremely 
sensitive to these patterns and each conformation gives rise to characteristic spectral 
features. For example, α-helical proteins have a negative peak at 222 nm and 208 nm 
and a positive peak at 193 nm. Proteins with well defined anti parallel β-pleated 
sheets (β-helices) present a negative peak at 218 nm and a positive peak at 195 nm. 
On the other hand disordered proteins present a small ellipticity above 210 nm and a 
negative band near 195 nm [149]. A typical CD spectrum from a globular protein is 
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therefore the sum of all these contributions (see fig 24). Therefore, the CD spectrum 
c(λ) of a protein can be reconstructed as the linear combination of the base spectra 
multiplied by the abundance of the respective structure elements: 
 
( ) ( )λλ in
i
ibfc ∑
=
=
1
      Equation 35 
 
 
Here, n is the number of secondary structure 
components, and fi is the fraction of structure i 
in the protein. 
This direct relationship between protein 
secondary structure and circular dichroism 
spectra means that CD is an excellent 
spectroscopic technique for studying the 
conformation changes due to temperature, 
mutations, heat, denaturant or binding 
interactions [150]. Although CD is not giving 
detailed information on a residue basis such as 
NMR or X-ray crystallography, the real power 
of CD resides in the analysis of structural 
changes in a protein upon some perturbations. 
This chapter focuses on the use of CD to follow 
the structural change of the native state of the 
enzyme upon MTX binding but also its thermal 
stability when it is bound to specific ligand such 
as H2F and MTX. 
 
 
 
Figure 23. Elliptical polarized 
light is composed of unequal 
contributions of right (ER) and left 
(EL) circular polarized light. 
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4.3. Material and Methods 
4.3.1. Sample preparation. 
 Bs DHFR was dissolved in potassium phosphate buffer 10 mM, pH 8, 
degassed, and centrifuged at 14000 rpm for 5 min to remove any insoluble particles 
from the solution. Protein concentration was estimated by UV spectroscopy using an 
absorption coefficient ε280 of 25440 L/Mol/cm. Since MTX is a tight binder, it was 
added at a 1/1 molar ratio with respect to the enzyme. H2F was used at a 10 fold 
 
 
 
Figure 24. CD spectra of polypeptides 
and proteins with representative 
secondary structure such as α-helices (α) 
β-sheets (β) or random coils. 
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excess with respect to the enzyme. The concentrations of H2F and MTX were 
estimated by UV spectroscopy using ε282 28000 and ε258 23250 L/Mol/cm 
respectively. Their respective contribution (below 5% of the overall signal) was 
subtracted from the CD spectrum. 
4.3.2. Thermal unfolding at a single wavelength. 
 CD experiments were carried out in a Jasco J-810 with a Jasco PTC-348WI 
peltier effect temperature controller. Quartz cell with a 1 cm path length with a stir 
bar were used for thermal unfolding. Samples were monitored for helical content by 
circular dichroism at 222 nm at an enzyme concentration of 7 µM in potassium 
phosphate buffer of 10 mM pH 7. Thermal denaturation was performed at scan rate of 
1 and 2°C/min with a data pitch of 0.2 nm and a bandwidth of 4 nm; denaturation 
behaviour did not vary with the ramp at these specific rates.  
4.3.3. Secondary structure estimation and thermal unfolding 
 Far-ultraviolet (far-UV) spectra were monitored using a 0.1 cm quartz cell at 
wavelength between 190 and 250 nm. The final spectrum was the summation of five 
accumulated spectra taken at a scan rate of 100 nm/min every five degrees. The 
temperature increment was 1°C/min. 
4.3.4. Data processing 
 Thermal denaturation was analyzed using the program Sigma plot 10 from 
Systat, Inc to calculate all T1/2 values. The relationship between the CD signal 
measured at a temperature T, y (T), and the proportion of the unfolded state, %U (T), 
is given by the following equation: 
 
 %U(T)= [y(T)-yN(T)]/ [yU(T)-yN(T)]     Equation 36 
 
 
yN(T) and yU(T) are the linear dependency of T of the native and unfolded protein in 
order to take in account the pre and post dependencies of the CD signal on the final 
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spectrum [148]. Because the reaction was not reversible, the thermodynamic 
parameters were not determined using the fitting procedure. 
 Secondary structure estimation was analyzed using the deconvolution software 
SOMCD [151]. This method is based on a self organizing neural network. The 
reference spectra consists of 24 CD spectra taken from Yang et al [152]. 
4.4. Results 
 
 Far-UV CD spectra of a protein generally reflects its secondary structure 
composition [149]. The 
analysis of the CD spectra 
using the SOMCD software 
has given an estimate of the 
secondary structures content 
in the enzyme Bs DHFR in 
presence or in absence of 
MTX. As shown in figure 
25, the two spectra are 
overlaid. The common 
features between the spectra 
are a large negative 
ellipticity below 205 nm 
with broad minima between 
205-220 nm. The CD signal 
obtained from the Bs DHFR-
MTX complex presents two 
minima at approximately 
207 and 218 nm whereas the free enzyme only shows one minima centered between 
208 and 210 nm. Table 5 summarized the characteristics of these spectra and those 
predicted from the X-ray structure of the free enzyme. A large contribution of the 
secondary structure elements in Bs DHFR is described by random and β-turn 
structures which contribute to almost 80 % of the overall secondary structure. Other 
 
 
Figure 25. Far UV spectra of unbound Bs DHFR 
(orange line) and MTX complexed Bs DHFR (grey 
line). 
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secondary structures: α-helix and β-structures account for ~ 17 % and ~ 35-40 % 
respectively. These findings agree well with the predicted value from X-ray 
crystallography [56]. Although the two spectra graphically differ in the 215-225 nm 
regions, the additional minimum observed at 222 nm in presence of MTX, typical of 
α-helix, seems to have a limited impact on the overall secondary structure 
distribution. Their estimation reveals only a slight decrease in β-sheets in favor of 
more random and β-turn conformational elements but according to the relative error, 
it seems that these differences are not significant. 
 
 Figure 26 illustrates the melting of secondary structures over temperature 
increase. For the non-complexed enzyme, as the temperature increases, the intensity 
of the CD spectrum progressively decreases. The loss of CD signal in the far-UV 
region started at a temperature equal to or over 55°C with the strongest transition 
occurring between 60 and 65°C. The overall shape of the graph remains essentially 
unchanged below 65°C. Above this temperature, the initial minimum centered at 218 
nm is shifted to ~ 208 nm. Finally, heating at 80°C caused a total loss of ellipticity 
and absorbance, suggesting aggregation and precipitation of the protein. On the other 
hand, the spectra of the binary complex between Bs DHFR and MTX denotes a very 
different behavior. The temperature effect on the CD signal is relatively low below 
65°C with no change in the minima position (207 and 218 nm). We clearly observed 
a red shift of the initial minima observed at 207 nm to approximately 220 nm. An 
extremely sharp transition reinforcing this observation occurred between 80 and 85 
 Secondary structure 
Sample α-helix 
(%) 
β-sheet 
(%) 
Other* 
(%) 
Bs DHFR 17.4± 6.4 41.4± 8 41.2± 15.2 
Bs DHFR-MTX 17.6± 5.1 34.6± 9.4 47.9± 11.3 
DSSP prediction Bs DHFR 22 34 Not given 
Table 5. Secondary structure of Bs DHFR estimated from experimental circular 
dichroism data and predicted from X-ray structure using the DSSP model (database 
of secondary structure assignments) [153]. 
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°C. Heating to 90°C leads to almost a complete loss of CD signal over the observed 
region. 
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Figure 26. Temperature dependence of the far 
ultraviolet CD spectra of Bs DHFR (A) and MTX-
Bs DHFR (B). The temperatures are indicated in 
the inset. 
 
A 
B 
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We also attempted to fractionate the loss of secondary structure elements using the 
SOMCD method [151]. It seems that the CD changes with or without MTX were 
consistent with loss of most protein’s β-sheet structure concomitant with an increase 
in random structures. However, we have also noted a significant increase in α-helix. It 
might indicate the limit of the analysis especially at high temperature where the 
protein is actually ‘seen’ as a pure α-helix rich protein. The model used could weight 
external factors from the unfolding process in the conformational analysis misleading 
the data interpretation. 
 Because the loss of CD signal was relatively well marked at 222 nm, we have 
examined the thermal behavior of the enzyme and its binary complex with MTX and 
H2F at this single wavelength (figure 27). 
 
 
 
 
Figure 27. Temperature dependence of the CD at 222 nm of Bs DHFR (a), Bs DHFR-
H2F (b) and Bs DHFR-MTX (c). The dots are the raw data and the solid are the best fit. 
In the inset, the T1/2 values are listed. 
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Thermal denaturation of the Bs DHFR resulted in the progressive and irreversible 
changes in the CD spectra as shown in figure 27. Indeed, once the initial melt was 
complete, the sample was brought back to 30 degrees to verify the folding was 
reversible. The spectra before and after could not be superimposed indicating that the 
protein can not refold once the temperature is reduced. This inability of the protein to 
completely renature is the result of either precipitation or aggregation of the unfolded 
form [154]. Only if the melting is fully reversible, the melting temperature is directly 
related to conformational stability and the thermodynamics of protein folding can be 
extracted from the data. In our case, it is more appropriate to depict a T1/2 since the 
melting temperature reflects primarily the kinetics of aggregation and the solubility of 
the unfolded form as well as the intrinsic conformational stability. Heat denaturation 
of E. coli DHFR gave a similar pattern and was found to be irreversible in [155, 156]. 
Under the experimental conditions, Bs DHFR was denatured at an average 
temperature T1/2 of 65.7°C. The presence of the natural substrate H2F results in a 
significant increase of the T1/2 by 2.7°C with no change in the unfolding progress 
curve. In marked contrast to the heat induced effect on the enzyme and its binary 
complex with H2F, the presence of MTX has a drastic effect on the T1/2. The T1/2 
value was increased by 13.8 °C reaching the value of 79.5 °C. This later finding 
corroborates well with the heat denaturation temperatures obtained in binary 
complexes with MTX between E. coli and bDHFR (Bovine liver DHFR) in 
comparison with the free enzyme. The stabilization effect was as much as 14.2 ˚C and 
13.3 ˚C for E. coli and bDHFR respectively. Interestingly, there was also a slight shift 
from the fitted curve and the raw data between 70 and 75°C and a steeper transition in 
the T1/2 region in comparison with the free enzyme and its binary complex with H2F. 
It possibly denotes a cooperative effect [157, 158] in the unfolding process. 
4.5. Discussion 
 Comparing the secondary structure in the free enzyme and its binary complex 
with MTX, we observed a notable change in the CD signal centered around 220 nm, 
when MTX binds. As inferred by Hood et al it could reflect some reorganization of 
secondary structure on MTX binding but it could be also due to far-UV transition of 
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MTX itself [159]. However the secondary structure analysis did not yield a 
significant difference between the two folds. Standard error observed for 
spectroscopic techniques such as CD is probably beyond the calculated difference 
between the uncomplexed and MTX complexed enzyme. The validity and limitations 
of the deconvolution packages such as SOMCD is discussed in [151]. Overall, the 
technique, gives accuracies up to 95 % for α-helical content but drop to 50 or 75% for 
β structures or mixed structures. Other CD deconvolution packages were used such as 
DICROPROT [160] and k2d [161] but they gave very similar results without bringing 
further information. This ambiguity is noticeably introduced by the nature of the 
protein reference set used in the statistical analysis or in the strength of the 
mathematical model to take in account only the conformational factors in the 
spectroscopic analysis. CD is a low resolution technique, only a high resolution 
technique such as X-ray crystallography could measure the possible differences. 
 Similarly, the dissection of the melting of secondary structures upon 
temperature increase did not yield solid evidence in the hierarchy of the unfolding 
process. Theoretical studies using MD on E. coli DHFR have suggested that α-helical 
structures unfold prior to the β ‘core’ [162]. Our results disagree with those finding 
but we clearly observed a very distinctive behavior between the two temperature 
scans. The red shift observed in the presence of MTX might underlie a different 
unfolding pathway. It could reflect the presence of alternative structural intermediates 
along the unfolding landscape. Additionally, the single wavelength denaturation 
performed on the MTX binary complex seems to emphasize this hypothesis. The 
shoulder prior to the thermal transition might indicate a possible non-cooperative 
effect in the unfolding process. At this stage, only, very flexible regions of the protein 
are unfolding or partially unfolding leading to a heterogeneous population of folded 
structures [163, 164]. On the other hand when the temperature approaches T1/2, the 
cooperativity which is measured qualitatively by the width and shape of the unfolding 
transition is steeper in comparison with the free enzyme or with its binary complex 
with H2F. A calorimetry study also reported an asymmetry of the melting curve, a 
shoulder in the low temperature part of the heat induced transition was observed for 
the binary of E. coli DHFR and MTX [165]. It reflects the melting of at least two 
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regions of the protein at different temperatures but also it may be indicative of the 
unfolding of more compact or well folded structure. The presence of an intermediate 
in the unfolding pathway has been previously reported for E. coli DHFR [166]. 
Interestingly, the kinetic cycle also involved well defined intermediates. MTX could 
therefore bind, induce and stabilize preferentially particular enzyme conformations 
but what are the fundamentals behind the MTX stabilization effect? 
A ligand such as MTX may have stabilized DHFR against thermal unfolding 
over a variety of mechanisms. The increase thermal stability is the result of a 
combination of effects such as ligand-protein specific interactions and or 
conformational changes. One hypothesis explaining the high temperature stability of 
the MTX-Bs DHFR complex suggests that there are more stable interactions than in 
the free enzyme. The natural substrate H2F binds to DHFR at the same site as MTX, 
however, the stabilization effect is not as effective as when MTX binds. The 
difference in their binding constants, and other studies highlight the presence of 
different interactions between the enzyme and its inhibitor MTX, compared to its 
natural substrate [73]. These interactions could contribute directly by resisting to the 
unfolding process. Using various complexed form of E. coli and bDHFR with anti-
folate compounds (such as TMP or MTX) and/or the natural cofactor NADPH, Sasso 
et al suggested that the main driving force in the E. coli DHFR structure stabilization 
originated from hydrophobic contacts [165]. A recent study using single molecule 
atomic force microscopy further supports this hypothesis [167]. The DHFR 
mechanical stability was found to be increased in the presence of MTX but the 
origins of this increased mechanical stability was not discussed. As previously 
demonstrated, the binding strength of MTX is three orders of magnitude higher than 
H2F. This discrepancy might be one of the key factors in the unique properties of 
stabilization. However, we can also speculate that thermal fluctuations are involved. 
Indeed, thermal unfolding is mainly induced by the enhanced thermal fluctuations 
overcoming the stabilisating forces such as hydrogen bonds and Van der Waals 
interactions [168]. Using hydrogen/deuterium exchange Yamamoto et al found that 
the binding of ligands such as NADPH, H2F or MTX reduce DHFR structural 
fluctuations [147]. They also point out that MTX was exerting the most significant 
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effect among the later ligands. In addition according to the X-ray structure, MTX 
binding causes a ‘tightening’ of E. coli enzyme-a general decrease in the distances 
within the molecule [146]. It is therefore very tempting to conclude that the reduction 
of in the amplitude of fluctuations are directly correlated to the binding of MTX and 
change in thermal stability. However, the role of fluctuations is not fully understood. 
In conclusion, in the present study we have observed a puissant stabilization effect of 
MTX toward the thermal unfolding of the enzyme Bs DHFR. Noteworthy, we should 
also see that thermal stability depends on multiple forces. The sum of these forces 
necessarily implies a global effect. Interestingly the binding of MTX is a local event. 
Since CD as mainly all spectroscopic technique gives an average view of the studied 
system, the binding of MTX must have been propagated far away from its binding 
site to affect the overall stability of the protein. A potential chain of connectivity 
could be also assigned upon this particular binding event as inferred by Benkovic et 
al [45]. The pre-existing equilibrium hypothesis or Monod-Wyman-Changeux model 
(MWC) have also ‘propagated’ this idea in the field of enzymology and protein 
function 40 years ago [31]. The binding of MTX have therefore a deep and complex 
impact on the dynamics and structure of the enzyme. It might underlie a synergistic 
mechanism that could imply cooperativity.  
 
5. Protein dynamics and stability: the distribution of 
atomic fluctuations in thermophilic and mesophilic 
dihydrofolate reductase derived using elastic 
incoherent neutron scattering 
5.1. Introduction 
 The structures of enzymes reflect two tendencies that appear opposed. On the 
one hand, they must fold into compact, stable structures; on the other hand, they must 
be flexible to bind or accommodate a ligand. It appears that there is a trade off 
between enzyme stability and enzyme function [17]. Indeed, it has given rise to a 
paradigm, that activity and stability are inversely related by internal dynamics; i.e.  
 
Activity ∝ Dynamics (flexibility) ∝ 1/Stability 
 
Consequently, enzymes need to be sufficiently flexible to be catalytically active, but 
not so flexible that they readily denature. According to that, thermophilic proteins are 
believed to be less flexible, more stable and less active than their mesophilic 
counterpart at room temperature. However, the nature of the dynamic requirements 
for activity and stability and in particular whether they are the same are unclear. In 
this chapter which has been recently published, the relationship between thermal 
adaptation and fast protein dynamics (pico-second timescale) is explored by neutron 
scattering means. My input in this collaborative work was to provide both enzymes 
(E .coli DHFR and Bs DHFR) in 100 mg quantities. I tested the activity of both 
enzymes. I prepared the neutron sample, i.e.: bringing the protein to the appropriate 
hydration threshold and taking care of the sample holder. I also assisted in the 
neutron scattering experiment. 
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6. Effect of perdeuteration on the thermal stability of Bs 
DHFR 
6.1. Introduction 
 Sample preparation, especially for biological molecules can be the bottle 
neck of a neutron scattering study. To overcome this problem, a number of strategies 
have been explored. The ability to deuterate selectively biological molecules has 
facilitated the use of neuron scattering techniques in biology [80]. For instance the 
use of contrast variation based on the dramatic scattering difference between 
hydrogen and deuterium atoms has a major impact on the range of applications of 
small angle neutron scattering [169]. The solution conformation of macromolecular 
complexes such as viruses [170] or enzymes [171] have elegantly highlighted the 
power of perdeuteration in structural biology. Consequently, the number of dedicated 
laboratories producing specifically labelled proteins for NMR, SANS or incoherent 
neutron scattering is growing fast. Although the applicability of deuteration is 
unquestionable, the effect of deuteration on living organism is nevertheless poorly 
understood. A deuterium nucleus contains one neutron and one proton whereas the 
hydrogen atom does not contain any neutrons. Deuterium behaves similarly to 
ordinary hydrogen, but there are differences (due to the large mass rest of deuterium 
atoms) which are larger than the isotopic differences in any other element (see table 
6) [172]. The effect of exchanging hydrogens by deuterons is further magnified in 
biological systems, which are very sensitive to small changes in the solvent properties 
of water. For instance, at high concentration, mice, rats and dogs (over 25% of body 
weight) suffer from acute neurological symptoms, liver hyperplasia, anemia, and 
eventually death [173]. On a molecular level, the effects of H/D exchange is more 
tricky. As a solvent D2O increases stability of proteins [174-176], on the other hand 
perdeuteration does not affected thermal stability of stable proteins whereas proteins 
with low denaturation temperatures are profoundly destabilized by perdeuteration 
[177]. In the case of gluthatione S-transferase, the destabilisation effect of side chain 
deuterons outweighs the stabilisating effect of the core hydrogen bonding [177]. The 
stability of perdeuterated proteins seems therefore to depend on a number of factors, 
including steric crowding of the transition state, in which hydrogens have been 
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exchanged especially in hydrophobic regions [178]. Perdeuteration can also modify 
protein function, it lowers antifreeze activity of glycoproteins [179]. On the other 
hand enzymic activities have been reported to be positively [177], negatively (this 
study) or remain unaffected [180, 181]. Protein structure is often not modified by 
such isotopic replacement but the differences are very subtle and hard to discern 
[182]. However, if there is a recent growing interest in protein labelling for structural 
biology there are too few examples on the effect of perdeuteration (substitution of 
non exchangeable carbon-bound H for D atoms) on protein structure and function in 
the literature [181].  
Property D2O H2O 
Melting point (○C) 3.82 0.00 
Boiling point (○C) 101.72 100.0 
Density (20 ○C, g/mL) 1.1056 0.9982 
Viscosity (20 ○C, centipoise) 1.250 1.005 
Surface tension (25○C, µN-cm) 719.3 719.7 
Heat of fusion (cal/mol) 1515 1436 
Heat of vaporization (cal/mol) 10864 10515 
Table 6. Some physical properties of deuterium oxide and 
water (from [173]). 
 
This chapter will assess the consequence of H/D exchange in the functional 
and thermal behaviour of the enzyme Bs DHFR. As hydrogens can be replaced in 
proteins by two ways, it is important to distinguish two sets of effects in this study. 
The first is a ‘solvent isotope effect’ that results from the change of solvent from H2O 
to D2O. Only exchangeable hydrogens bound to sulfur, nitrogen or oxygen atoms 
(relatively weak for C atoms) will be readily replaced by deuterium in a reversible 
(and time dependent) manner when the solvent is deutrium oxide. This solvent 
isotope effect, often called the ‘primary isotope effect’ [183] will principally affect 
hydrogen bonding in proteins and their hydration shell since D2O is more structured 
than H2O. Secondly the ‘Deuterium Isotope Effect’ (DIE) resulting from the ability of 
deuterium to replace H with D in biological molecules at non exchangeable positions. 
The replacement of non exchangeable hydrogen in protein is obtained by biosynthesis 
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in fully deuterated media and is called perdeuteration. The DIE is usually considered 
only in terms of D linkage to C atoms since these linkages are essentially irreversible. 
These hydrogens are essentially bound to the carbon atoms of the protein backbone 
and also to the side-chains of amino-acids. This secondary isotope effect [184] will be 
studied in both H2O and D2O solvent. 
To follow the effect of perdeuteration and the solvent isotope effect on the 
thermal stability and activity of Bs DHFR, we have used a novel and original model: 
The Equilibrium model developed at the University of Waikato and University of 
Bath [185, 186]. 
6.2. Technique overview: The ‘Equilibrium’ model 
Rates of all reactions, including those catalysed by enzymes, rise with increase 
in temperature in accordance with the Arrhenius equation [187]. 
RT
∆G
AeK
‡
−
=                                     Equation 37 
where K is the kinetic rate constant for the reaction, A is the Arrhenius constant, also 
known as the frequency factor, ∆G‡ is the standard free energy of activation (kJ M-1) 
which depends on entropic and enthalpic factors, R is the gas law constant and T is 
the absolute temperature. In general, it would be preferable to use enzymes at high 
temperatures in order to make use of this increased rate of reaction. However, 
enzymes are proteins and undergo essentially irreversible denaturation (i.e. 
conformational alteration entailing a loss of biological activity) at temperatures above 
those to which they are ordinarily exposed in their natural environment. The effect of 
temperature has therefore a profound effect on enzyme activity and is often described 
by two well-established thermal parameters: the free energy of activation ∆G‡cat, 
which describes the effect of temperature on the catalytic rate constant and ∆G‡inact, 
which describes the effect of temperature on the thermal inactivation rate constant. 
The so-called 'classical model' assumes a simple two states equilibrium (see diagram 
4) between an active and a thermally-denatured state X [188]. 
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The variation in enzyme activity with temperature and time of assay can be described 
as in equation 38 
 
                                                                                                                        Equation 38 
 
Where Vmax is the maximum enzyme velocity; kcat is the catalytic constant of the 
enzyme; kinact is the thermal inactivation constant; [E0] is the total enzyme 
concentration; and t is the assay duration. 
The variation of the two rate constants in equation 38 with temperature is given by 
equation 39 and 40. 
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                                            Equation 40 
Where kB is the Boltzmann’s constant; R is the gas constant; T is the absolute 
temperature; and h is the Planck’s constant. ∆G‡cat and ∆G‡inact are the activation 
energy of the catalysed reaction and thermal inactivation process respectively. 
However, this model presents some anomalies as it does not account for the observed 
temperature-dependent behaviour of enzymes. For instance, at least one study 
indicates that enzymes at elevated temperature can become less active over timescales 
which seem too short to involve denaturation [189]. This behaviour means that the 
observed loss of activity can not be directly associated with an irreversible 
denaturation process. Indeed, the common graphical temperature optimum: Topt 
when the enzyme activity (V) is plot versus temperature T : V= f(T) (figure 28) is 
actually a time dependent parameter, which means experimentally, the longer the 
assay duration is, lower is Topt and vice versa. Consequently, Topt is not an intrinsic 
Vmax= kcat . [E0] . e - K inact .  
E act                       X                                      Diagram 4 
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enzyme property but a mixture of at least two effects: the effect of temperature and 
time on both enzyme activity and stability. 
 
 
Figure 28. A schematic diagram showing the effect of the temperature on the 
activity of an enzyme catalysed reaction. ------ Long incubation time, ─── short 
incubation time. Note that the apparent temperature optimum varies with  the 
incubation time 
 
To describe a true temperature optimum, a new model has been developed and 
validated [185, 186]. This model namely the ‘Equilibrium model' describes a new 
mechanism by which enzyme loses activity at high temperatures. This model includes 
an extra step in the mechanism where an inactive form of the enzyme Einact undergoes 
in a reversible equilibrium with an active form of the enzyme Eact (very similar to that 
found in protein unfolding model). According to the postulate (see below), this newly 
inactived form of the enzyme will irreversibly go to the denatured state X [190, 191].  
 
 
 
 
                                                                                                                        Diagram 5 
Temperature 
Enzyme  
activity 
Kinact Keq 
E act E inact X 
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The mathematical description of the reaction velocity introduces a new component: 
[Eact] and becomes dependent of the equilibrium between the inactive and active form 
of the enzyme. It can be written as followed: 
 
 
                                                                                                                        Equation 41 
 
The concentration of Eact and Einact at any time is defined by: 
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=
                                                            Equation 42 
 
Where Keq is the equilibrium constant between the active and inactive form of the 
enzyme 
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The variation of Keq with temperature is given by equation 38: 
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eq                                                Equation 44 
 
Where ∆Heq: is the enthalpic change associated with the conversion of an active to an 
inactive enzyme, Keq: Equilibirum constant, R: gas constant, Teq: equilibrium 
temperature. This equilibrium includes both reversibility and time-dependent enzyme 
inactivation and can be described by an equilibrium constant Keq. Keq is characterized 
in terms of temperature dependence by the enthalpy term ∆Heq and a third thermal 
parameter Teq which is the temperature at which the concentration Eact and Einact are 
equal (see equation 44). Teq can be considered as the thermal equivalent of Km. In 
addition, we can yield a zero time temperature optimum Topt, independent of the 
assay duration. Since Teq arises from Keq, it is independent of enzyme thermostability. 
In other words, Teq reflects a more intrinsic enzyme property albeit it is not directly 
measurable by experimental means. The overall dependence of enzyme activity on 
temperature with time is defined by equation 45. 
Vmax= kcat . [Eact] 
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This equation is therefore used to derive the parameters of interest; ∆G‡cat, ∆G‡inact, 
Teq, and ∆Heq using a data set using thousand of points. Figure 29 shows the main 
graphical difference for both models, the classical model does not present a 
temperature optimum at zero time (a) in contrast with (b), which actually shows an 
activity optimum at zero time. Secondly, (b) gives a strong evidence of the 
inactivation equilibrium has taken place since half of the activity is lost at ~350 K, 
without any contribution deriving from thermal denaturation (zero time).  
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Figure 29. Comparison of the (a) Equilibrium and (b) Classical models of 
temperature dependence of enzyme activity. The data were simulated using parameter 
values: (a) ∆G‡inact=95 kJ mol−1, ∆G‡cat=75 kJ mol−1, Teq=320 K; (b) ∆G‡inact=95 kJ 
mol−1, ∆G‡cat=75 kJ mol−1. Note the absence of a temperature optimum at zero time in 
the Classical model [192].  
 
 
 
If currently, there is no evidence for the molecular basis of such a reversible 
equilibrium, experimental observations suggested that such interconversion must take 
place on a ms scale or faster [193]. To date, this recently proposed and 
experimentally validated model provides a full description of the temperature effect 
on enzyme catalytic activity for all 40 or so of the enzymes to which it has been 
applied and for which Vmax values can be obtained. Furthermore the equilibrium 
model has shown its usefulness in enzyme eurythermalism and thermophily [193]. 
For a more detailed description see [194, 195]. 
6.3. Material and Methods 
6.3.1. Enzyme perdeuteration 
For protein expression in perdeurated media, the plasmid encoding the DHFR 
gene was subcloned in a pET-24a (Novagen) vector that confers kanamycin 
resistance. Perdeuterated Bs DHFR was expressed in E. coli BL21 (DE3) competent 
cells. Cells were grown in minimal media ENFORS: 6.86 g/L (NH4)SO4, 1.56 g/L 
KH2PO4, 6.48 g/L Na2HPO4.2H2O, 0.49 g/L diammonium hydrogen citrate, 0.25 g/L 
MgSO4.7H2O, 0.5 mg/L CaCl2.2H2O, 16.7 g/LFeCl3.6H2O, 0.18 g/L ZnSO4.7H2O, 
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0.16g/L CuSO4. 5H2O, 0.15g/L MnSO4.4H2O, 0.18g/L CaCl2.6H2O, 5 g/l glycerol, 
40mg/L Kanamycin. To minimise hydrogen contamination, mineral salts were dried 
out in a rotary evaporator (Heidoph) at 333 K and labile protons were exchanged for 
deuterons by dissolving in pure D2O (99.8 %) and re-dried. Perdeuterated d8-glycerol 
(Euriso-Top, France) was used as a carbon source. Since D2O is toxic for most 
organisms at high concentration, E. coli cells were therefore adapted to fully 
deuterated medium in three steps [196]. Firstly cells were plated on Luria Bertani 
solid medium containing Kanamycin (40 mg/mL). A colony was selected and plated 
on a solid hydrogenated minimal medium. After overnight growth, cells were plated 
on a partially deuterated medium (v/v 15 % D2O). After 24-36 hours a colony was 
selected and plated on a v/v 30 % D2O medium. This operation was repeated until 
reaching a value of v/v 100 % D2O. Liquid deuterated media minimal medium was 
then inoculated with the adapted cells. Typically, 1500 mL of deuterated medium was 
inoculated with 100 mL preculture of pre-adapted cells in a 3 L fermentor (labfors, 
Infors). During the batch and fed-batch phases the pH was adjusted to 6.9 (by 
addition of NaOD) and the temperature to 303 K. Gas-flow rate was 0.5 L/min. 
Stirring was adjusted to ensure a dissolved oxygen tension (DOT) of 30 %. The fed-
batch phase was initiated when the optical density at 600 nm reached 6.0. D8-glycerol 
was added to the culture to keep the growth rate stable during fermentation. When 
OD600nm reached 12, DHFR overexpression was induced by the addition of 1 mM 
IPTG and incubation continued for 24 hours. Cells were then harvested, washed in 
100 mM NaCl, 10 mM HEPES (pH 6.8) and stored at 193 K. Purification of 
perdeuterated Bs DHFR was undertaken as described previously [56]. Protein purity 
was assessed by SDS-PAGE and molecular weight was determined by MALDI-TOF 
spectrometry. 
6.3.2. Determination of protein concentration 
Protein concentration was estimated using the Buiret reaction [197]. 0.5 mL of 
the the unknown protein solution concentration is mixed with 2.5 mL of Buiret 
reagent. The mix is let to stand for at least 15 min and no more than an hour. 
Absorbance is read at 540 nm and the protein concentration is determined against the 
protein standart curve. Samples are made in duplicate. The protein standart curve is 
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made by varying concentrations of stock standard bovine serum albumine solution 
from 1 to 10 mg/mL. The Buiret reagent consists of 0.96 g of CuSO4 (5 H2O); 4.89 g 
of sodium potassium tartrate; 300 mL of 10 % sodium hydroxide. The final solution 
is brought to 1 L with distilled water. 
6.3.3. Mass spectrometry: MALDI-TOF 
MALDI-TOF (Matrix-assisted Laser Desorption Ionization Time-of-Flight) 
analyses were performed using a Brucker Autoflex MALDI-TOF from Daltonik 
(Bremen, Germany) in linear mode. Data for several 2 ns pulses of the 337 nm 
nitrogen laser were averaged for each spectrum. An acceleration voltage of 25 kV and 
a laser intensity of of approximately 10 % greater than the threshold were used. A 
peptide calibration standard mixture (Brucker) of insulin (5734 Da), ubiquitin (8566 
Da), cytochrome C (12361 Da) and myoglobin (16952 Da) was used for external 
mass-axis calibration. A saturated solution of sinapinic acid in acetonitrile/water 
(70:30, v/v) containing 0.1 % TFA (Trifluoroacetic Acid) was used as a matrix 
solution. The protein (0.5 mg/mL) was mixed with the matrix solution at 1:10 
(sample: matrix, v/v) ratio. The sample/matrix solution (1 µL) was then deposited on 
the target plate and air-dried at room temperature. Samples were ionized with 100 
laser shots and spectra were obtained by summing at least 500 laser shots. Peptide 
masses were submitted to an analysis programme: Flex-analysis from Brucker 
Daltonik (Bremen, Germany) and molecular weights were determined using a 
Savitzky-Golay filter. 
6.3.4. Enzyme assays 
 Bs DHFR activity was measured continuously by following the decrease in 
absorbance at 365 nm (ε365= 16700 M -1 L cm-1) associated with the oxidation of 
NADPH and the reduction of dihydrofolate. Standard assay mixtures used sodium 
phosphate buffer 100 mM at pH 8 or pD 8 (using the relationship pD= pH +0.4), 800 
µM NADPH, H, 500 µM H2F and Bs DHFR at a concentration of typically ~3 nM. 
These substrates concentrations were maintained at ~ 10 times Km to ensure Vmax or 
near Vmax values were obtained. The reaction was initiated by the addition of 5 µL of 
enzyme to a cuvette containing 472.5 µL of buffer, 10 µL NADPH, H and 12.5 µL 
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H2F which has been preincubated 5 min at the appropriate temperature. Assays were 
run for 150 s 
 To analyse the solvent isotope effect, phosphate salts were prior exchanged 
three times in D2O before use by rotoevaporation. The substrate and cofactor were 
also deuterium exchanged at pD 8 and then lyophilized in presence of 1 mM DTT in 
a 100 mM ammonium bicarbonate buffer at pD 7.9. A detailed account of the 
experimental procedures needed to determine the Equilibrium model parameters is 
described in [198]. 
6.3.5. Data collection 
 The data were collected on a thermospectronic helios γ spectrophotometer 
equipped with a thermospectronic™ single cell peltier effect cuvette holder. This 
system was networked to a computer installed with Vision™ 32 (version 1.25, 
Unicam Ltd.) software including the vision enhanced rate programme: the time 
interval was set so that an absorbance reading was collected every second. Enzymatic 
assays were performed at a variety of temperatures, from 25 °C to 85 °C with 5 °C 
increments. Reaction progress curves were recorded in triplicate. The reaction rate for 
each assay was determined using Vision32™ Rate Programme and were repeated if 
the data deviated by more than 10 %. 
6.3.6. Data analysis 
 Using the values for ∆G‡cat (80 kJ.mol-1), ∆G‡inact (95 kJ.mol-1) ∆Heq (100 
kJ.mol-1) and Teq (320 K) as initial parameter estimates [191], the experimental data 
were fitted to the Equilibrium model using a standalone Matlab® (Version 7.1.0.246 
(R14) Service Pack 3, the Mathworks, Inc.) application, enabling the facile deviation 
of the equilibrium model parameters from a Microsoft® Office excel file of 
experimental progress curves (product concentration versus time). 
The standard deviation was not included in the tables as it refers to the fit of the data 
to the model. Based on the variation between the individual triplicate rates from 
which the parameters are derived for all the enzymes we have assayed thus far, we 
have found that the experimental errors in the determination of ∆G‡cat, ∆G‡inact and  
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Teq are less than 0.5 %, and less than 6 % in the determination of ∆Heq. For more 
details see [198]. 
6.4. Results 
 Below, are the results from four sets of experimental data aiming at 
understanding the effect of perdeuteration on the thermal parameters of Bs DHFR and 
also the solvent isotope effect induced by heavy water (table 7). I have only plotted 
one graph since the shape was very similar in all cases (figure 30).  
 
 
 
 
 
Enzyme Buffer Topt Teq ∆G‡ cat ∆G‡ inact ∆Heq 
  °C °C kJ mol-1 kJ mol-1 kJ mol-1 
Bs DHFR H2O* 64.2 53.3 66.5 97.9 91.9 
Bs DHFR D2O** 69.4 53.6 66.8 99.3 86.2 
dBs DHFR H2O* 70.5 55.5 67.9 96.9 90.0 
dBs DHFR D2O** 68.4 55 68.4 98.7 91.3 
 
Table 7. Summary of experimentally determined thermodynamic 
parameters.*sodium phosphate buffer 100mM pH 8 in H20, ** deuterated sodium 
phosphate buffer 100mM pD 8 in D2O 
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Figure 30. 3D plot of temperature dependence of Bacillus stearothermophilus 
dihydrofolate reductase activity. This plot was created as described in 'Methods' 
from experimental data to fit the equilibrium model. 
 
 
6.4.1. Teq, Topt 
 The hydrogenated Bs DHFR presents a Teq and Topt values of 53.3° C and 
64.2 ° C respectively. A previous study on Bs DHFR using the same methodology 
reported very similar values for Teq 53.9 ° C and Topt 63 ° C [199, 200]. In addition 
Klinman et al [56] have reported optimum activity values peaking at 75 °C at pH 7 
and 65 °C at pH 9. These findings corroborate well our results and also emphasize the 
thermal origin of the source organism. G. stearothermophilus is a moderate 
thermophilic organism with an optimal growth temperature of 55 °C. The close value 
of Teq and the growth temperature of G. stearothermophilus supports the idea by 
which Teq is an excellent parameter to predict the thermal environment of organisms 
as proposed in [200].  
 Teq shows a dependency by solvent substitution, the temperature shift is about 
1.5 to 2° C but is unaffected upon solvent substitution. We recall that Teq reflects the 
reversible equilibrium between the inactive and active form of the enzyme. An 
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increase means a higher ‘buffering effect’ in the interconversion Eact to Einact. As 
perdeuteration consists of exchanging covalently bound hydrogens to deuterium, it 
implies that only the interactions affected by deuterons are responsible for such shift. 
Additionally, it is interesting to note that solvent substitution does not significantly 
affect Teq. The H2O/D2O substitution primarily affects exchangeable hydrogens found 
thorough the protein structure and solvent. Consequently, these observations suggest 
that the ‘hydrogen-exchangeable’ network, a prerequisite in normal enzyme structure, 
did not modify the equilibrium between the active and inactivated complex. On the 
other hand, Topt behaves differently over perdeuteration. The Topt value is higher 
upon perdeuteration ≈ 5 °C, but in the mean time, this effect is annealed upon solvent 
substitution. The values remain constant around a mean value of 68-69 °C. This 
compensation over solvent substitution might underlie a complex interaction between 
the effect of temperature on activity and stability.  
6.4.2.  kcat, ∆G‡ cat 
Table 8. Summary of experimentally determined ∆G‡ cat and kcat 
* Sodium phosphate buffer 100 mM pH 8 in H2O 
** Deuterated sodium phosphate buffer 100 mM pD 8 in D2O 
 
 
 The perdeuteration systemically lowers the turn over number of the enzyme 
whether a deuterated buffer is used or not. The kcatD/kcatH ratio between the light and 
heavy enzyme is almost constant ~0.5-0.6 at all tested temperatures (see Appendix). 
Perdeuteration changes the temperature dependence of the rate constants as shown by           
∆G‡cat values. Additionally, solvent substitution impacts clearly in this discrepancy. It 
accounts for a decrease of 10 to 15 % in the kcat values for both enzyme preparations. 
These data together with those from the literature, indicate that perdeuteration can 
affect negatively the rate of catalysis [201-203]. However, this effect is relatively low 
H2O buffer* D2O buffer** 
 
kcatD/kcatH Enzyme 
 
∆G‡ cat 
( kJ mol-1) 
 
kcat 
(s-1) kcat
D/kcatH 
 
∆G‡ cat 
( kJ mol-1) 
 
 
kcat 
(s-1) 
 
 
Bs DHFR 66.5 117 66.8 105 
dBs DHFR 67.9 69 0.59 68.4 58 0.55 
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in comparison of DIE effect which accounts usually over tenfolds difference in rate 
[204, 205]. 
6.4.3. ∆G‡inact, t1/2, 
Table 9. Summary of experimentally determined ∆G‡ inact and t ½ at 323 K. * 
sodium phosphate buffer 100 mM pH 8 in H2O, ** Deuterated sodium 
phosphate buffer 100 mM pD 8 in D2O 
 
  
The half-life (t 1/2) of an enzyme is the time it takes for the activity to reduce to a half 
of the original activity. The deuterated enzyme shows a lower inactivation energy 
which means a lower t1/2 both in heavy and light water. The perdeuterated enzyme is 
almost ≈ 1.5 fold less stable than its protiated equivalent. Additionally, using a 
deuterated buffer we observed an increase in t1/2 of 1.7 and 1.9 for the hydrogenated 
and perdeuterated enzyme respectively. The observed effect is very similar for both 
enzymes and reveals a clear stabilisating effect over solvent substitution. 
6.4.4. ∆Heq 
 
∆Heq gives the enthalpy change from the active to the inactive form of the 
enzyme. It can be considered as a measure of the sensitivity of the enzyme catalytic 
activity to temperature.  Due to the very small amplitude of the differences and the 
relatively high error introduce by the experimental sampling (5%), the values 
presented here between perdeuterated and protiated enzyme and over solvent 
substitution are not considered to be statistically significant. Nevertheless ∆Heq is in a 
quantitative fashion a measure of the enzyme’s ability to function over a broad range 
of temperature: eurythermalism [200]. The application of the model to 22 enzymes 
[200] has allowed to scale up ∆Heq. Bs DHFR and alkaline phosphatase from Bos 
taurus present the smallest ∆Heq over the various enzymes studied. It means that Bs 
H2O buffer* D2O buffer** 
Enzyme ∆G
‡inact 
( kJ mol-1) 
t1/2 
(s) 
∆G‡inact 
( kJ mol-1) 
t1/2 
(s) 
Bs DHFR 97.9 713 99.3 1189 
dBs DHFR 96.9 480 98.7 930 
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DHFR will function at relatively high activity over a broad range of temperature, i.e. 
behaves in a eurythermal manner. Conversely, the perdeuration has no effect on this 
thermal property.  
6.5. Discussion 
The first goal of this study was to characterize the effect of perdeuteration on Bs 
DHFR kinetic and temperature dependency prior neutron crystallography. We have 
obtained significant changes upon deuteration (which are commonly believed to be 
small) using an original model: the equilibrium model.  
We have observed a lower catalysis efficiency: kcat upon perdeuteration, about 
half of the activity is lost in both heavy and light water buffer. A similar reduction of 
the rate of catalysis was reported by Rokop et al using a deuterated alkaline 
phosphatase [206]. The reasons for this decrease in activity might be widespread 
since many factors contribute to enzyme activity. For instance, perdeuteration was 
reported to change significantly the pKa of catalytic residues [207]. Thus, it can led to 
a completely new reaction site motif and modify the recognition of substrate, bond 
formation and so on. Other studies using gluthatione S-tranferase reported an increase 
of 25 % of the catalytic rate of the enzyme when deuterium labelled [177]. 
Cytchrome P450 [181] or Human Arginase I [180] exhibit identical activity upon 
perdeuteration. It seems that perdeuteration can affect rates of catalysis either 
positively or negatively. Consequently, the effect of perdeuteration on protein and 
enzyme activity is very versatile. The structural and physicochemical requirement 
implied by the reaction pathway might be the key stone in this interdependency but 
need to be tested over a large number of enzymes with various kinetic mechanisms.  
Teq is higher upon perdeuteration and it is suggested to be an active site linked 
phenomena [185, 192]. If it is clear that Teq is independent of ∆G‡cat and ∆G‡inact, it is 
interesting to note that the observed change in kcat is accompanied with a change in 
Teq: higher Teq with lower kcat. It might be a coincidence but the inter-relationship 
between these two parameters is intriguing but it has not been discussed since the 
molecular basis of the model is not known. kcat measures the overall catalytic power 
of the enzyme and if it is highly dependent of the active site, distal portions of the 
enzyme might also participate in the catalysis. On the other hand Teq examines 
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possible conformational changes at the active site and more precisely a subtle 
equilibrium between an active and inactive form of the enzyme. A simple hypothesis 
would be: A higher Teq might reflect a higher resilience (rigidity) of the system 
enabling a higher buffering effect between Eact and Einact. However, the cost of this 
stiffening effect would result in a reduced kcat. Interestingly Teq remains unchanged 
over solvent substitution. One explanation is that the effect is too small to be 
measured (less than 5%) or the hydration and water network has little influence on 
the equilibrium. Stabilizing agent such as glycerol has no effect on Teq. Glycerol 
protective mechanism is often attributed to a ‘preferential hydration’ of the protein 
without modifying its conformation [208]. Overall it seems that D2O and glycerol 
enhance the stability of the whole protein rather at the active site. If Teq is an active 
site parameter then it is normal that the value remains constant over solvent isotope 
substitution. Interestingly Teq is related to the fundamental thermodynamic 
parameters the enthalpy ∆Heq and entropy ∆Seq as follow: 
 
eq
eq
S
H
∆
∆
=eqT
                                                                Equation 46 
  with   eqeqeqeqeq ∆ST∆HRTlnK∆G −=−=                             Equation 47 
 
Equations 46 and 47 show unambiguously that an entropy and enthalpy compensation 
mechanism can explain why Teq remains constant over solvent substitution. Such 
enthalpy-entropy compensation have been observed in many systems [209]. It has 
been suggested that hydration was probably responsible for the observed 
consequence. However to fully understand this phenomenon, the dissection of the 
energetics behind Teq is necessary. Important details of the inactivation process are 
certainly impaired. The thermal stability of a protein depends generally on the 
balance of several factors, including ionic force, pH, steric crowding of the transition 
state, etc...[82]. In the present study, the measured ∆Ginact reflects the irreversible 
thermal inactivation of the inter-conversion of Einact to X. The perdeuterated enzyme 
shows systemically a smaller ∆G‡inact. This clearly demonstrates a destabilization 
effect due to perdeuteration. Deuterated proteins are generally less stable against 
thermal unfolding [181, 206, 210]. The exchange of the covalently bound hydrogens 
by deuterium reduces essentially the hydrophobic interactions between amino acids 
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[210, 211]. Hence, hydrophobic forces are believed to be the key stones in protein 
stability [178]. A reduction of these stabilisating forces would invariably decrease the 
overall stability of the protein. The destabilizing effect may be caused by steric 
crowding. Hattori et al [211] suggested that C-D bonds have a lower steric 
requirement compared to the C-H bonds. This implies a reduction of the bond 
vibration amplitude which diminishes the steric constraints for forming the activated 
complex and therefore diminishes the activation energy for the thermal unfolding of 
the protein to occur. With the present model we can not probe in the strictest sense if 
the protein is globally unfolded or tends to form aggregates. However it has been 
argued than intermolecular contacts between side chains are more pronounced in 
perdeutrated proteins. The side chains become more hydrophobic and less bulky 
which facilitate aggregation [212]. Non-specific or inappropriate interactions would 
result in a whole destabilizing effect of the ensemble. In contrast, the solvent 
substitution outweighs the destabilizing effect of perdeuteration. It is well known that 
protein in D2O buffer show a higher thermal stability than in H2O [105, 174-176]. 
This is curious at first glance since proteins have evolved in protonated environment 
but the explanation of this apparent contradiction is: Substitution of H2O by D2O 
affects only the exchangeable hydrogens which form the hydrogen bonds in proteins. 
Hydrogen bonds are strengthened by deuteration cause of their larger mass rest that 
leads to lower vibration frequencies, respectively lower bond energy for the donator-
D bond (peptide N-D) compared to the donator-H bond (peptide N-H). This facilitates 
the bonding to the acceptor atom (peptide C-O). Consequently, it is predicted that 
hydrophobic bonds involving non polar side chains of protein will be slightly stronger 
in D2O than H2O [178]. For proteins, it leads to stronger hydration bonds a lower 
solubility of apolar group which favours hydrophobic interactions [105]. 
Accordingly, the native structure of the protein will be better maintained in D2O than 
H2O. To understand the energetics behind this stabilisating effect, a thermodynamic 
analysis is required. It has been undertaken in a number of studies using calorimetry 
[213], enzyme kinetics [174] or analytical centrifugation [178]. As deuterium bonds 
are somewhat stronger than hydrogen bonds, it will not be surprising to find larger 
enthalpy values for the inactivation process in D2O than H2O. Accordingly if the 
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enthalpy changes, the entropy term is also expected to be changed too. Conversely, as 
described by the following equilibrium  
 
 
 
                                                                                                                           Diagram 5 
 
The critical step at which Einact undergoes the irreversible denaturation to state X must 
be energetically more demanding than Eact to Einact. The dissection of the energy 
involved in both conversions would undoubtedly reinforce the relevance of the 
equilibrium not only in enzymology but overall in protein thermal stability. 
Biophysical means such as calorimetry, circular dichroism or fluorescence would 
certainly help to initiate the first step.  
In conclusion, the Equilibrium model has been successfully applied in this 
study. It has yielded a number of significant differences in the thermal and functional 
behaviour of the deuterium labelled and non labelled DHFR. As presented in the 
introduction, the major application of perdeuterated proteins is ‘structural’. It is 
actually a tool aimed at resolving atomic structure by neutron crystallography, SANS 
or NMR. This particular application may have led to a common idea that 
perdeuteration is not invasive as the differences in terms of structures are very subtle 
and difficult to draw (depending on the resolution shell). However, differences exist 
and are not easy to predict. The methodology used during this particular study allows 
and required the presence of the substrates and or products (i.e., physiological 
conditions) and may have also magnified the effect. Our data with those from the 
literature indicate that, the physicochemical properties between protonated and 
perdeuterated proteins can be quite different [177, 181]. If in general it is not easy to 
draw a common pattern, the thermal behaviour and the solvent isotope effect 
observed agreed well with a number of studies [174, 181, 210, 211, 213, 214]. 
However the effect on enzyme activity was quite surprising, being large in 
comparison with other studies which tend to favour a limited effect on protein 
activity [177, 181, 207]. These findings might indicate either a specific case with Bs 
DHFR or ability of the model to emphasize small differences which are thought to be 
small. The effect of perdeuteration and or solvent substitution is maybe more 
complex or magnified when the effect of temperature is investigated in parallel.  
Kinact Keq 
E act E inact X 
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It is also interesting to note the lack of evidence on the molecular basis of the 
equilibrium between Eact and Einact. Although there is no currently no evidence of 
connecting protein dynamics to the molecular basis of the equilibrium, there is a 
strong correlation between protein stability and protein dynamics. Thus we might 
expect a change in protein dynamics maybe localised at the active site when 
temperature is raised or approaches Teq. The debate of how global and active site 
protein dynamics participate in protein function is still unravelled. Interestingly a 
recent study using α-chymotrypsin has concluded conformational dynamics at the 
active site have a distinct connection with the enzyme functionality [215]. It is very 
tempting to include Teq in this scheme. Teq is considered as the thermal equivalent of 
Km so it is intrinsically a measure of the energetics involve in the transition state. Teq 
could be an informative probe of active site dynamics reflecting their connection to 
temperature (i.e. activation energy). This hypothesis needs to be tested but actually 
the bottleneck is coming from the timescale and space covered by the instruments. In 
this quest, there may be role for perdeuterated proteins as an indirect informative 
probe. Selective deuteration of active site residues may shed the light if Teq is an 
active site phenomenum without the requirement of fast acquisition methods such as 
stop flow in combination with laser temperature jump devices [216]. Techniques 
using the kinetic isotope effect (induced by the labelling of at least one of the reactant 
in enzyme reaction) have been extremely powerful to detail enzyme mechanisms 
[217]. The perspectives of heavy water and deuterated compounds are therefore 
widespread and also extended to physiological, pharmacological and also drug design 
[173]. 
 
7. Preparation of samples for neutron crystallography 
and protein perdeuteration 
7.1. Introduction 
 
One of the subsidary goals of this thesis is to rationalize the tremendous power 
of MTX. Here the proposal is to use X-ray crystallography and neutron 
crystallography in combination with the ITC data to obtain a comprehensive picture 
of the energetic and architecture that govern the MTX-DHFR complex. This chapter 
will summarize the actions that have been taken to prepare samples for X-ray and 
neutron experiments, including efforts to obtain crystals and to effectively fully 
deuterate the enzyme Bs DHFR. 
Although this chapter does not provide the full description of the atomic 
structure of the MTX-DHFR complex (refined structure), a number of preliminary 
results have been obtained. Technical parts such as protein perdeuteration, crystal 
genesis are described. The reason why the X-ray structure has not been entirely 
refined is primarily financial. This work as the neutron experiment, planned originally 
at the end of this year, 2008, have been therefore postponed. I have done this work 
with the help of Dr Suzanna Teixeira, ILL, Grenoble. She has introduced me to all the 
aspects of protein crystallization and data collection at the ESRF, Grenoble. I have 
grown and successfully obtained crystals. The structure refinement was made by 
myself under her supervision and kindly advice.  
 The catalytic mechanism and ligand binding of DHFR is still a matter of 
controversy. Indeed previous evidence from X-ray crystallography, NMR, UV/VIS 
difference, and fluorescence spectra suggest that the N1 atom of MTX is protonated 
and, thus, positively charged when bound to DHFR [67, 70, 218-220]. The binding of 
MTX in the DHFR active site is such that the N1 atom is within 2.6-2.7 Å of the Oδ2 
of Asp27. It has been suggested that the orientation of the pteridin ring is flipped over 
a 180° rotation about the C6-C9 bond as compared to the folate and H2F [218]. The 
close proximity of N1 (MTX) when bound to Asp27 carboxylate group (DHFR) 
strongly suggests an electrostatic interaction, possibly a salt bridge (please see figures 
9-11 for additional details on the DHFR/MTX complex and interaction). In contrast a 
recent study using molecular dynamics suggests that Asp27 is protonated whereas the 
N1 of MTX is not [221]. The interaction is suggested to be neutral dipole-dipole 
rather than ionic. In order to resolve the present controversy that represents a gap in 
our understanding of DHFR’s catalytic mechanism and ligand binding, a number of 
structural studies have been initiated. Structural insights on an atomic scale can be 
explored with a number of techniques such as X-ray crystallography. However, 
hydrogen atoms interact weakly with X-rays, causing ambiguities in their accurate 
positioning upon electron density maps. On the other hand neutron crystallography is 
well suited for resolving the position of hydrogen atoms in macromolecules [222]. It 
can resolve the position of hydrogen atoms, especially the deuterium isotope at a 
moderate resolution (at 2.5-2.0 Å and beyond) [222]. Nevertheless, neutron 
crystallography has a number of disadvantages. The refinement of the structure and 
phasing need a model which is often determined by X-ray crystallography. The first 
step is therefore to obtain the X-ray structure and then move to the neutron 
experiment. In addition, because of the weak flux generated by spallation or reactor 
sources, crystal volume needs to be sufficiently high to get sufficient signal to shorten 
the time needed for the data collection. For instance, crystal volume of 1 mm3 is often 
a pre-requisite for a neutron structure and the data collection is generally operated 
over 15 days (LADI, ILL, Grenoble). Another disadvantage of neutron 
crystallography is that hydrogen nuclei have a strong incoherent component. 
Hydrogen atoms appear as negative peaks in neutron density maps and impair the 
signal by ‘cancelling’ positive neutron scattering from the atoms to which they are 
covalently bound like carbon or nitrogen. This problem can be overcome and the 
signal to noise ratio improved by exchanging hydrogen atoms (H; M= 1.0063 Da) by 
deuterium (D; M= 2.0126 Da). This can be done by soaking or growing the crystal in 
D2O based buffer. In this case, only chemically exchangeable hydrogens (such as 
hydrogen bound to amino, hydroxyl and carboxylate groups) would be replaced by 
deuterons. Another way is to express the protein in E. coli cells grown in D2O based 
media. This latter process is called perdeuteration and has the advantage to replace all 
the hydrogens by deuterons even at chemically non-exchangeable positions such as 
hydrogens bound to aliphatic or aromatic carbons. H/D exchange in proteins 
significantly reduces the background of neutron data collection, due to deuterium 
positive and coherent scattering behaviour.  
7.2. Technique overview: X-ray crystallography 
X-ray crystallography is a method used to resolve the three-dimensional 
structure of a molecule or complex of molecules [223]. This is done through the 
interpretation of the characteristic diffraction pattern obtained when a crystal of such 
a compound is irradiated with X-rays of a certain wavelength, under specific 
experimental conditions. 
X-ray crystallography has proven its significance with the determination of 
keystone mechanisms in enzymology, chemistry and physics [224]. The structure of a 
macromolecule contains vital informations on its function. There is a tight 
relationship between structure and function, at many levels, in all living organism. 
We can therefore understand or predict the properties of an increasing number of 
compounds with this technique. The range of application has increased tremendously 
with instrument development and new sources opening around the world.  
The following pages will introduce to the main aspects of the theory of X-ray 
scattering. Additionally the description of the methods used in crystal genesis, data 
collection and refinement process will be given. 
7.2.1. Crystallization theory 
7.2.1.1.Protein crystallization 
Obtaining crystals is currently the bottleneck in protein structure 
determination by X-ray crystallography [225]. The most frequently used 
crystallization methods are the vapour diffusion and the dialysis technique. The first 
technique is usually aimed at defining the crystallization conditions, and the 
screening can be carried out relatively rapidly. With the development of nano-drop 
robots, hundreds of conditions can be tested within a day. The second technique using 
dialysis buttons is less frequent in lab routine but it is very useful when large crystals 
are needed for neutron experiments. We have used both techniques to obtain large, 
well diffracting crystals. 
Crystallization is not a trivial and fully understood process. It is still a semi 
empirical process often described as ‘an art’ in the literature [226]. Crystallization is a 
fine equilibrium between a fluid and solid phase of a given material. It depends and 
can be influenced by a high number of interdependent variables difficult to control 
such as temperature, ionic strength, pressure, impurities, etc. The interplay between 
these various ‘actors’ make crystallization very complex and hard to predict. In 
contrast, the fundaments behind the process of crystallization can be simply 
illustrated by figure 31. 
 
Figure 31. A schematic diagram of a typical solubility curve (from www-
structmed.cimr.cam.ac.uk). 
 
This schematical picture shows a typical solubility curve for a macromolecule 
to be crystallized. Nucleation is achieved with either increasing the molecule or 
precipitant concentration. The plot can be divided into four main phases: Above the 
solubility curve there is the so called metastable zone, where supersaturation is 
achieved. Nucleation does not occur here, as an energy barrier needs to be overcome 
for protein/protein contact to occur (figure 32). At higher concentrations (either 
protein or crystallizing agent) the nucleation zone begins, and therefore the 
crystallization process. Ideally, when a few nuclei are present, crystals start to grow 
and the concentration of the protein in solution starts to decrease, reaching the 
metastable zone. If the concentrations are increased, the protein will start to 
precipitate and eventually lead to phase separation. 
 
Figure 32. Energy diagram for crystallization (from www-
structmed.cimr.cam.ac.uk). 
 
Crystallographers have found ways to rationalize this particular work: statistical 
approaches based on the experimentally resolved structures [227] or specific 
screening methods. Crystallization usually begins by screening over a wide range of 
conditions until preliminary conditions are determined. The refinement of the primary 
conditions will operate as a fine tuning, enabling the production of optimal crystals. 
This process can take from days, to months or even years. Several techniques have 
been developed to crystallize proteins with a better control of the variable at stake, 
reproducibility, efficiency, and cost in terms efforts and samples. By far the most 
popular are the vapour diffusion methods which basically concentrate the sample 
slowly through vapor diffusion. The two most well known variants of this technique 
are the hanging drop and the sitting drop. The macromolecule is usually placed in a 
drop containing a buffer and one or more salts. The drop is equilibrated against a 
reservoir containing one or more molecules such as PEG (Polyethylene Glycol), 
MPD (methyl 1-2, 4-pentanediol) These act as precipitating agents and the 
spontaneous diffusion of water vapour from the drop to the reservoir will concentrate 
the macromolecule in the drop, which ultimately will form nucleation sites. These 
methods are easy to set up, relatively cheap and alow the fast screening of a large 
number of conditions. However, they usually require a large amount of sample. The 
representation of the apparatus needed for these operations is given by figure 33. 
 
 
Figure 33. Schematical representation of the two variants of the vapour diffusion 
method. (A) corresponds to the hanging drop method whereas (B) illustrates the 
sitting drop method (from www.kenividilaseris.wordpress.com). 
 
Others strategies make the use of different techniques such as the batch method, 
liquid-liquid diffusion methods, dialysis methods. The batch method brings the 
macromolecule to the nucleation zone when the system moves slowly from the 
supersaturation zone to the metatasble zone. This method requires a relatively small 
amount of the macromolecule and other reagents but remains less successful than 
vapour diffusion. In liquid-liquid diffusion methods the macromolecule is slowly 
mixed with the precipitating solution by diffusion. When capillaries are used, gels 
create barriers between solutions thus slowing down the process. This usually creates 
a concentration gradient itself intiating the nucleation process. This method requires a 
considerable amount of material but produces large crystals that can be easily and 
directly tested for diffraction. Dialysis methods are somewhat interesting as they 
allow a slow change of the precipitating solution. This method is often used in 
dialysis buttons sealed with a permeable membrane with a defined cut off. The 
advantages of this technique are of particular importance when the macromolecule is 
not stable if sudden changes are made in the crystallization buffer. It could also allow 
the diffusion of any molecules at any stage of the crystallization. This is particularly 
useful when one wants to add a specific ligand to an enzyme or add a cryo protecting 
solution with minimal damage to the crystal. In addition because of the large volume 
of the buttons (50 to 200 µL) large crystals can be obtained which is an asset for 
neutron crystallography.  
Besides these common techniques, a number of factors have to be taken into 
account for the optimization of the crystals. For instance, the drop size, the 
temperature, the speed of diffusion, etc, could have a strong influence on the results. 
If a ‘good looking’ or promising crystal is obtained the next step is to test their 
diffracting pattern.  
7.2.2. X-ray scattering and crystals 
A crystal is a periodic solid with an internal ordered structure, made of the 
repetition of building locks called a ‘unit cell’ in three dimensions [223]. The unit cell 
can be described by the length of its edges (a, b and c) and the angles between them 
(by convention: α is the angle between b and c, β is the angle between a and c, γ is the 
angle a and b). A crystal structure can be made of primitive or multiple unit cells but 
certain conventions have been established to guide the choice. The unit cell should be 
of the smallest for which, the vector coincides with direction of the highest 
symmetry. A symmetry operation is an operation that can be performed either 
physically or imaginatively that results in no change in the appearance of an object. 
For crystals the symmetry is internal and if each unit cell can be represented by a 
single point, the result is called a crystal lattice, which is an imaginary three-
dimensional arrangement of points such that the view in a given direction from each 
point in this lattice is identical to the view in the same direction from any other lattice 
point. The convolution of the structural motif and the crystal lattice will detail the 
entire crystal structure. 
The defining property of a crystal is its inherent symmetry, by which we mean 
that under certain operations the crystal remains unchanged. Depending on the type of 
unit cell, there are seven possible crystal systems. Crystal systems are a grouping of 
crystal structures according to the axial system used to describe their
lattice. Each crystal system consists of a set of three axes in a particular geometrical 
arrangement. The simplest and most symmetric, the cubic (or isometric) system, has 
the symmetry of a cube, that is, it exhibits four threefold rotational axes oriented at 
109.5 degrees (the tetrahedral angle) with respect to each other. The other six 
systems, in order of decreasing symmetry, are hexagonal, tetragonal, rhombohedral 
(also known as trigonal), orthorhombic, monoclinic and triclinic. Combining the 
various possible lattice centerings with the different crystal systems defines the 
Bravais lattices. They describe the geometric arrangement of the lattice points, and 
thereby the translational symmetry of the crystal. In three dimensions, there are 14 
unique Bravais lattices which are distinct from one another in the translational 
symmetry they contain. Symmetry operations in a crystal are not limited to 
translation, other types of symmetry are found: rotation, reflection and inversion. The 
crystallographic point group or crystal class define mathematically the different group 
of symmetry enumerated earlier. There are 32 possible crystal classes, classified into 
one of the seven crystal systems. The result of combining the 14 Bravais lattices with 
the 32 point groups and translational symmetry (glide and screw axes) define the 
space group of the crystal structure. There are 230 distinct space groups but for 
proteins this number is lower, as only L amino-acids occur naturally and because of 
the chirality of α-helices. In fact, any symmetry operation that would change the 
handedness of the structure is not allowed (mirror planes, inversion centers). The 
same thing can be said about DNA with its helical structure. This leaves 65 possible 
space groups for biological molecules [223]. 
7.3. Diffraction 
7.3.1. Bragg’s Law 
The scattering of electrons, X-rays and neutrons by crystals can be described 
as a reflection of the beams at planes of atoms (lattice planes). If the incident plane 
wave hits the crystal at an arbitrary angle, the interference of the reflected waves can 
be either destructive or constructive. For a constructive interference to occur, the path 
difference between the two incident and the scattered waves, which is 2dsinθ, has to 
be an integer number of wavelengths (nλ). For this case, the Bragg law then gives the 
relation between interplanar distance d and diffraction angle θ: 
dhkl 
nλ = 2dsinθ                                         Equation 48 
When X-rays strike a crystal they will be diffracted when and only when, this equation 
is satisfied (figure 34). 
 
 
7.3.2. Notions of reciprocal lattice 
The crystal lattice describes the internal crystal structure but does not provide 
information on the detailed arrangement of atoms within a unit cell. The main 
question is: How do we know the relationship between the crystal and the diffraction 
pattern that we will obtain from it? 
In this case it is often easier to think of the diffraction experiment with respect 
to a reciprocal lattice rather than the crystal lattice plane. The concept of reciprocal 
lattice was proposed by Josiah Willard Gibbs in 1884 [228] and introduced in 
crystallography by Ewald in 1921 [229]. The reciprocal lattice is constructed from the 
spacing between the crystal lattice planes dhkl. In the reciprocal lattice the point hkl is 
drawn at a distance 1/dhkl from the origin and in the direction of the perpendicular 
between the lattice planes. The concept of reciprocity has already appeared intuitively 
in Bragg’s law. It is clear that sinθ is proportional to 1/d. It is therefore easier to 
convert 1/d to a reciprocal d* that will have a direct relationship to sinθ. For this 
 
 
Figure 34. Schematic representation of a crystal lattice (black dots correspond to the 
lattice point) with a distance dhkl between the lattice plane. θ is the angle of reflection. 
(from www.microscopy.ethz.ch/bragg.htm). 
reason it is more convenient to describe scattering of X-rays by a crystal in an 
imaginary lattice called the reciprocal lattice. The reciprocal lattice is constructed on 
the a*, b*, c* axis derived from the (direct) crystal lattice axis so that a* is 
perpendicular to b and c, b* is perpendicular to a and c and c* is perpendicular to b 
and a. 
7.3.3. The Ewald sphere 
The Ewald sphere is a geometrical description of diffraction which 
encompasses both the Bragg’s law and the Laue equations. It was initially proposed 
by P.P. Ewald [229] In the Ewald construction (please see figure 35) a circle with a 
radius proportional to 1/λ with the crystal as is drawn. The Ewald construction 
provides a geometrical relationship between the orientation of the crystal and the 
direction of the X-ray beams diffracted by it. The advantage of this description is that 
it allows the determination of which Bragg reflections will be observed knowing the 
orientation of the crystal with respect to the incident beam. As the crystal is rotated, 
so is its crystal lattice and thus also the reciprocal lattice. If during the rotation of the 
crystal a reciprocal lattice point (hkl) intersects the sphere, Bragg's law is satisfied. 
 
Figure 35. The construction of an Ewald circle, radius 1/λ, with the crystal at the 
center C. So and S are the incident wave vector and scattered wave vector 
respectively. 
 
The result is a reflection in the direction So, with values of h, k, l corresponding both 
to the values of the reciprocal lattice point and for the crystal lattice planes.  
7.3.4. Structure factors and electron density: the phase problem 
Previously we have seen how to obtain a diffraction pattern. The question 
arising now is: how do we get from the diffraction data to a model of the actual 
protein structure? 
The X-ray diffraction pattern of a crystal is made of a multitude of spots with 
various intensities. If we measure the intensities and the position of reflections, we 
would in principle determine the geometry of the crystal lattice (driven by the spatial 
arrangement of the spots) and the arrangement of atoms within one unit cell (given by 
the intensities). With the symmetry operations implied by the direct lattice, the entire 
crystal structure will be solved with only one cell. The intensities recorded on an X-
ray detector during data-collection can be expressed as: 
))((2 AbsLpFKI =                      Equation 49 
Where F is the structure factor, K is a scale vector (necessary to bring all reflections 
into the same scale), Lp is a geometric correction (combination of geometric 
corrections-shape, orientation and composition of the crystal), Abs is a correction due 
to absorption effects. This intensity is proportional to the square of the structure 
factor amplitude, |Fhkl|. A structure factor describes the way in which an atom or 
group of atoms scatter X-rays. The structure factor F|hkl| for a reflection h,k,l itself is a 
complex number derived as follows : 
( )[ ]jjjn
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                                            Equation 50 
fj is the scattering factor of atom j, and h, k, l the three indices of the 
corresponding reflection. Of particular importance is the exponential which appears 
as a complex number with x,y,z the fractional coordinates of each atom in the 
summation. There is an imaginary component that applies to the phase component: α, 
of the structure factor. The real importance of this missing component is signified in 
the electron density (ρ) equation, which is described as a Fourier series: 
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Equation 51 
Where |Fhkl| is the amplitude of the structure factor, V is the volume of the 
unit cell, i is the imaginary part of the complex number and αhkl is the phase of the 
reflection hkl. As seen in equation 45, the electron density is expressed as a function 
of structure factors. We are transforming an inverse space into a real or direct space 
(the electron density at a real point x,y,z in space). This transformation is accurate 
and in principle complete but several parameters need to be determined to calculate 
the real structure. Particularly, we need the complex structure factors F(hkl) but we 
know only their magnitude |Fhkl|. Indeed, we know only the absolute value 
(magnitude) of the complex structure factor Fhkl but not its phase, αhkl. To fully 
characterize the electron density, the phase angle of each reflection αhkl must be 
known. However, it can not be measured directly: this called the ‘phase problem’ in 
crystallography. A number of methods have been established to solve this problem 
and will be described next. 
7.3.5. Methods to solve the structure 
Because we can not measure the phase directly, we have to deduce it 
indirectly. There are a number approaches following four general methods (that can 
be used either separately or combined): direct methods, Molecular Replacement 
(MR), Isomorphous Replacement (IR) and Multiwavelength Anomalous Dispersion 
(MAD). Selection between different techniques and between different programs is a 
very important step for protein structure solution. Many structures were never been 
solved due to mistakes in structure solution procedure, which in fact ruins all protein 
crystallography experiments. 
7.3.5.1.Direct methods 
The argument that phase information is lost in the diffraction process is not 
totally correct. The phase problem can be solved directly from the experimental data: 
|Fhkl| values. The direct methods basis [230] exploits two conditions. Firstly, the 
scattering density must be a positive real number (or zero) as the probability to find 
an electron at a position (x,y,z) can not be negative. Secondly, the electron density 
maps should have high values near atomic position and zero elsewhere else. If these 
two conditions are satisfied then the correct value of α(hkl) would appear in the Fourier 
series. Herb Hauptman and Jerome Karle won the Nobel Price in chemistry (1985) 
owing to their pioneering and outstanding contributions on direct methods. At 
present, direct methods are the preferred method for phasing crystals of small 
molecules having up to 1000 atoms in the asymmetric unit. However, they are 
generally not appropriate for larger molecules such as proteins [230, 231]. 
7.3.5.2.Molecular replacement 
This is by far the most popular method to solve protein structure and the basic 
ideas were described by Michael G. Rossman and David M. Blow in 1962 [230, 232]. 
The principle is quite simple, as you need to place the model structure in the correct 
orientation and position in the unknown unit cell. To orient a molecule you need to 
specify three rotation angles and to place it in the unit cell you need to specify three 
translational parameters. The molecular replacement problem is therefore a 6-
dimensional problem but to minimize time and power it is separated in two 
independent searches. So, it became two three-dimensional problems. A rotation 
function can be computed to find the three rotation angles, and then the oriented 
model can be placed in the cell with a 3D translation function. Molecular replacement 
(MR) commonly used a structurally related model (or portion) of the unknown 
structure in the crystal. As a rule of thumb, MR requires a model that shares at least 
40 % sequence identity with the unknown structure. It becomes progressively more 
difficult as the model becomes less complete or shares less sequence identity. The 
first step in MR is to calculate the Patterson map for both, the models and the 
unknown structure. The Patterson function was introduced by A. Lindo Patterson in 
1934 [233]. It is a Fourier synthesis that does not require phase information. It is 
usually defined as: 
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Where (u v w) is a vector from a position x, y, z to another x + u, y + v, z + w. The 
Patterson map gives information on the orientation of a molecule of known structure 
in the unit cell. It is therefore very useful for positioning the unknown structure in the 
new unit cell. First a rotation function is used to assess the degree of agreement or 
coincidence between the two Patterson function from each model, i.e.if peaks overlap 
in the two maps. Once the orientation of the molecule is determined it is necessary to 
position the molecule with respect of the crystallographic axes. A translation function 
is therefore used to find the translation necessary to move the correctly oriented 
molecule in the unit cell. The solutions are found when the differences between the 
observed and calculated positions are minimal. 
There are a number of different MR methods, all differing in the rotation and 
translation function used. For instance AMoRe (automated Molecular replacement 
package, [234]) screens the superposition of the Patterson maps in a particular 
volume of the unit cell. However AMoRe requires a high homology between the two 
structures. It also often fails when there are multiple copies of the model inside the 
unit cell. To overcome this problem, alternative MR methods using different 
maximum likelihood algorithms were introduced. MR programs such as Refmac 
[235], MOLREP [236] or Phaser [237]. Maximum likelihood is a statistical method 
used for fitting a mathematical model to some data. In crystallography it means that 
the likelihood of the model given the data is defined as the probability of the data 
given the model. It asserts that the best model on the evidence of the data is the one 
that explains what has in fact been observed with the highest probability [238]. The 
introduction of maximum likelihood estimators into the methods of refinement, 
experimental phasing and, with Phaser, has substantially increased success rates for 
structure solution [237]. However, in case of DNA, MR methods show their 
limitations. Elongated molecule or stacked structures are non trivial and are usually 
approximated with errors. 
7.3.5.3.Isomorphous replacement 
This method derives the relative phase by comparing the intensities of 
corresponding Bragg reflections from two or more isomorphous crystals (the crystal 
possesses the atom arrangement but differs in the atomic number of one or more 
atoms). The derivatives are prepared by soaking the crystal of a sample to be 
analyzed with a heavy atom solution or co-crystallization with the heavy atom. A 
dataset of the native structure is collected along with at least one heavy-atom 
derivative. The interpretation of the Patterson difference map reveals the heavy 
atom's location in the unit cell. This allows both the amplitude and the phase of the 
atom to be determined. Since the structure factor of the heavy atom derivative (Fph) 
of the crystal is the vector sum of the lone heavy atom (Fh) and the native crystal 
(Fp), the phase of the native Fp and Fph vectors can be solved geometrically. 
hpph FFF +=
                                                                             
Equation 53 
At least two isomorphous derivatives must be evaluated but the more derivatives 
available the more accurate the phase determination will be. Multiple Isomorphous 
replacements are among the most successful methods for phasing. 
7.3.5.4.Multiwavelenght Anomalous Dispersion (MAD) 
The MAD technique is conceptually similar to the isomorphous replacement 
methods. It uses only one crystal, which contains anomalous scatterer atoms (Se, Hg, 
Fe, Pt, U). Anomalous dispersion will occur when the refractive index of the radiation 
changes when absorbed. So by changing the wavelength of the X-rays, you can 
change the degree to which the anomalous scatterers perturb the diffraction pattern 
and therefore there will be a phase change. This phase shift in anomalous scattering 
leads to a breakdown of Friedel's law (Ihkl= I-h-k-l.αhkl= -αhkl) which is shown in the 
complex scattering factor of the anomalous atom ( anomf ). 
'''
jjjanom fifff ∆+∆+=                                                                       Equation 54 
Where i= 1− , jf  is the normal scattering factor of atom j and 'jf∆ , fi∆ are the 
perturbed scattering factor of the anomalous scatterer j. They will vary with the 
wavelength of the incident radiation. The ∆ contribution of the anomalous scatterer 
will be determined by collecting data at several wavelengths, two near the absorption 
edge of the anomalous element in the crystal and one further away. From this, you 
can obtain phase information analogous to that obtained from MIR. The MAD 
technique has become very popular in protein crystallography with the development 
of tuneable synchrotron sources and protein engeenering (selenomethionine labeling). 
7.3.5.5.Fitting and refinement 
Whatever the method chosen to obtain the phase and therefore the structure, 
now the second phase is to build an optimal model from the measured data. Indeed 
the phase information is usually not accurate, so is the electron density map. As a 
result, the initial model contains a lot of errors and needs to be modified. The first 
phase is the fitting process which involves a number of numerical and graphical steps 
testing the overall agreement between the experimental and calculated data. 
Basically, it uses software such as Coot [239] or O [240]. First, the initial model is 
modified to fit the electron density maps. Differential maps such as: (Fobs-Fcalc) and 
(2Fobs-Fcalc) (see equations 49 and 50) are usually compared to graphically fit the first 
model. 
( ) ( ) ( ) ( ) ( )( )lzkyhxiiFFxyzxyz calchkl calcobscalcobs ++−≈− ∑ piφρρ 2expexp
 
   Equation 55
 
Where Φ is the phase Fobs and Fcalc are the observed and calculated structure factors. 
The residual map defined by equation 49 indicates how much different is the model 
compared to the observed structure factors. For instance, a positive peak would 
definitively imply a lack of atoms in the model and on the other hand a negative peak 
will sign an atom misplacement in the model. A second map is used to judge the 
imperfections of the model, it is a linear combination of the electron density map and 
the previous differential map defined by equation 50. 
( ) ( ) ( ) ( ) ( )( )lzkyhxiiFFxyzxyz calchkl calcobscalcobs ++−≈− ∑ piφρρ 2expexp22  
   Equation 56 
An atomic model can never be perfect, but it can be improved a great deal by a 
process called: refinement, in which the atomic model is adjusted to improve the 
agreement with the measured data. Basically, the strategy uses the addition of 
"observations" in the form of restraints, or constraint of the model by reducing the 
number of parameters. Typical restraints include bond lengths, bond angles and van 
der Waals contact distances. They derive from high resolution models and use 
softwares such as Refmac or SHELX [237, 241]. On the other hand, constraints 
aimed at reducing the number of parameters. For instance, constraining the model can 
be made by fixing the torsion angle, as rigid body, or the number of copies present in 
the asymmetric unit. 
7.3.5.6.Validation tools 
To validate the model, we need to know the overall accuracy of the model. 
There are a few common validation tools and other coefficients to guide the search 
and hopefully find the best solution. The solutions are then compared through the use 
of correlation coefficient (CC(Fobs, Fcalc) defined as: 
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Equation 57 
 
The correlation coefficient between Fobs and Fcalc must be over 0.9. The correlation 
coefficient is a measure of the similarity between the structure factors calculated 
directly from the structural model and one calculated from experimental data. 
Another popular tool is the R-factor (Rfact). Several types of R-factors have been 
defined [242, 243], all based in the simple principle of comparing measured or 
theoretical values and calculated variables. It gives a crude measure of the correctness 
of the structure and data quality. It is defined as: 
∑
∑ −
=
hkl obs
hkl calcobs
fact F
FF
R                                                                   Equation 58 
The R-factor for macromolecules should be equal or below 20 % depending on the 
data quality. Imprecise structures have higher R-factors (over 25 %). At moderate 
resolutions, it is possible to overfit the data. This problem can be circumvented by 
introducing an analog of the R-factor, the Rfree. The Rfree is based on a test set 
consisting of a small percentage (usually 5-10%) of reflections excluded from a 
structure refinement.separate a subset of the data (usually around 5%) [244]. It is 
defined as: 
∑
∑ −
=
hkl obs
free calcobs
free F
FF
R
                                                                 
Equation 59
  
If Rfree drops, then the model must really have improved because there is no pressure 
to overfit Rfree. Rfree is very relevant to keep the model objective in respect with the 
experimental data. Rfree values for macromolecules are usually around 25 % to 30 %. 
Analysing the quality of the model also involves other types of tools. Those 
validation coefficients used are model based. For instance, the well known 
Ramachandran plot [245, 246] for protein is often used to compare average or 
behaviour pattern from a protein database with the new structure. A typical example, 
is the program Procheck [247] which checks the stereochemical quality of a protein 
structure by examining torsion angles between residues and/or side chains. Other 
methods such as Profile from Eisenberg’s group [248] detects if the model does not 
present anomalies. It basically peforms a ‘threading’along the peptide chain to find 
polar or hydrophobic regions. If a hydrophobic region is solvent exposed, this will 
result in an unfavourable environments for amino acids and therefore the model must 
contain errors. 
In conclusion the success of an atomic model is often judged through a 
number of crystallographic indices such as Rfact, Rfree, or whether it satisfies 
validation methods. However if the accuracy of the model has greatly improved over 
the last 30 years, the structure determination from other physical methods such as 
NMR often disagree with X-ray models. There are still a number of biases conferred 
for instance by the crystallization process, data collection or modelling. At present, 
improvement must be aimed at converging those methods for structure determination.  
 
 
7.3.6. Data collection 
Data collection is the next step after crystallization. X-ray data collection is a 
time consuming procedure and is very expensive. A correct prediction of the strategy 
of data collection is crucial. The crystal needs to be placed in front of a radiation 
source and a very important part of this process is the geometry of the experiment. 
Correct alignment of the crystal with controlled rotation allow the completeness on 
the final data set, improve signal/noise ratio and reduce radiation damage [223]. 
7.3.6.1.Crystal mounting 
Protein Crystallography deals sometimes with crystals about 0.1 mm in size. It 
must be mounted for data collection on a goniometer. This apparatus allows the 
crystal to be rotated around different axes without moving away from the beam. 
Several devices have been engineered to obtain a maximum of degree of freedom. In 
the past, it was common to mount a crystal in a glass capillary but if this method is 
still used for room temperature experiment, it needs considerable practice and 
delicate handling of the crystal. Nowadays, the most common methods use loops in 
cryo conditions. The crystal is maintained in a cryo-protecting liquor inside the loop 
and then flash cooled in a stream of nitrogen gas at temperature of 100-120 K.The 
advantages of the technique are numerous; including reduction of radiation damage to 
the crystal, and improvement of the resolution shell. Cryo-crystallography has 
therefore tremendously enhanced the quality and amount of results possible [249]. 
More recently automatic mounting devices are available for high throughput 
crystallography. This expands the number of collections that can be made in a 
relatively short period of time. 
7.3.6.2.X-ray sources 
Discovered by Röntgen in 1895, X-rays are radiation on the 10 to 0.001 
nanometers range of wavelengths (energies in the range 120 eV to 120 keV). X-rays 
have many well-known applications in medicine (radiography, radiotherapy) but they 
can also be used to reveal important information in structural sciences since their 
wavelengths are in the same order of magnitude of bond lengths. X-rays are produced 
from heavy elements when their electrons make transitions between the lower atomic 
energy levels. This occurs when a beam of electrons with sufficient energy knocks 
out an electron atom’s inner K shell. This vacancy will be quickly filled by electrons 
dropping down from higher levels, emitting X-rays with a sharply defined energy. 
There are different ways to produce X-rays, some processes used X-ray tubes, 
rotating anode and other synchrotrons. X-ray tubes or rotating anodes typically 
involves bombarding a metal target with high speed electrons which have been 
accelerated by tens to hundreds of kilovolts of potential. The X-ray radiation 
produces in these cases can be used in crystallography but their intensity limits the 
resolution shell to the Ångstrom range. For instance, the copper anode which is often 
used in the studies of macromolecules present a typical wavelength defined by CuKα= 
1.5418 Å. The achievable resolution is not sufficient for high resolution structural 
studies. These X-ray sources have been challenged by synchrotron facilities (please 
see figure 36). Synchrotron radiation was first observed in 1947 [250] and began to 
be used as a research tool in the mid-1960s. Synchrotrons are based on the principle 
that an accelerated electron emits radiation in proportion to its energy. Indeed, when 
an electron is accelerated close to the light velocity, it emits photons and X-rays. 
 
 
Figure 36. Photo of the European synchrotron radiation facility situated in the 
Grenoble, France. The ESRF is a third generation synchrotron and one of the three 
most powerful synchrotrons in the world. 
 
In synchrotron facilities, electrons are emitted by an electron gun and are first 
accelerated in a linear accelerator (linac). Afterwards they are transmitted to a circular 
accelerator (booster synchrotron) where they are accelerated to reach an energy level 
of 6 billion electron-volts (6 GeV). These high-energy electrons are then injected into 
a large storage ring (844 metres in circumference at the ESRF) where they circulate 
in a vacuum environment. The storage ring is made by a series of magnets separated 
by straight sections. The bending magnets maintain the electron in their trajectory 
(circular orbit) and as the electrons are deflected through the magnetic field created 
by the magnets. They give off electromagnetic radiation that leaves the storage ring  
 
through beam ports in a direction tangential to the ring where experimental hutches 
have been designed (see figure 37). Because electrons loose energy during their 
rotation, other type of magnets are found in the straight section of the storage ring. 
These insertion device magnets create a periodic acceleration. There are two main 
 
Figure 37. General diagram of a synchrotron. 1 is the electron gun, 2 is the linac, 3 is 
the booster ring, 4 is the storage ring, 5 the beamline, 6 end station. The synchrotron 
emits a "synchrotron radiation", especially X-rays; these are sent into the various 
beamlines (the straight lines branching out of the synchrotron). Each beamline 
contains scientific instruments, experiments etc. and receives an intense beam of 
radiation ( from http://www.synchrotron.vic.gov.au). 
 
Figure 38. Schematic representation of a wiggler (from 
http://www.synchrotron.vic.gov.au). 
classes of insertion devices namely: wigglers (figure 38) and undulators (figure 39). 
Wigglers deflect the particle beam from side to side in a ‘wiggling’ way. The 
radiation emitted is a broad beam of incoherent synchrotron light and can feed several 
beamlines at the same time. As the cones of light can superimpose on each other the 
intensity is increased at each bend. Undulators are a multipole wiggler but with a 
moderate magnetic fields and a large number of poles closer together. In this respect, 
the poles produce less deflection of the electron beam. This results in a narrow beam 
of coherent synchrotron light, with certain frequencies amplified by up to 10,000 
times. 
 
 
Figure 39. Schematic representation of an undulator (from 
http://www.synchrotron.vic.gov.au). 
 
The advantages of synchrotron radiations are multiple: 
 
High brightness: synchrotron light is extremely intense (hundreds of 
thousands of times more intense than that from conventional x-ray tubes) and 
highly collimated. 
Wide energy spectrum: synchrotron light is emitted with energies ranging 
from infrared light to hard x-rays. 
Tunable: it is possible to obtain an intense beam of any selected wavelength. 
Highly polarised: the synchrotron emits highly polarised radiation, which can 
be linear, circular or elliptical. 
Emitted in very short pulses: pulses emitted are typically less than a nano-
second (a billionth of a second), enabling time-resolved studies. 
 
Nowadays, synchrotron facilities are in the so called third generation. The 
main advances made from the first and second generation synchrotron came 
essentially from bending magnets and insertion devices. Third generation 
synchrotrons aim at optimising the intensity that can be obtained from insertion 
devices and uses the three different types of light sources (bending magnets, 
multipole wigglers and undulators). These third generation synchrotrons have been 
optimized not only in their architecture but also in terms of sample facility, wet lab at 
the ESRF, automated crystal loading (see millennium upgrade program at the ESRF), 
etc. A fourth generation synchrotron exists with intensities four to nine orders of 
magnitude higher than the current ones but the relevance to crystallography is 
questionable [251]. 
7.3.6.3.Detectors 
A diffraction pattern presents thousands or even millions of intensities for 
separated reflections and there is no such thing as a perfect detector: each design has 
its virtues and problems. Diffractometers have become obsolete due to their poor 
resolution and sensitivity to radiation damage [252], area detectors have gained 
popularity in X-ray crystallography. There are four common types of area detectors: 
 
Film-based detectors 
Image plate 
Charged Coupled Device (CCD) 
Multi-wire detectors 
 
Film based detectors used photographic film but even if the resolution is very 
high, they have become obsolete due to their cost and time consuming efforts. Image 
plates have replaced them. Image plates are made of a photostimulable phosphor 
matrix. When the plate is exposed to X-rays the image is temporarily stored in the 
phosphor coating. After exposure the image is read out by the laser head which scans 
across the plate radially as the plate rotates. The plate may be immediately erased and 
re-used. There are different image plate designs depending on the size, the shape, the 
laser used, etc. Image plates present a major disadvantage since the immediate 
processing of the diffraction spots is not possible. The introduction of gas-filled 
ionization chambers (multi-wire detectors) or image intensifiers (video based or 
Charged Coupled devices-CCD) have overcome this problem. A CCD detector is 
composed of a phosphor screen (up to thousand mm2) that converts X-rays into 
visible light. The phosphor screen is usually coupled to the CCD with a tapered 
optical fiber. A CCD chip collects the electron charge image. This electric charge is 
read out and digitized in order to transfer to the computer. The pixel size is about 10-
50 µm with readout times of less than 1 s. CCD detectors generally show high 
signal/noise ratio and a good dynamic range. They are currently the “standard” 
detector technology in macromolecular crystallography. However they are expensive, 
too small and require correction for image distortions. Improved CCD array systems 
are being made: better phosphors, reduction of electronic noise, increased 
multiplexing of parallel readout (to increase speed), and increased numbers of 
modules (to increase size). 
7.4. Material and methods 
7.4.1. Protein perdeuteration, purification and enzyme assay 
The same procedure as described in chapter 2.4.2 was applied to obtain 
hydrogenated Bs DHFR and 6.3.1 for fully perdeuterated Bs DHFR. Specific 
activities of Bacillus stearothermophilus dihydrofolate reductase were measured 
continuously by following the decrease in absorbance at 340 nm using a molar 
extinction coefficient of ε340= 12300 M -1 L cm-1 [116]. The standard assay mixtures 
contain sodium phosphate buffer 100 mM at pH 8, at a fixed concentration of 
NADPH (100 µM) and H2F (50 µM). The final enzyme concentration was typically ~ 
0.3 nM. The reaction was initiated by the addition of 1 µL of enzyme to the reaction 
mixture (469 µL), pre-incubated 2 min at a temperature of 30 °C. Assays were run for 
60 seconds using a thermospectronic helios γ-spectrophotometer interfaced with the 
Vision™ 32 software (version 1.25, Unicam Ltd.). Reaction progress curves were 
recorded in triplicate and repeated if the data deviate by more than 10 %. One unit of 
enzyme is defined as that amount of the enzyme that catalyzes the conversion of 1 
micro mole of substrate per minute under the previous assay conditions. 
 
 
7.4.2. Protein crystallization 
The MTX-Bs DHFR binary complex was crystallized using the hanging drop 
method vapor diffusion method at 291 K and an automatic system for crystallization 
using a robot to set up 96-well crystallization plates. Initial crystallization trials were 
performed using 0.2 M Tris (pH 7.4) and 1.75 M ammonium sulfate. As MTX is not 
soluble at high concentrations, the protein and the drug were incubated for several 
minutes at relatively low concentration 1mg/ml with a protein/MTX ratio of 1/2 at 
room temperature. After complexation the protein concentration was increased up to 
15 mg/ml with a Centricon YM10 membrane filtration device (Millipore, MA, USA). 
Crystals were grown by mixing equal volumes (10 µL) of the protein/ MTX complex 
and reservoir buffer. Crystal appeared in two days and grew to full size within a 
week. Before X-ray exposure, a cryoprotecting solution was made by adding glycerol 
to the mother liquor to a final concentration of 20 %. Crystals were mounted onto 
loops and frozen in liquid nitrogen prior to data collection. 
7.4.3. X-ray data collection and structure refinement 
Diffraction data were collected on the ID14-EH1 beamline of the ESRF, 
Grenoble, France which is equipped with a two crystal monochromator and a 
Quantum 210 CCD detector. A wavelength of 0.934 Ǻ was used together with 
oscillations of 0.5 ˚. Crystal to detector distance was set at 1024 mm. Crystals were 
cryocooled in a stream of nitrogen to minimize radiation damage (100 K). A total of 
360 frames were recorded. Data were indexed, integrated and scaled with Mosflm 
software package on the basis of a centered orthorhombic space group I222 with the 
following dimension a= 123.82 Å, b= 156.23 Å, c= 179.53 Å with α =β =γ = 90˚. 
Molecular replacement was performed using the maximum likelihood software 
Phaser. A molecular solution was found using Bs DHFR (PDB entry 1ZDR) as a 
search model, with non conserved residues mutated to alanine. There are 8 molecules 
in the asymmetric unit corresponding to a solvent content of 57.6 %. Molecular 
packing of alternative solutions was checked manually using the program Coot based 
on 2Fobs−Fcalc and Fobs−Fcalc electron density maps. Solvent building was done using 
the program ARP/wARP [253] from the CCP4 package. 20 ARP/wARP refinement 
cycles were run in total. Atoms were removed if below 1.0 sigma in 2Fobs−Fcalc map 
and atoms added if above 3 sigmas in Fobs−Fcalc map. 
7.5. Results 
7.5.1. Protein perdeuteration 
7.5.1.1.Production 
The aim of this work was to produce reliably and economically a fully 
deuterated form of Bs DHFR. In order to achieve this goal the preparation of 
deuterium resistant bacterial strain is necessary and performed by a multi-stage 
adaptation process by plating on a solid deuterated minimal media and repeated liquid 
deuterium cell culture (with increasing D2O content). When the strain is adapted to 
the growth in deuterated media with glycerol as the sole source of carbon, the second 
step is to obtained a high cell density culture (HCDC). The ‘batch fed batch’ 
technique is a suitable method to control the growth rate of the adapted strain and to 
minimize inhibition from the by products of the HCDC and obtain a large amount of 
recombinant protein. The growth rate is generally lower than in hydrogenated media 
but the final yield in terms of biomass will be essentially the same. HCDCs are 
generally obtained in bioreactor also called fermenters. These present a number of 
advantages, noticeably in their ability to control simultaneously pH, oxygen pressure, 
temperature, feeding. In figure 40, the fermentation profile of the E. coli cells 
expressing the Bs DHFR gene is given. The different phases of the ‘batch fed batch’ 
culture are delimited and the respective parameters such as OD600, PO2, pH, are 
shown. The inoculation of the culture media marks the beginning of the batch culture. 
A short latency phase is observed with a diminishing PO2, lower pH, and increased 
stirring. During this phase the cells are using the glycerol present in the initial media 
and will reach their maximum growth rate (exponential). OD600 follows an 
exponential law. The second phase, ‘fed batch’, is initiated when the PO2 and stirring 
reach a critical value. It indicates a change in the metabolism of the cell, the carbon 
source glycerol becomes limiting, and the cells start to exploit other compounds such 
as lactate or acetate. To avoid a stationary phase, glycerol is added to the culture 
media during the ‘fed batch’. During this step the growth rate is controlled and 
remains linear. This step is sub-optimal but limits the formation of toxic by products. 
The last phase induced by the addition of IPTG initiates the protein expression. The 
glycerol feeding is stopped as the protein production is not greatly limited by the 
energy demands of the cells. The biomass does not increase significantly which 
shows that cell division has ceased. From 50 grams of d8 glycerol (99 % deuterated 
glycerol) 45 grams of cell were obtained. Perdeuterated Bs DHFR was readily 
expressed, yielding approximately 8 mg of protein per gram of cell paste. In 
comparison, the unlabeled enzyme is produced at 10 mg of protein per gram of cell 
paste. The two-step purification protocol consisting of: heat precipitation and cation 
exchange chromatography yielded typically 150 mg of pure protein/L of culture. As 
implied by by table 10, the protein purification factor is low ~ 4 which indicates a 
relatively high level of enzyme in the cell supernatant compared with other proteins. 
The purified protein is pure as assessed by SDS-PAGE electrophoresis (a single band 
of approximately 19 kDa in lane 1, figure 41). 
7.5.1.2.Characterization by MALDI-TOF 
MALDI-TOF mass spectra indicate (see figure 42) that the molecular weight 
(Mw) of unlabeled protein is 18697 Da and perdeuterated protein 19740 Da in H2O 
(figure 43). For reference, the theoretical molecular weight of unlabeled Bs DHFR is 
18695 Da [56] and that of perdeuterated Bs DHFR is 19724 Da (including only non-
exchangeable). The theoretical number of exchangeable hydrogens is 1315 
The extent of deuteration can be determined using the following equation: 
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=ion% Deuterat                       Equation 59 
 
Where MW PerExp is the experimental molecular weight of the perdeuterated DHFR, 
HydrExp is the experimental molecular weight of the hydrogenated DHFR, MW PerTheo 
is the theoretical molecular weight of the perdeuterated DHFR and MW HydrTheo is 
the theoretical molecular weight of the hydrogenated DHFR. From these data, the 
extent of perdeuteration is 101 % indicating that not all exchangeable deuterons are 
substituted in the protein sample when soaked in H2O. A similar observation was 
made by Di Costanzo et al [180] where the deuterium enrichment exceeded the 
calculated value (105 %). 
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Figure 41. SDS-PAGE gel of Bs DHFR purification. (1) is the collected fractions of 
pure Bs DHFR, (2) and (3) is the molecular weight ladder and its correspondence in 
kDa. (4) is a cell extract before induction, (5) is a cell extract after induction and (6) 
is the heat treated supernatant. 
 
Protein Enzyme 
Step 
Fraction 
volume 
(mL) 
Protein 
concentration 
(mg/mL) 
Total  
(mg) 
Specific 
activity 
(units/mg) 
Total  
(units) 
Yield 
(%) 
Purification  
factor 
(fold) 
Cell extract 200 7.5 1500 1.2 x 106 1.9 x 109 100 1 
Heat 
denaturation 200 4.5 900 1.9 x 10
6
 1.7 x 109 90 1.5 
Anion 
exchange 
 
100 2.8 280 4.6 x 106 1.3 x 109 68 3.8 
Table 10. Bs DHFR purification table summary. The cell mass used was 30 grams. 
One unit of enzyme is defined as that amount of the enzyme that catalyzes the 
conversion of 1 micro mole of substrate per minute under our assay conditions. 
 
The back exchange between hydrogen and deuterium is dynamic process, largely 
favorable, occurring spontaneously in a well-hydrogenated environment. However, 
some deuterons are so deeply embedded in the protein structure that their solvent 
access is very limited. To test this possibility pre-incubation of the perdeuterated 
protein in mild denaturing conditions would certainly help to exchange those 
deuterons [177]. Nevertheless, our data indicate that the protein is deuterated at an 
appropriate level and therefore suitable for crystallization and X-ray analysis. 
 Figure 42. MALDI mass spectra of hydrogenated Bs DHFR. The main peak 
corresponds to a m/Z of 18697. 
 
Figure 43. MALDI mass spectra of perdeuterated Bs DHFR. The main peak 
corresponds to a m/Z of 19740. 
 
7.5.2. Crystallization 
A previous crystallographic study has determined the structure of the free 
enzyme [56]. We have therefore crystallized the MTX-Bs DHFR complex over 
relatively similar conditions (figure 44). Crystal obtained in A and B were relatively 
large, for instance, using the conditions described in (B), the approximate volume is 
0.4x0.7x0.2=0.06 mm3. However we found that the most appropriate crystals for 
crystal diffraction were obtained using a solution containing 0.1 M HEPES; pH = 7.0 
; 1.6 M (NH4)2SO4. These crystals were the most resistant to the cryo-protecting 
process. Indeed, the crystals in (A) and (B) tend to crack when the cryo-protecting 
solution was added to the mother liquor. This is a relatively common consequence 
when the crystal volume is large. A second problem comes from the presence of 
(NH4)2SO4 in the precipitating solution. When flashed cooled, (NH4)2SO4 salt crystals 
grow rapidly impairing the data collection. To circumvent these problems, we have 
therefore worked with the relatively small crystals shown in (C). 
 
 
Figure 44. Crystals of Bs DHFR. Crystals shown in (A) were obtained using 0.1 M 
NaCl ; 0.1 M HEPES ; pH = 7.5 ; 1.6 M (NH4)2SO4, in (B) the precipitating solution 
used was 1.0 M (NH4)2SO4; 0.1 M HEPES ; pH = 7.0 ; 0.5 %w/v PEG 8000 and 
crystals presented in (C) were grown using 0.1 M HEPES ; pH = 7.0 ; 1.6 M 
(NH4)2SO4. The bar gives the scale in mm.  
 
7.5.3. Preliminary X-ray structure 
7.5.3.1.Data processing 
After X-ray exposure, we have obtained via the CCD detector a diffraction 
pattern (figure 45). This map, made of hundred of spots, contains all the information 
to solve the structure of the MTX-Bs DHFR complex. The current diffraction pattern 
0.3 mm 0.3 mm 0.3 mm 
A B C 
show well defined spot, not overlapping. Mosaicity is a useful indice to examine the 
degree of long-range order of the unit cell within a crystal. The mosaicity is 0.434 
which indicates a well behaved crystal (mosaicity is generally between 0.2 for well 
diffracting crystals to 1.5 for badly behaving crystals such as thin plates, or damage 
by cryo cooling). The resolution range achievable according to this image is expected 
to be not less than 2.5 Ǻ since the spots are going beyond the most outward circle 
corresponding to a resolution shell of 2.5 Ǻ. The set of native data is therefore 
promising for structure determination. However, this two-dimensional map needs to 
be converted into a three dimensional model. The strategy used during data collection 
was based on the rotation oscillation method. As a result the full data set consists of 
360 separate images taken at different orientations of the crystal.  
 
The goal is now to convert these raw data into a list of Bragg reflections with 
measured intensities. This process called data processing can be broken down into 
three sections:  
 (1) Data Indexing : determination of crystal orientation, cell parameters, possible 
space group 
  
Figure 45. Diffraction pattern of MTX-Bs DHFR crystal on the beamline. The 
purple circles give the relative resolution shells: 9.9, 4.9, 3.3, 2.5 Ǻ (from the most 
inner circle to outer shell respectively). 
(2) Integrating the data: define the reflection list from the image sets 
(3) Scaling and merging the data 
We have performed these steps using MOSFLM [254] and SCALA [255] . 
Integrating the data show that the space group of crystallization was I222 (centred 
orthorhombic) with the following cell parameters a= 123.82 Å, b=156.23 Å, c= 
179.53 Å with α=β=γ=90˚. The Matthew’s coefficient was calculated with the 
following relationship: 
NZMW
VV unitcellM
××
=          Equation 60 
Where VM is the Matthew’s coefficient, MW the molecular weight of Bs DHFR 
(18695 Da), Z the number of asymmetric units per unit cell (8 for space group I222) 
and N is the number of molecule per asymmetric unit. VM gives the most probable 
number of molecules in the asymmetric unit and usually falls into the range of 1.6-2.5 
Å3 [256]. Using a cell volume of 3472899.9 Å3 the number of molecules per 
asymmetric unit was 10 corresponding to a VM of 2.90 Å3 Da-1 with a solvent 
percentage of 57.6 %. 
After indexing and integration of the intensities from the 360 images, the data 
set was merged and scaled together. The summary of the data is given in table 11. 
The data corresponds to 158956 unique reflections. The resolution limits range from 
the highest shell: 1.66 to 65.94 Å to the lower shell 7.44 to 65.94 Å. Probably the best 
criterion to describe the quality of the structure is the resolution limit of the data. In 
order to define this limit a number of factors have been defined, such as the ratio of 
recorded intensity and its standard deviation I/σ(I), the completeness, R-factors and 
data redundancy. As presented earlier in 7.3.5.6, R-factors are the traditional overall 
measures of quality. They measure the relative agreement between equivalent 
observations. There are a number of R-factors. Merging R factor arises from the 
averaging of multiple measurement of reflection of the same (hkl) and of symmetry-
related reflections. Rmerge is defined as: 
( )
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 I R                                                    Equation 61 
Note that Rsym is often used in literature instead of Rmerge. Rsym is a subset of Rmerge 
since it is measure of how well symmetry related to reflection merge. 
Another calculator than can be helpful in data quality assessment is the so-called 
precision-indicating merging R factor Rp.i.m. [257]. It describes the precision of the 
average measurement. 
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Rp.i.m gets better (smaller) with increasing multiplicity. It estimates the precision of 
the merged <I>. 
R factor: Rmeas [258] is the subsitute of Rmerge and describes the precision of the 
individual measurements independent on how often a given reflection has been 
measured. 
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A second quantity is the completeness.
 
The completeness of a data set at a 
given orientation is defined as the ratio of the number of unique reflections measured 
on the total of unique reflection. In practise completeness should be equal to, or over 
95 % for the electron density calculation [225]. The inner shell completeness of our 
data set is 99.7 % for a resolution range of 7.44 and 65.94 Å. For the highest 
resolution shell, 1.66-7.44 Å, it is 78.4% and 8.9 % at 1.66-1.71 Å. For these later 
values, the number of unique reflection is too low and therefore a truncation of data is 
needed for accurate model building. Symmetry related reflections are usually more 
accurate in defining the overall quality of the data set. The information given by the 
different geometrical conditions is preferred over repeated measurement of the same 
reflection. The factor used is called redundancy or multiplicity of intensity 
measurement. The overall multiplicity 5.6 and 6.5 for the overall and inner shell 
respectively, but falls to 1.8 for the outer shell. If the first two values are well 
behaved, the third value is too low and corroborates the finding enumerated earlier. 
The building of the electron density should exclude the highest resolution shell. 
Within table 12, we are able to assess in a satisfactory way data quality according to 
the value of R-factors, multiplicity, and completeness. Dmin is defined as the minima 
distance at which two features in the electron density map can be resolved. The 
completeness is dropping with Dmin below 1.92 Å. A decrease in completeness clearly 
demonstrates a deterioration of the model parameters [257, 259]. It indicates that the 
data must be truncated before this threshold.
 
 
 Overall InnerShell OuterShell 
Low resolution limit (Å) 65.94 65.94 1.71 
High resolution limit (Å) 1.66 7.44 1.66 
Rmerge 0.108 0.043 1.831 
Rmeas (within I+/I-) 0.119 0.046 2.554 
Rmeas (all I+/I-) 0.119 0.046 2.554 
Rp.i.m. (within I+/I-) 0.048 0.018 1.773 
Rp.i.m. (all I+ & I-) 0.048 0.018 1.773 
Fractional partial bias -0.034 -0.024 -0.387 
Total number of 
observations 897723 15993 2358 
Total number unique 158956 2445 1317 
Mean ((I)/σ(I)) 9.0 37.9 0.3 
Completeness (%) 78.4 99.7 8.9 
Multiplicity 5.6 6.5 1.8 
Table 11. Summary of data statistic processed in space group I222 (centred 
orthorhombic). 
 
 Dmin 
(Å) 
Number 
of 
reflection 
Completeness 
(%) 
multiplicit
y Rmeas Rsym Rp.i.m. 
7.44 15993 99.7 6.5 0.046 0.043 0.018 
5.26 30998 100.0 7.2 0.061 0.056 0.023 
4.30 40374 100.0 7.4 0.064 0.060 0.023 
3.72 47745 100.0 7.4 0.068 0.063 0.025 
3.33 54389 100.0 7.5 0.076 0.071 0.028 
3.04 60114 100.0 7.5 0.089 0.083 0.032 
2.81 65199 100.0 7.5 0.115 0.107 0.042 
2.63 69953 100.0 7.5 0.164 0.153 0.060 
2.48 74609 100.0 7.5 0.210 0.196 0.076 
2.35 78477 100.0 7.5 0.281 0.261 0.102 
2.24 82734 100.0 7.5 0.362 0.337 0.132 
2.15 73909 100.0 6.4 0.448 0.411 0.175 
2.06 54496 100.0 4.6 0.573 0.506 0.264 
1.99 43694 96.5 3.6 0.766 0.651 0.392 
1.92 34681 87.1 3.1 0.951 0.782 0.527 
1.86 26800 74.0 2.7 1.126 0.898 0.661 
1.80 19891 59.2 2.5 1.292 0.998 0.803 
1.75 13579 43.4 2.2 1.444 1.081 0.942 
1.71 7730 26.5 2.0 1.671 1.218 1.135 
1.66 2358 8.9 1.8 2.554 1.831 1.773 
Overall 897723 78.4 5.6 0.119 0.108 0.048 
Table 12. Reflection statistics for the data used in the refinement. Dmin is the 
nominal resolution.  
 
7.5.3.2.Model and refinement 
Structure solution search used Molecular Replacement in space group I222 (no 
solutions were found in space group I212121) with the program Phaser [237]. The 
model for the refinement was based on the structure of Bs DHFR deposited in the 
protein data bank (accession code 1ZDR). The search was set with 1 monomer of the 
DHFR from Bacillus stearothermophilus with protein atoms only (no solvent 
molecules) and a resolution range of 40-4 Ǻ. Phaser was run in the "automated 
molecular replacement mode" by searching for 10 solutions (10 monomers) in the 
asymmetric unit (according to most probable number as given by the Matthew's 
coefficient).  
 
 Solution 
number RFZ TFZ PAK LLG 
1 4.0 10.3 0 74 
2 4.0 19.5 0 262 
3 5.2 18.5 0 534 
4 4.4 21.7 0 845 
5 3.4 24.6 0 1236 
6 3.6 26.4 0 1694 
7 4.0 23.8 0 2062 
8 3.0 23.2 0 2375 
Table 13. Summary of the Phaser runs. 
 
PAK= Number of C-alpha atoms that can clash within 2 Ǻ. 
TFZ= Translation Function Z-score 
RFZ= Rotation Function Z-score 
LLG= Log Likelihood Gain 
 
8 solutions were found as indicated by table 13. With MR, the problem is to 
define which solution is correct. The ranking of the various solutions is assessed by 
various coefficients such as TFZ, LLG or packing arrangement. The first possibility 
to find the solution is to look at the packing of the top 8 solutions. This is a very 
discriminating criterion since it discards physically clashing models. Indeed, if one 
solution is well detached (see TFZ score or LLG values), it is essential to examine 
carefully the packing arrangement either graphically or through the summary of the 
logfile. Here no clashes were found as given by the zero values presented in table 13. 
This is therefore very encouraging for generating the correct solution. Using Phaser, 
other commonly used criteria are the Z-score and LLG. The log likelihood gain is the 
probability that the data would have been measured, given the model. It allows us to 
measure how much better the data can be predicted with your model than with a 
random distribution of the same atoms. The LLG should always be positive, and it 
should increase as the solution progresses. Our data clearly demonstrate an increasing 
LLG when new components are added to the solution. It peaks at 2375 for solution 8. 
Additionally, the TFZ (the translation function Z-score) for the correct solution is 
generally (number of standard deviations above the mean value) over 5 and well 
separated from the rest of the solutions. The Z score for the final translation function 
is the highest: 23.2 and therefore it reinforces the probability that the correct solution 
has been found. For, the rotation function, the correct solution is within a Z-score 
under 4. As these criteria are fulfilled, it indicates that the solution number 8 is the 
correct solution.  
7.5.3.3.Model building 
Since the phases are known, the next step is to build the model from the 
current available electron density. A crucial point here is that the initial phase 
estimates are not of the best quality which results in a relatively incorrect electron 
density map. The model which can be built from such maps may be in parts incorrect 
or incomplete. It requires extra rounds of refinement combined with model 
rebuilding. Model building and refinement are therefore a phase improvement 
procedure. The protocol and softwares are chosen in order to optimize the parameters 
for the building of the macromolecular model. For a detailed comparison of some 
popular model building package see reference [260]. In our case, we have used the 
software ARP/wARP from the CCP4 package. ARP/wARP links model building and 
refinement in a general view [253]. Basically, it processes iteratively towards the 
model by optimizing the phases through the manipulation of atoms coordinates. The 
procedure is based on the concept that the electron density is made of a collection of 
free atoms. Free atoms account for the electrons without the need of applying 
chemical knowledge or distance restraints between them. The originality and power 
of ARP/wARP comes from the way it establishes the atoms connectivity. It proceeds 
iteratively through snapshots, positioning atoms according to the electron density and 
then building blocks when stereochemical informations (inter-atomic distances) and 
restraints are satisfied with confidence. The parts that are less certain are still allowed 
and can be filled at any point of the procedure. The generated ‘hybrid model’ which 
is a mixture of free atoms and fragment of the protein structure is refined using the 
maximum likelihood program REFMAC5 [235]. 
To monitor the refinement progress over the various refinement cycles, the 
crystallographic R factor defined previously in equation 52 is very useful. It measures 
the fit between the model and the observed data. In addition to the standard R factor, 
the so-called free R value is used as a cross-validating indicator to monitor the overall 
progress and avoid ‘over’ fitting [244]. In table 14, the data used for the refinement 
are listed. 
 
20 refinement cycles were run in total. Further refinement using REFMAC in each 
ARP/wARP cycle. The starting model after REFMAC gives a Rfact = 0.413 and Rfree 
= 0.417. The first cycle shows an improvement of both parameters, Rfact = 0.362 and 
Rfree = 0.413. After 20 cycles a final Rfact of 0.254 and Rfree of 0.318 were obtained. 
The refinement in modern crystallography aim at minimizing both the standard R 
factor and the Rfree value however these factors are often biased according to the 
chosen protocol and sometimes do not give the model that best describes the data 
[226]. The R factor progression and its cross validation are not sufficiently sensitive 
to indicate whether or not a lateral chain is well positioned. The correct conformation 
need a graphical checking and therefore depends on user creativity. Preliminary 
pictures of the model are shown in figure 46. They were generated using the graphical 
interface Coot [239] and Pymol [54]. Coot, the crystallographic object oriented 
toolkit is a CCP4 module for model building, completion and validation. 
Resolution limits 42.000-2.000 Å 
Number of used reflections 110893 
Percentage observed 99.7360 
Percentage of free reflections  5.0175 
Overall R factor  0.4130 
Free R factor  0.4172 
Overall correlation coefficient 0.7515 
Free correlation coefficient 0.7442 
Table 14. Data statistics using REFMAC 5. 
  
Overall, the electronic density map of the MTX-Bs DHFR complexe is well defined 
and therefore gives a solid base for model building. Upon initial inspection, the 
electronic density shows in all monomers a significant nuclear density in the vicinity 
of the active site (positive peak in green color). Using the CCP4 library for small 
molecules, this density was fitted with the atomic coordinate of MTX. The result for 
chain C is presented in figure 47. It clearly outlines without ambiguity the presence of  
 
Figure 46. Content of the asymmetric unit. The eight molecules are represented in 
stick. The picture was made using Pymol . The asymmetric unit contains 8 molecules 
corresponding to eight monomers. Solvent molecules are omitted to provide a better 
overview. 
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MTX. Preliminary examination of the interaction of Asp27 and MTX at the Bs DFR 
active site confirms the common pattern observed (figure 48). The N1 atom of MTX 
is well positioned to interact with Oδ2 of Asp27. Although the precise features of the 
interaction can not be accurately highlighted, these results are very encouraging. 
 
Figure 48. Electron density maps for the MTX pteridine ring and the DHFR active. 
Shown in blue is the 2Fobs-Fcalc electron density map contoured at 2.0 σ. The distance 
are given in Å and were computed using Coot [239]. 
 
 
The reconstruction of the model was therefore pushed further and figure 49 was 
generated. As commonly observed with other bacterial DHFR, these models possess 
the original structure consisting of a pseudo Rossman fold [51, 261] of alternating β-
strands (8, named βA- βH) and α-helices (4, named αB,C, E, F) with three main loop 
regions.  
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The next step in the analysis would certainly assess any possible difference between 
the 8 monomers and the description of the MTX binding interaction with Bs DHFR. 
At this stage it is possible to look at these hpotheseses but it is a preliminary analysis. 
The main difference between the monomers as discussed in [73, 262], often comes 
from the loop conformations adopting the closed and partially occluded 
conformations. A preliminary inspection of the Met20 loop region show potential 
differences in the loop conformation (see figure 50). However the differences are 
weak and need to be compared with the other available data from various DHFR 
sources. 
 
7.6. Discussion 
The primary goal of this work was to determine the X-ray structure the MTX-
Bs DHFR complexe. The work presented here is incomplete, but we expect these 
preliminary results to lead to a final model, which after careful analysis will be 
deposited in the Protein Data Bank (PDB) [263]. The structure validation is crucial. 
 
Figure 50. Comparison of the eight monomers in the asymmetric unit (ribbon 
representation). On the left, the eight monomers are superposed. On the right, the 
MTX binding site in the vicinity of the Met20 loop region is magnified. This 
picture was made using Pymol [55]. 
Met20 Loop
MTX
Grossly incorrect structures have been published according to the R factors and 
should be avoided with the progress of validation tools [226, 264]. The validation of 
macromolecular structures are quite standardized now [265]. The PDB’s automated 
deposition system used PROCHECK [247] for checking bonds, angles, dihedrals and 
possible atom clashes. The SFCHECK [266] validates the structure factors. The 
number of parameters generates an important number of possibilities which must be 
carefully checked computationally and visually. The handling of this information is a 
problem in terms of time and computing power. Human intuition and experience is 
indispensable in validating atomic models. This work described here has not been 
completed in a satisfactory fashion since the lack of resources (financial, computing, 
experience) have drastically limited the author progress. The primary perspectives of 
this research are fairly simple as stated previously: further refinement and validation 
of the model before structure deposition. The restrained refinement is ongoing with 
REFMAC 5. The refinement is primarily graphical using the difference maps and aim 
at correcting rotamer conformations and water molecules positioning.  
The model is at medium resolution between 2.0 and 2.4 Å and would not be 
suitable for determining hydrogen positions. However as presented in chapter 7.1 the 
ambiguity of hydrogen and water positions could be achieved by neutron 
crystallography. The X–ray model would serve as a model for the neutron structure 
building. Furthermore, the long term perspectives of this project is to provide a 
precise description of the energetics involved in the MTX binding. The cross-
correlation of the ITC data from chapter 3.3 within the structural information from X-
ray and neutron crystallography would definitively shed the light on the binding 
mechanism and its molecular basis.  
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8.  PEGylation of Bs DHFR  
8.1. Introduction 
The early goals of my project aimed at investigating the effect of small ligand 
molecules on fast protein dynamics. As described previously we have initiated this 
research project with the inhibitor MTX and the model protein DFHR. However, it 
was clear that projects based on a similar approach could be of interest too. In vivo, 
proteins are often modified and conjugated with non peptidic substance through 
process such as acylation [267]; methylation [268]; phosphorylation [269]. The 
properties of the conjugate are often drastically modified. In this respect we have 
tested the possibility of using a non specific, covalently bound molecule to perturb 
simultaneously; activity, stability and dynamics. However various classes of 
molecules can fulfilled these criteria since any hydrophilic polymer such as dextran, 
polysaccharides [270], or even insoluble matrices can be linked to a protein [271]. 
However one molecule, namely PEG: Poly-ethylene glycol receives our attention. It 
medical use over the last twenty years has made PEGylation a standard technique in 
protein modification [272]. The following chapter will deal with the production and 
purification of a PEGylated form of our protein model Bs DHFR. Two experimental 
objectives will be presented, first the investigation of PEG dynamics when coupled to 
Bs DHFR by neutron scattering and the solution structure of the conjugate by Small 
Angle Neutron Scattering (SANS). 
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8.2. The pegnology science 
The technique aiming at coupling polymers to proteins originated in the 1950s 
and 1960s through ‘gentle chemistry’ but the ‘origin of pegnology’ came later, in the 
late 1970s in the laboratory of Professor Frank Davis of Rutgers University and also 
with the work of Professor Abuchowsky [272]. F. Davis qualified PEGylation in its 
early stage as a ‘library shelves quest’. The initial problem was to provide the benefits 
of non-human bioactive proteins to humans. The first two key papers dealt with 
catalase [274] and albumin [275]. These pioneering steps have made PEGylation a 
choice technique in medicine with a tremendous commercial power. It is well known 
that proteins can be used as therapeutic agents such as insulin or interferon [276]. 
However, the direct use of protein in the body presents a number of disadvantages. 
Protein are stable under certain conditions, a slight change in pH or ionic strength 
may have a dramatic effect on the protein bioactivity. The circulating body life is also 
a major drawback in protein pharmaceutical. As a general rule, the protein life span in 
blood circulation is very limited. Serum concentrations of interferons decay quickly 
during the initial 24 hours. The half life (t1/2) of interferon-α-2a is 2.3 hours and 2.1 
min for interleukin-6 [277]. These short-lived actions are the results of a number of 
effective clearance mechanisms such as glomerular filtration, proteolysis or 
 
Figure 51. Schematical representation of a PEGylated protein. The main 
advantages of the conjugate are outlined. The figure was reproduced from [273]. 
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phagocytose (see figure 51). The action of protein therapeutic implies therefore 
repetitive doses, which increases, not only the amount of drug needed and treatment 
costs, but may also cause severe secondary effects for the patient [273, 277, 278]. 
PEGylation is a challenging strategy in drug delivery, which has the potential to 
overcome these problems. Among all the advantages provided by the PEGylation, 
there are: a decrease in toxicity, immunogenicity and increase in body life time 
circulation. For instance the half time circulating life of a PEGylated form of 
interferon-α-2a is 50 hours instead of 2.3 hours originally [277]. The pharmacokinetic 
profile of drugs can be profoundly reformulated. The direct outcomes clearly lead to 
the optimization of blood circulating life; drug elimination and time distribution of 
therapeutics [279]. 
 
Table 15. Example of clinical applications of PEGylated protein therapeutics. The 
table was taken from [280] based on www.biospace.gov and www.fda.gov. 
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Direct applications in medicine (table 15) are illustrated with a number of 
commercially and FDA (Food and Drug Administration) approved drugs. Interferons, 
which are routinely used in the treatment of hepatitis C, are an example of the clinical 
challenges involved in protein PEGylation. One of the direct clinical application of 
interferons is PEGASYS (Roche), which is a PEGylated form of interferon α-2a 
with a 40 kDa branched PEG [281]. Other drugs have been designed such as 
Exubera® from Pfizer, which consists of an inhaled form of insulin to cure patients 
suffering of type 1 and 2 diabetes [282, 283]. These examples illustrate the value of 
PEGylation as a methodology for drug delivery. 
8.3. Polyethylene glycol’s properties 
PEG molecules are made of the repetition of ethylene oxide units. This 
polyether diol, highly soluble, amphiphilic is relatively chemically inert. PEGs are 
prepared by anionic polymerization of ethylene oxide, providing a variety of 
molecular sizes. PEGs are named based on the number of ethylene oxide units in the 
polymer chain. PEG is a viscous liquid at molecular weight below 1000 Da and solid 
at higher molecular weights [278]. PEGs can be categorized in two main classes: 
linear and branched polymers (figure 52). In addition PEGs can be divided into two 
groups: PEGs with free hydroxyl (-OH) groups at both ends and PEGs with one or 
two methoxylated end group(s) (-OH replaced by –OCH3). 
 
Figure 52. Typical molecular structures of poly-ethylene glycols (PEGs). The 
structure of "Y-shaped" branched PEG is shown at the bottom where X is the 
functional or active group [278]. 
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If figure 52 presents the ‘raw’ materials used in PEGylation, PEG molecules can not 
react directly with proteins, the molecule needs to be ‘activated’. The basis of the 
activation is to modify at least one of the free hydroxyl groups into a protein reactive 
end. 
8.4. The PEGylation reaction 
Basically, the PEGylation reaction is to conjugate the protein to PEG 
molecule(s) but this task is not straightforward [284]. For instance, the first activated 
PEG molecules suffer from a number of disadvantages. Since PEG is obtained by 
chemical synthesis, the PEG batch yielded was polydispersed (polydispersity is the 
ratio between the observed molecular weight (Mw) of the PEG molecules and their 
calculated value according to the number-average molecular weight (Mn)) in terms of 
molecular weights and the choice of PEG chain lengths was restricted. Nowadays 
with the development of synthetic and purification procedures polydipersity has 
decreased and activated PEG molecules over a large range of molecular weights (2 
kDa up to 60 kDa) with original architecture (branched PEG, comb-shaped 
copolymer PEG) [285] are available. Another crucial drawback was the chemistry 
behind the PEGylation reaction. Protein amino groups were the first entities to be 
PEGylated by acylation or alkylation but these procedures presents a lack of 
specificity, stability and reproducibility [286]. A number of PEGylation procedures 
are now at hand. Various protocol using enzymatic [287] or chemical procedures 
offers a wide variety of ways to conjugate a specific target protein [284, 286]. The 
choice of the appropriate functional group for the PEG derivative is based on the type 
of available reactive group on the molecule that will be coupled to. For proteins, 
typical reactive amino acids include lysine, cysteine, histidine, arginine, aspartic acid, 
glutamic acid, serine, threonine, tyrosine. The N-terminal amino group and the C-
terminal carboxylic acid can be also used. With the help of chemistry this large 
variety of reactive groups has increased the spectrum of PEGylation [284]. Site-
specific PEGylation is therefore possible, when for instance free cysteines are 
available naturally or via protein engineering. Site specific binding avoids the number 
of isomers obtained, which made PEGylated product purification easier and also their 
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FDA approval. The choice and the guidance toward a specific reactive PEG are 
therefore more flexible and have increased the potential of this technology. 
PEGylation chemistry is well documented now, details of the conjugation methods 
can be found in [284, 286]. Additionally, a number of companies offer activated PEG 
for research and commercial use. To review the important catalogue of available 
PEG, consult the NOF website (www.peg-drug.com) which is one of the leading 
companies in this growing and important market. Continuous research efforts from 
the manufacturers have led to the so-called second generation PEG chemistry. It 
utilizes branched PEG with a central protein conjugation functional group surrounded 
by two or more identical methoxy-PEG chains. However it seems that multi-arm 
activated PEG are challenged by bi or heterofunctional PEG or even comb-shaped 
copolymers leading ultimately to a third generation of PEG (www.peg-drug.com). 
8.4.1. PEGylation at cysteine residue 
For proteins that possess thiols suitable for PEG binding, PEGylation can be 
very specific and reversible [286]. In fact, cysteines are rarely present in proteins and 
the limited cross reactivity with other reactive groups present in proteins made 
PEGylation at thiol group very relevant. A number of thiol PEGylating agents are 
presented in table 16. Among these, PEG-orthopyridyl-disulfide reacts with thiol 
groups forming a stable symmetric disulfide [288]. Another agent, PEG-maleimide 
based on the well known Michael reaction takes advantage of thiol addition to the 
activated double bond [289]. PEG-vinylsulfone reacts slowly with thiols to form a 
stable thioether linkage to the protein. PEG-iodoacetamide reacts with free thiols by 
nucleophilic substitution, creating a stable thioether linkage. All these derivatives 
targeting specifically thiol groups have their own advantages and disadvantages [288, 
290, 291]. For instance, PEG-vinylsulfone is stable in an aqueous environment but 
may react with lysine at elevated pH. PEG-orthopyridyl-disulfide reacts specifically 
with sulfhydryl groups under both acidic and basic conditions (pH 3-10) to form a 
stable bond but in reducing environment the linkage is readily converted to thiols. 
The thioether bond between PEG-maleimide and the protein is stable but slow 
cleavage of the amide linkage can occur in aqueous solution. Our choice led us to use 
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PEG maleimide because of its price and availability in a number of molecular 
weights. It has been reported that a relatively stable linkage with a good specificity 
toward sulfur groups.  
 
8.5. STRUCTURAL CONFORMATION OF PEGYLATED 
PROTEIN SPECIES 
The tremendous value of PEGylated therapeutic proteins is unquestionable 
however, it is inversely related to the amount of data available on the molecular basis 
of its biological effectiveness. The effects of PEGylation are unpredictable and their 
molecular basis and dynamic properties are unclear. It is believed that the improved 
properties of the PEG-protein conjugates derive mainly from the PEG molecule [280, 
292, 293]. Significantly, PEG molecules are hypothesised to act in vivo as a 
‘molecular shield’ [273, 294], therefore the spatial conformation and dynamical 
behaviour of PEG molecules seem crucial (figure 51). In vivo branched PEG-protein 
conjugates have been found to be more effective than their linear counterparts with an 
equivalent total molecular weight [295]. The longer circulation half-life of the 
branched PEG was attributed to a more efficient masking mechanism of the protein 
surface but also to a larger effective size [296] or hydrodynamic volume of the 
 
Table 16. PEGs reactives towards thiol group from [273]. 
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branched PEGylated protein [295]. The structure details of the PEG molecules when 
conjugated to a protein are therefore the key stones in the elucidation of PEG 
bioeffectiveness. X-ray structural analysis shows that free PEG molecules can assume 
at least two distinct conformations according to the chain length: first the zigzag or 
random coil structure for short chains and secondly a helical structure for longer 
chains [297]. These conformations are interchangeable in water and depend on the 
solution conditions. Another intriguing property of PEG is its solubility. It is either 
soluble in aqueous or organic solvent. The PEG solubility properties are extensively 
used in protein crystallography. PEG is a choice precipitating agent. In fact, the 
presence of the ether oxygen atom allows the hydration of the carbon chains through 
the formation of the oxonium ion (The oxonium ion in chemistry is any positive 
oxygen cation, which has three bonds). This specific chemistry makes PEG chains 
heavily hydrated. In aqueous solution PEG monomers can established up to three 
water bridges [298]. The large exclusion volume is believed to drive the overall 
hydrodynamic properties of the PEG conjugate and reinforce the concept of 
‘molecular shield’. These structural information are useful but until now the atomic 
structure of a PEG protein conjugate is still not known: does the (extremely mobile) 
PEG chain shroud the protein, or does it sit adjacent to the protein as an unperturbed 
random coil? In what way, if any, does the conformation change when the conjugate 
approaches other molecules, substrates, binding sequences or surfaces? 
As stated previously, the effect of PEG polymer on protein structure and the 
three-dimensional structure of the PEG-protein conjugate are unknown. The 
relatively large, highly flexible PEG polymer conjugate impedes crystallization and 
structural determination by protein crystallography. However two models have been 
suggested (figure 53). 
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The first model supports a shell like structure where water molecules solvate 
hydrophilic regions around the protein whereas hydrophobic patches interacts with 
hydrophobic PEG clusters. According to this view, PEG molecules are therefore 
wrapping the protein. There is also an alternative model in which there is no 
interaction between the PEG and the protein. The conjugate forms a worm like helical 
structure that fluctuates freely in solution. A few studies have approached this issue. 
Using Size Exclusion Chromatography (SEC) [299] Fee et al have suggested that the 
viscosity radius of a PEGylated protein depends only on the molecular weight of the 
native protein and the total weight of grafted PEG. They also suggested that PEG 
molecules form a dynamic layer over the surface of the protein. In conclusion, the 
PEG-protein hybrid can adopt various conformations but the stabilising interactions 
are unknown. On the other hand SAXS (Small Angle X-ray Scattering) and analytical 
centrifugation have given the first lines of evidences of PEGylated protein solution 
structure [292, 293]. A model of the PEGylated structure of hemoglobin was 
proposed by Svergun et al using an ab initio method [292]. The proposed model 
clearly outlines no change in the tertiary structure of the protein and a compaction of 
the quaternary structure. Additionally, PEG molecules were found to interact with the 
                           
Figure 53. Schematical representation of potential structures of a PEG-protein 
conjugate. In A, the worm-like model is in equilibrium with an intermediate model 
where PEG interacts locally with the protein. The B model illustrates the shell-like 
structure. The PEG molecule wraps and interacts more thoroughly with the protein. 
This picture was modified and reproduced from [280]. 
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core of the protein, cavities between subunits and surface to form either a dual-
mushroom or a dual-mushroom to brush. The transition between the two PEG 
conformations was proposed to depend on the distance between the grafting sites 
(DG) and the Flory dimension (RF) of PEG chain length.  
RF=aN 3/5                                                      Equation 63 
Where N is the number of units per polymer, a the effective length of an oxyethylene 
unit (a=3.5 Å) [300]. Basically, the brush conformation is the predominant form 
when DG < RF whereas the mushroom like structure occurs at DG > RF. The PEG 
conformation depends primarily of the chain length but also on the available space 
between them. When sterical hindrance is high, the PEG chain adopts an elongated 
form, brush like, whereas a non crowded area favours the folding of the PEG chain on 
itself. This study has unambiguously brought some evidence of the three-dimensional 
structure of PEGylated conjugate, however SAXS is a low resolution technique; 
model building is not accurate to determine the architecture of the complex at atomic 
resolution. Moreover, the PEG chains used in this study were relatively small, 5 kDa, 
in comparison with PEG molecules used in medicine. Generally PEGs with relatively 
high molecular weight (≥ 30 kDa) cause a sharp increase in the in vivo circulation 
half-life [301]. Lower molecular PEG may not have a relevance in medicine since 
their size would not be high enough to avoid kidney elimination [302]. 
Our first goal is to address this problem by means of Small Angle Neutron 
Scattering (SANS) which allows a direct measurement radius of gyration (Rg). With 
the help of contrast variation, we could extract specifically the PEG and or protein 
structure, which is not possible by SAXS. It will provide a detailed map of the three 
dimensional conformations of PEG molecules when bonded to a protein. The analysis 
will highlight the basis and the nature of the interactions that maintain and govern the 
PEG/protein complex. Additionally, these results will be implemented with an ab 
initio modelling in the hope of building a more thorough understanding of the 
molecular basis of PEG biological effectiveness.  
Another goal is the dynamical behaviour of PEG molecules when grafted to a 
protein. A recent study has pointed out that a difference in molecular flexibility 
between linear and branched PEGylated protein could explain differences in 
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clearance rates by glomerular filtration [303]. The restricted dynamical behaviour of 
branched PEG would reduce the ability of PEG chain to deform and cross glomerular 
pores. If this hypothesis turns out to be correct, molecular flexibility is a milestone in 
PEG bio-effectiveness. Our second goal in this study is to investigate the effect of 
PEGylation on PEG dynamics. We will use the technique of neutron scattering to 
follow nano and picosecond dynamics at a sub-Ångstrom scale. As a subsidiary 
benefit, we hope to test the effect of PEG molecules on protein dynamics at a later 
stage. 
The following chapters will describe the production and characterization of a 
PEGylated form of Bs DHFR.  
8.6. Materials and Methods 
8.6.1. PEGylation reaction 
Hydrogenated Bs DHFR was purified as described previously in section 2.4.2 
and fully deuterated Bs DHFR as described in section 6.3.1. Purified Bs DHFR 
protein was diluted to a final concentration of 6 µM in 100 mM sodium phosphate 
buffer at pH 7.5, 0.5 mM EDTA, 0.2 M NaCl and reduced by incubation with a 25-
fold molar excess of dithiothreitol (DTT) for 1 hour at room temperature. The 
reduced mixture was then desalted by chromatography using a Hi-Prep G-25 26/10 
desalting column (GE healthcare, Uppsala, Sweden) in 100 mM sodium phosphate 
buffer at pH 8, 0.5 mM EDTA, 0.2 M NaCl to remove the DTT. The PEGylation 
reaction was initiated by the addition of 6 µM Bs DHFR to a 5-fold molar excess of 
PEG maleimide (NOF corporation, Tokyo, Japan) reagent in 100 mM sodium 
phosphate at pH 8, and 0.5 mM EDTA, 0.2 M NaCl for 2 hours at room temperature 
under gentle stirring. PEGylated Bs DHFR was separated from unPEGylated protein 
and unreacted PEG by ion exchange chromatography using a customed MacroCap SP 
column (GE, Healthcare, Uppsala, Sweden) equilibrated in 50 mM MES pH 6. The 
bound protein was eluted using a linear gradient of 1 molar NaCl. Column fractions 
containing the PEGylated Bs DHFR protein were identified by non-reducing 
SDS−PAGE and freeze-dried for 24 hours in the dark. This method was used to 
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prepare Bs DHFR modified with a 5 and 12.5 kDa maleimide PEG (NOF corporation, 
Tokyo, Japan). 
8.6.2. Protein determination 
Protein concentration was estimated with a modified Bradford method [304] 
using the Bio-Rad protein assay kit (Bio-Rad, Hercules, United States). The micro 
assay procedure was followed to determine protein concentration. The method 
consists of mixing 0.8 mL of the the unknown protein solution concentration (ranging 
from 1 µg/mL to 10 µg/mL) with 0.2 mL of Bio-Rad reagent. The mix is let to stand 
for at least 15 min and no more than an hour. Absorbance is read at 595 nm and the 
protein concentration is determined against the protein standard curve. Samples are 
made in duplicate. The protein standard curve is made by varying concentrations of 
stock standard bovine serum albumin solution from 1 to 10 µg/mL. The Bio-Rad 
reagent was purchased from Bio-Rad (Hercules, United States). 
8.6.3. Enzyme assays 
The same procedure as described in chapter 2.4.2 was applied to obtain 
hydrogenated Bs DHFR and 6.3.1 for fully perdeuterated Bs DHFR. Specific 
activities of Bacillus stearothermophilus dihydrofolate reductase were measured 
continuously by following the decrease in absorbance at 340 nm using a molar 
extinction coefficient of ε340= 12300 M -1 L cm-1 [116]. The standard assay mixtures 
contains sodium phosphate buffer 100 mM at pH 8, at a fixed concentration of 
NADPH (100 µM) and H2F (50 µM). The final enzyme concentration was typically ~ 
0.3 nM. The reaction was initiated by the addition of 1 µL of enzyme to the reaction 
mixture (469 µL), pre-incubated 2 min at a temperature of 30 °C. Assays were run for 
60 seconds using a thermospectronic helios γ-spectrophotometer interfaced with the 
Vision™ 32 software (version 1.25, Unicam Ltd.). Reaction progress curves were 
recorded in triplicate and repeated if the data deviate by more than 10 %. One unit of 
enzyme is defined as that amount of the enzyme that catalyzes the conversion of 1 
micro mole of substrate per minute under the previous assay conditions. 
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8.6.4. SDS-PAGE electrophoresis 
The same procedure was applied as described in section 2.4.3 except that no 
reductive agent was present 
8.6.5. Neutron scattering sample preparation 
PEGylated conjugates of fully perdeuterated Bs DHFR with PEG-maleimide 
of 5 kDa and 12.5 kDa were synthesized, purified and characterised using the same 
procedure described in section 8.6.3. To minimize the contribution of hydrogen 
scattering, the labile hydrogen atoms from the PEGylated Bs DHFR were exchanged 
with deuterium oxide (D2O). PEGylated perdeuterated Bs DHFR was dissolved in 
D2O (10 mg/mL), gently stirred 12 hours at 4 °C and then freeze-dried. The operation 
was repeated two more times with higher grade D2O (purity 99.9 %), freeze-dried, 
and then stored at 4 °C until use. Activity was checked and less than 10 % of the 
original activity was lost during the process. After lyophilisation, the PEGylated 
perdeuterated Bs DHFR preparations (100 mg) were dried over phosphorus 
pentoxide. To reach a higher hydration level, the proteins were equilibrated in a 
desiccator over a saturated solution of NaBr (which gives a relative humidity of 50 % 
at 20 °C). After exposure at this relative humidity (for two days), the D2O content 
was shown to be 20 %, (i.e.25 mg of D2O per 100 mg of dry weight protein). At this 
hydration level the sample holder was quickly sealed and stored at 4° C until use. The 
NaBr salt was rotary evaporated before use to near dryness in order to remove as 
much as possible any remaining water molecules and then dissolved in high grade 
D2O (99.9 %). 
8.6.6. Small angle neutron scattering preparation 
PEGylated conjugates of fully deuterated Bs DHFR as described previously 
were dissolved at 2.5 mg/mL in a series of solvent contrast 0, 25, 50, 75 and 100 % 
2H2O:H2O ratio. Quartz cuvettes of 1mm were used for measurements at room 
temperature. Data were collected using the D22 diffractometer at the ILL (with two 
detector distances covering a Q range of 0.01–0.25 Å−1). 
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8.6.7. Size Exclusion chromatography 
Chromatographic experiments were carried out on a AKTA Explorer 100™ 
liquid chromatography system with protein and PEG-protein conjugate detected by 
UV absorbance at 280 nm (GE Healthcare Technologies, Uppsala, Sweden). The 
chromatography system was controlled and data analysed using the Unicorn software, 
version 4.1 (GE Healthcare Technology, Uppsala, Sweden). Tricorn™ 10/30 GL 
Superdex 200 pre-packed SEC columns were obtained from GE Healthcare 
Technologies (Uppsala, Sweden). 40 µL samples were injected onto each size 
exclusion column, using a 100 mM sodium phosphate buffer pH 7 with a flow rate of 
1 mL/min. Size-exclusion column was calibrated against a High Molecular Weight 
(HMW) gel filtration calibration kits containing ovalbumin (43 kDa), conalbumin (75 
kDa), aldolase (158 kDa), ferritin (440 kDa) and thyroglobulin (669 kDa), obtained 
from GE Healthcare Technologies (Uppsala, Sweden). Blue Dextran (2000 kDa) was 
purchased from Sigma (Saint Louis, MO, USA). The extraparticle void volume, V0, 
was measured by the elution volume of Blue Dextran marker. Kav values were 
calculated for each sample using equation 64. 
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=                                                                                Equation 64 
Where Ve is the elution volume of the sample and Vc is the total column liquid 
volume, V0 the column void volume. 
8.6.8. Mass spectrometry 
Molecular weights of PEGylated conjugates were determined using an 
Autoflex II MALDI-TOF mass spectrometer (Bruker Daltonics, Bremen, Germany). 
Sample were dissolved in deionised water and mixed 1:1 with 5 mg/mL 
dihydroxybenzoic acid matrix (Bruker Daltonics, Bremen, Germany) in 2:1 0.1 % of 
trifluoroacetic acid/acetonitril. 1 µL of sample was loaded onto an AnchorChip™ 
target plate and allowed to dry at room temperature. A protein Calibration standard I 
(Brucker Daltonics, Bremen, Germany) kit was mixed with matrix in the same 
manner and 0.5 µL was loaded on the calibration spots on the target. Spectra were 
collected in linear detection mode as described previously in section 6.3.3. 
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8.7. Results 
8.7.1. Purification  and analysis of PEGylated Bs DHFR 
The primary structure of Bs DHFR presents only one cysteine in position 73. 
After inspection of the three-dimensional structure, it was hypothesised this single 
cysteine could potentially react with the PEG-maleimide following the reaction 
described in figure 54. 
The purification of mono-PEGylated Bs DHFR was performed using ion exchange 
chromatography with a specifically designed resin: MacroCap SP (GE healthcare, 
Uppsala, Sweden) in a single run. The chromatogram shows three main peaks. The 
unbound material (figure 55, peak A) was identified as unreacted PEG. The SDS-
PAGE analysis of this fraction did not reveal any band (figure 56, lane 6) when 
stained by Coomassie blue. Indeed PEG molecules do not absorb at 280 nm but 
maleimide groups do, therefore it is not surprising to have a UV signal at 280 nm. As 
expected the first peak (figure 55, peak B) obtained during elution corresponded to a 
mono-PEGylated form of Bs DHFR (lanes 4 and 5, figure 56) whereas the second 
peak (figure 55, peak C) was unambiguously free Bs DHFR as assesed by the SDS-
PAGE (lanes 1, 2, 3, figure 56). This selective elution was reported in a number of 
studies [305, 306]. This specificity of PEG molecules to modify the physical and 
chemical properties of the protein conjugate such as the iso-electeric point, pKa or 
hydrophobicity is clear but the mechanism is not completely understood. Indeed, it is 
believed that PEG molecule when grafted to a protein modify these properties [280] 
but the interactions remain complex to assess [307]. The MacroCap SP resin, which 
is a cation exchanger, is designed to purify PEGylated proteins with high recovery 
yields (GE, healthcare information).  
 
Figure 54. Schematical representation of the reaction between PEG-maleimide (on 
the left) and a protein thiol group (SH-R) from [286]. 
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Figure 56. SDS-PAGE analysis of the purification PEGylated Bs DHFR with 5 kDa 
PEG-maleimide in non reducing conditions. Lane 10 corresponds to the molecular 
weight marker (BenchMark Protein Ladder, Invitrogen), lane 9 to native Bs DHFR, 
lane 8 to the reaction mixture, lane 7 desalted reaction mixture, lane 6 unbound 
material, lane 5 and 4 first eluted peak, lane 1, 2, 3 correspond to fraction collected in 
the last eluted peak. 
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Figure 55. HPLC chromatogram of the purification of Bs DHFR conjugated with a 5 
kDa PEG-maleimide on MacroCap SP. Peak (A) corresponds to the unbound 
material whereas peak B and C are the eluted fractions. 
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The SDS-PAGE analysis is rich in information. As implied by lane 8 in figure 56, 
almost all Bs DHFR is PEGylated in a single and homogenous conjugate. The 
desalting step has a slight effect on the stability of the linkage established between the 
protein and the PEG molecules. It seems that approximately 20 to 30 % of PEG 
molecules leach the protein as shown by the extra band of lower molecular weight. 
This band corresponds to free Bs DHFR as it migrates as the same position of the Bs 
DHFR control. Lane 6, which is empty, corresponds to the non reacted PEG. 
Coomassie blue staining can not stain free PEG molecules, a specific staining 
designed by Kurfurst can probe specifically PEG moieties [308]. Lanes 4 and 5 
correspond to pure mono-PEGylated Bs DHFR albeit a very slight amount of free 
enzyme is present. The estimated molecular weight of the conjugate is according to 
 
 
the protein ladder approximately 30 kDa which does not strictly corresponds to one 
monomer of Bs DHFR with a 5 kDa PEG molecule. The last lanes (1, 2, 3) show a 
single band corresponding of the free Bs DHFR which has leached the PEG-Bs 
DHFR conjugate. The PEGylation yields for both Bs DHFR, deuterium labelled or 
Protein Enzyme 
Step 
PEG-
maleimide 
5 kDa 
(mg) 
Protein 
quantity 
(mg) 
Yield 
(%) 
Specific activity 
(units/mg of 
protein) 
% 
activity 
PEGylation 150 100 100 3.9 x 10 
6 
±0.2 x 10 6 100 
Desalting 
step  90 90 
3.3 x 10 6 
±0.3 x 10 6 84 
Anion 
exchange 
 
 73 73 3.2 x 10 
6 
±0.2 x 10 6 81 
Table 17. PEGylated Bs DHFR purification table summary. The PEGylation 
reaction was done with a PEG-maleimide of 5 kDa. Protein quantities were 
determined using the Bradford method. One unit of enzyme is defined as the 
amount of enzyme that catalyzes the conversion of 1 micro mole of substrate per 
minute under our assay conditions.  
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hydrogenated were very similar. For us, it was critical to recover as much enzyme as 
we can. The cost of the PEG reagent (~250 US $ per gram) was relatively low in 
comparison to fully deuterated Bs DHFR which approximately costs 7000 US $ per 
gram of pure protein. From 100 mg of pure protein, the final yield of PEGylated 
protein in terms of mass was 73 mg (see table 17). The procedure was therefore very 
efficient. Almost all the protein was PEGylated under our conditions and only 10 % 
was lost during the desalting step. The cation exchange procedure was experimentally 
the most ‘expensive’step but the free protein (as seen in peak C, figure 55) was 
almost entirely recovered and kept for further use if additional quantities of 
PEGylated material were needed. Looking at the specific activities of the PEGylated 
conjugate, it was clear under our assay conditions that PEGylation has a very limited 
impact on the enzyme catalysis (see table 18). The control, purified Bs DHFR has an 
activity of 3.8 x 106 units per mg. The activity of the PEGylated samples with either a 
5 kDa or 12.5 kDa PEG molecule is decreased (3.2 x 106 and 3.1 x 106 units per mg 
respectively). However, the lost of specific activity does not exceed 20 % in all tested 
samples. These results also indicate that the PEG chain length does not play a 
significant role in the lost of activity. The differences between both samples, 
hydrogenated and perdeuterated Bs DFHR does not exceed 5 %. These limited 
alteration of in vitro activities are not surprising since PEGylation has been found to 
be a none invasive method in respect of protein bio-activity [287, 309, 310]. 
Protein Units/mg of protein % activity 
Bs DFHR 3.8 x 106±0.4 x 10 6 100 
Bs DFHR-PEGmal 5 kDa 3.2 x 106±0.2 x 10 6 85 
Bs DFHR- PEGmal 12.5 kDa 3.1 x 106±0.3 x 10 6 83 
 
dBs DFHR 2.6 x 106±0.2 x 10 6 100 
dBs DFHR-PEGmal 5 kDa 2.1 x 106±0.1 x 10 6 81 
dBs DFHR- PEGmal 12.5 kDa 2.3 x 106±0.2 x 10 6 87 
Table 18. Bioactivity of PEG-modified Bs DHFR and dBs DHFR (perdeuterated Bs 
DHFR). PEGmal is PEG-maleimide. 
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In conclusion, the PEGylation of Bs DHFR with PEG-maleimide was very 
efficient and enable us to obtain at a single attachment point a PEGylated form of the 
enzyme Bs DHFR with both PEG-maleimide reagents, 5 kDa and 12.5 kDa 
respectively. In order to have a deeper characterization of the produced samples, we 
have performed a mass spectrometry analysis using the MALDI-TOF technique 
8.7.2. Mass spectrometry: MALDI TOF 
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Figure 57. MALDI-TOF mass spectra of (a) native Bs DHFR, (b) Bs DHFR 
PEGylated with a 5kDa maleimide-PEG and (c) Bs DHFR PEGylated with a 12.5 kDa 
PEG-maleimide. 
Fast proteins dynamics and its correlation to activity and stability 
 
178 
Figure 57 shows the MALDI-TOF mass spectra of Bs DHFR before and after 
PEGylation with PEG-maleimide. The MALDI-TOF mass spectrum of the native Bs 
DHFR show a single peak at m/Z 18697 which is relatively consistent with the 
calculated mass of a monomer (18695 Da) [56]. As expected the MALDI-TOF mass 
spectrum of PEGylated Bs DHFR show two peaks, one corresponding to an 
unPEGylated form of Bs DHFR and a second peak with a higher m/Z corresponding 
to a homogeneously mono-PEGylated form of Bs DHFR with PEG-maleimide. The 
mono-PEGylated Bs DHFR with 5 kDa PEG-maleimide produces a peak at m/Z 
24382 which corresponds to a conjugate of one PEG maleimide to one Bs DHFR 
monomer. As shown in (c) a very similar spectrum is observed. Two peaks, one 
corresponding to the native Bs DHFR at m/Z 18699 and a second peak at m/Z of 
31016 corresponding to a mono-PEGylated conjugate of Bs DHFR with a PEG-
maleimide of 12.5 kDa. In all inspected spectra, the peaks corresponding to the 
PEGylated conjugates have a bell shape which is due to the mass distribution of the 
raw PEG [311]. The mass distribution is usually quantified with the term 
polydispersity which is the ratio between the observed molecular weight (Mw) of the 
PEG molecules and their calculated value according to the number-average molecular 
weight (Mn). For the PEG-maleimide used in this present studies, the polydispersity 
given by the supplier company was 1,008 and their Mw were 5513 and 12645 Da for 
the 5 and 12.5 kDa PEG respectively. Our experimental data yield approximate 
values of 5.685 kDa and 12.317 kDa for the 5 and 12.5 kDa PEG respectively. These 
values are therefore consistent with the supplier data. The relative importance of peak 
heights for the native and PEGylated Bs DHFR depends primarily of the sample to 
matrix ratio and is not linked to the abundance of the molecule of interest. The best 
results were obtained with a sample to matrix ratio of 1:8. A similar analysis was 
performed for the fully deuterated Bs DHFR. As shown in figure 58, very similar 
spectra were observed for the native and PEGylated enzyme with both PEG-
maleimide reagent. The native enzyme produced a single peak at m/Z of 19740. The 
mono-PEGylated conjugate of fully deuterated Bs DHFR with a PEG-maleimide of 5 
kDa produced two peaks: one at m/Z of 19741 corresponding to the free enzyme and 
a second one centered at m/Z 25400. The mass difference is 5660, which again signs 
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a mono-PEGylation of the enzyme by a 5 kDa PEG. The PEGylation of Bs DHFR 
with the 12.5 kDa PEG-maleimide shows similarly two peaks, one at m/Z of 19738 
and a second one at m/Z of 32153. Again, the enzyme was successfully PEGylated at 
a single point attachment.  
 
 
 
 
 
Figure 58. MALDI-TOF mass spectra of (A) perdeuterated Bs DHFR PEGylated 
with a 12.5 kDa PEG-maleimide, (B) perdeuterated Bs DHFR PEGylated with a 5 
kDa maleimide-PEG. 
 
In conclusion, the MALDI-TOF analysis was very valuable to characterize our 
sample and follow the PEGylation reaction. It is a method of choice for PEGylated 
therapeuthic since it does not require large amounts of sample and time. 
8.7.3. Characterisation of PEGylated Bs DHFR by SDS-PAGE and 
chromatography 
Both samples were analysed by SDS-PAGE in non-reducing conditions. 
Under these conditions, only the size of protein affects the migration. As expected the 
native enzyme migrates at a position close to 20 kDa as indicated by the protein 
ladder in lane 9, figure 59. A faint band was also observed around 40 kDa, which is 
probably the result of the dimerization of the native enzyme as no reductive agent 
was present in the medium. Looking at lanes 7, 4 and 3, we can give an estimate of 
Mw of the PEGylated conjugate of Bs DHFR with a 5 kDa PEG-maleimide. It is 
19740.754
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approximately 30 kDa as reported previously. At high concentration (5 mg/mL) a 
smeared band (around 40 kDa) is observed in lane 7 with a small quantity of free 
enzyme as revealed by a band around 20 kDa. The smear is probably a contamination 
from the adjacent well (lane 6) containing the PEGylated Bs DHFR with a 12.5 kDa 
PEG-maleimide. In addition, a similar trend is observed when Bs DHFR is PEGylated 
with a 12.5 kDa PEG-maleimide (lanes 1, 2 and 6). The Mw of the PEGylated 
conjugate is approximately 50 kDa. The Mw estimation of the hybrid molecule 
between PEG and Bs DHFR can not be determined using protein molecular standards 
in SDS-PAGE. Again, the direct sum of the PEG and the protein molecular weights 
does not match the Mw given by SDS-PAGE analysis. 
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Figure 59. SDS-PAGE analysis of PEGylated Bs DHFR with 5 and 12.5 kDa PEG-
maleimide in non-reducing conditions. Lane 9 corresponds to the molecular weight 
marker (BenchMark Protein Ladder, Invitrogen), lane 8 to native Bs DHFR at 5 
mg/mL, lane 7 to PEGylated Bs DHFR with PEG maleimide 5 kDa at 10 mg/mL, 
lane 6 to PEGylated Bs DHFR with PEG maleimide 12.5 kDa at 10 mg/mL. Lane 5 is 
the native Bs DHFR at 2.5 mg/mL, lanes 3 and 4 contain PEGylated Bs DHFR with 
PEG maleimide 5 kDa at 2.5 and 5 mg/mL respectively. Lanes 1, 2 correspond to 
PEGylated Bs DHFR with PEG maleimide 12.5 kDa at 2.5 and 5 mg/mL 
respectively. 
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Figure 60. Elution profile of native Bs DHFR (blue curve), PEGylated Bs DHFR 
with PEG-maleimide 5 kDa (black curve) and PEGylated Bs DHFR with PEG-
maleimide 12.5 kDa (red curve) on a Superdex 200 10/30. 
 
 
A second way to characterize our PEGylated samples was carried out using Size 
Exclusion Chromatography (SEC) also called gel filtration (figure 60). Gel filtration 
is a useful technique to assess the purifity and homogeneity of a protein sample. We 
have therefore analysed the elution profile of our PEGylated conjugates of Bs DHFR 
against its native form. As shown in figure 60, the SEC curves of the native Bs DHFR 
present a single and well-defined peak with a Kav of 0.58. 
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distribution coefficient where Ve, V0 and Vc represent solute elution volume, void 
volume, and the total bed volume of fluid and SEC combined, respectively. The 
PEGylated forms of Bs DHFR gave a similar pattern with a single and well behaving 
UV peak. As expected, the modifications of the protein with PEG moieties have 
shifted the peak position. The Kav  were respectively 0.40 and 0.28 for the 5 kDa and 
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12.5 kDa modified Bs DHFR. These shifts are therefore proportional to the size of 
grafted PEG molecule. The distribution coefficient decreases when PEG molecules 
size increase. These profiles demonstrate that first; the preparation is pure and 
homogenous as reported previously by SDS-PAGE analysis. Secondly, PEGylation 
modifies drastically the conjugates size or shape since their Kav coefficients are lower 
than the Bs DHFR. Such behaviour has been extensively reported in the literature 
[294, 299]. It beyond the scope of this chapter to model the PEGylated conjugate 
however gel filtration chromatography is also often uses in the determination of 
molecular weight and size of proteins [312]. It is based on the comparison of the 
elution volume parameter, such as the gel phase distribution coefficient Kav of the 
protein of interest against a series of known standards. 
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Figure 61. Chromatographic separation and calibration curve for the gel filtration 
calibration kit HMW on the Tricorn™ Superdex 200 10/30 GL column. 
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As shown in figure 62 and table 19, a series of standards have been established. It is 
common to produce a chart in terms of Kav versus log (Mw). The relationship is 
approximately linear over a wide range of molecular weights [313]. From our 
experimentally determined MW, it seems that the PEGylated conjugates of Bs DHFR 
with a 5 kDa PEG or 12.5 kDa would have behaved as proteins with a MW of 59109 
and 151367 Da respectively. These extrapolated findings do not support the results 
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Figure 62. Molecular size plot of the protein calibration kit HMW (GE Healthcare, 
Uppsala, Sweden). 
 
Protein Molecular weight (Mw) Kav 
ovalbumin 43000 0.45 
Conalbumin 75000 0.37 
Aldolase 158000 0.27 
Ferritin 440000 0.15 
Thyroglobulin 669000 0.06 
Table 19. Gel calibration kit HMW from GE Healthcare, Uppsala, Sweden. Mw were 
obtained from [172]. 
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obtained by SDS-PAGE analysis, which have estimated much lower Mw: 
approximately 30 kDa for Bs DHFR with a 5 kDa PEG and 50 kDa for Bs DHFR 
with a 12.5 kDa PEG. A number of studies have reported such deviations when using 
SDS-PAGE analysis [314]. It has been suggested that PEG and SDS form a kind of 
complex [315]. The direct evidence of such interactions is given by the presence of 
broad or even smeared bands in some SDS-PAGE of PEGylated proteins. The 
migration property of PEGylated protein could be very different from that of the same 
molecular weight. Therefore, a simple comparison with the protein ladder will not 
give the correct information. On the other hand, if ‘ideal’ SEC separates solutes only 
on the basis of size, nonideal cases occur too. For instance, hydrophobic interactions 
between the support and the solute molecules can occur and therefore modify the 
elution profile of a given molecule. Accordingly, solute molecules with the same 
charge as that of the support will experience electrostatic repulsion from the pores, 
referred to as “ion exclusion,” and emerge earlier than expected on the basis of size 
[316]. To complicate the equation, PEG-proteins are hybrid molecules and their 
properties result of a mixed effect resulting from the direct association of a protein 
and a polymer: PEG. It has been noted by a number of SEC studies that determination 
of PEGylated conjugates Mw with protein Mw standards was unreliable [294]. The 
routinely used methods in SEC can not be strictly applied and need to be specifically 
designed for PEG-protein conjugates. Overall, if SEC is relatively cheap and easy to 
set up SEC chromatography reflects an average of many molecular level interactions 
depending on the solvent, ionic force, type of column, temperature. For instance the 
viscosity radius (Rh) which is often used to define the size (in Å) of a protein by SEC 
chromatography makes the assumption that all proteins of polymers in solution 
behave as spheres, whatever is the true shape of the molecule [317]. Therefore, we 
must be cautious in interpreting the gel filtration data. In other words, SEC can not be 
applied universally to obtain good estimates of molecular weights and the need of 
alternative techniques is crucial. Actually a number of techniques are available to 
investigate the possible solution behaviour of PEG when grafted to globular protein 
surface. For instance, analytical centrifugation, NMR, SAXS or SANS would 
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certainly help to draw a comprehensive picture of the solution conformation of 
PEGylated conjugates. 
8.8. Conclusions and perspectives  
The aim is of this chapter was to describe the different steps to provide a pure 
and homogenous preparation of a mono-PEGylated conjugate of the enzyme Bs 
DHFR with either a 5 kDa PEG-maleimide or 12.5 kDa PEG-maleimide. We have 
been successful in this work and we have produced in mg quantities both conjugates. 
Unfortunately the second step of this research effort was initiated and not fully 
achieved. Two projects were planned. As previously stated, PEG bio-effectiveness is 
believed to come from primarily its solution structure as it acts as a molecular shield 
[273, 318]. On the other hand, PEG molecules must be flexible so they will not 
impair the bioactivity of the protein, as for instance: in ligand-receptor recognition or 
enzyme catalysis. There is therefore an intricate balance between both properties. 
Because of our involvement with neutron scattering techniques, we thought that 
Small Angle Neutron Scattering was a potential technique to probe the effect of PEG 
on protein surface properties. Briefly SANS is a solution scattering technique probing 
the shape of nano-particle at a moderate resolution (1 to 1000 nm) [81]. The Guinier 
approximation of the scattering profile yields the radius of gyration (Rg) of the 
particle in solution and indicate its elongation or compactness [101]. The power of 
SANS resides also in the application of the contrast variation technique which is a 
powerful auxiliary that could highlight specifically element of a structure when the 
molecule is labelled. Contrast variation is based on the substitution of hydrogen 
atoms for deuterium atoms either in the solvent or in the molecule itself. For a 
detailed description of the technique see [319]. We have already began this work in 
collaboration with Pr. John Finney; Pr. Jeremy Smith; Dr. Moeava Tehei; Dr. 
Michael Hartlein and Pr. Fee Conan. We have produced the deuterated form of the 
enzyme Bs DHFR (since SANS require 1H labelled protein) in collaboration with the 
deuteration laboratory facility in Grenoble. We have also been successfully allocated 
8 days on the Diffractometer D22 at the Institut Laue Langevin which is the world 
leading neutron source in 2007. My role in this experiment was to produce and 
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prepare the PEGylated samples and assist the SANS experiment when possible. 
However, the data processing has not been performed entirely since the presence of 
aggregates has impaired the interpretation of the scattering curves. Since my role in 
this established collaboration with Dr. Hartlein (ILL) and Dr. Timmins (ILL) was not 
to process the data, I do not have the material from this specific experience and 
therefore I’m not able to discuss this issue here. However, it is critical for a successful 
SANS experience to test the stability and solubility of the sample in a deuterated 
media. Indeed the technique of contrast variation implies the substitution of aqueous 
buffer by a fully deuterated buffer from 0 % up to 100 % D2O content. It is known 
that proteins tend to aggregate more easily in deuterated media [320]. A simple 
experience using native gel electrophoresis or light scattering would be of great 
benefit to find the optimal conditions for protein solubility and for success. If a few 
studies have approached and shed the light on the aspects of PEGylated conjugates 
[292, 293], the structure of such hybrid polymers is still a matter of debate. Efforts 
are needed. With the development of bifunctional molecules and complexes PEG 
architectures the structural milestone underlying the power of Pegnology is crucial. 
As a subsidiary benefit, we have also investigated the dynamic properties of 
PEG molecules when conjugated to a protein by neutron scattering. We have used 
three different spectrophotometers, the backscattering spectrophotometers IN16 and 
IN13 and the time-of -flight IN6 for their complementary time and space windows. 
This experiment has taken place in May 2007 in collaboration with Dr Moeava Tehei. 
The data have not been processed and it is not possible to discuss them here until 
progresses are made. Depending on the previous results, the long term goal of 
PEGylation has definitively for us a role to play in the elucidation of protein dynamic 
toward activity and protein stability. We would like to set a similar experience on a 
hydrogenated form of Bs DHFR conjugated wih fully deuterated PEG molecules. In 
this respect, we would have access to the changes of fast protein dynamics when a 
non specific and covalently ligand is bound. 
In conclusion, the field of PEGylation which is increasingly popular in protein 
therapeutics has also a strong potential in fundamental research. The cross linking of 
applied and more fundamental research activities may reveal here a general consensus 
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which unambiguously would stimulate a constant development of new technologies 
in protein therapeutics. 
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9. General Conclusion & Perspectives 
 The primary goal of this work was to assess the role of fast protein dynamics 
and their inter correlation with protein activity and stability. We have therefore 
focused on the protein model DHFR and its dynamics dependency on the ps-ns 
timescales when bound to the anticancer drug MTX using the technique of neutron 
scattering and correlated these findings with activity and stability measurements. In 
addition, we have investigated the role of fast fluctuations in view of protein thermo-
adaptation by comparing two thermal variants of the enzyme DHFR, the moderate 
thermophilic: Bs DHFR and its mesophilic counterpart: E. coli DHFR. Collectively, 
the data have identified several features of the linkage established between the 
properties enumerated earlier.  
 The first chapters of the thesis have focused on the effect of the anti-cancer 
drug methotrexate. We have first explored the binding energetics in the interaction 
between the drug and the enzyme by isothermal titration calorimetry and steady state 
kinetics. ITC has revealed that the protein ligand recognition was largely favorable 
with an affinity constant in the nM range, enthalpy driven with unfavorable entropy. 
In a second step, we have assessed the type of inhibition mediated by MTX using 
steady state kinetics. The inhibition was found to be competitive with respect to the 
natural substrate H2F and MTX was characterized as a tight binder. This study has 
shown that even a small change in a ligand structure can have profound effects on the 
interaction and binding energetics. It also highlighted the prodigious efficiency of 
MTX to block DHFR activity at levels flirting with the nano-molar range.  
Chapter 4 was focusing on the effect H2F or the inhibitor MTX on DHFR 
thermal stability. From circular dichroism, we found that both ligands can 
significantly increase the thermal stability of the enzyme with a more pronounced 
effect with MTX. There are numerous ways to stabilize the enzyme structure and it is 
very difficult to accurately rationalize which contributions have led to the change in 
the thermal stability. Explanation for these shortcomings include the effect of 
dynamics, buried water accessibility, folding coupled with binding and other 
conformational change or structural rearrangements [82, 321]. As judged by the 
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crystal structure for the two complexes, the difference in thermal stability is 
apparently due to the unique binding geometry of MTX and the protein. The inverted 
position of the pteridin ring and the specific interaction with Asp 27 [51] has 
necessarily involved a structural rearrangement of the protein architecture but it might 
have also redistributed other discrete forces concurring in the stabilization of the 
chain upon the thermal effect. We have hypothesized that dynamics could be one of 
these underlying forces. The work presented in this chapter is therefore an important 
step toward the understanding of structural energetics toward ligand protein 
interaction and protein structure. 
 The data presented in this chapter 3 assess the effect of the binding of MTX on 
protein dynamics on the ps-ns timescales, and specifically the significance of this 
interaction to the overall macromolecular dynamics parameters: the flexibility <u2> 
and resilience <k>. Incoherent neutron scattering data obtained on the backscattering 
spectrophotometer IN13 have provided a global picture of the side chain dynamics on 
the ps timescale. Overall, a global decrease in flexibility and an increase in protein 
resilience (only below the dynamical transition) were observed in the presence of 
MTX. These changes provide support for the hypothesis that ligand binding induces 
changes in dynamics and these changes can be propagated through the structure. 
From a combination of sequence conservation, mutational analysis and molecular 
dynamics simulation Agarwal et al have suggested a concept of a correlated network 
of residues in DHFR critical for the hydride transfer step of the reaction [18]. 
Interestingly many of the strictly conserved residues are responsible for maintaining 
the hydrogen bonding contacts with ligands such as Thr 113 (threonine) and Asp 27 
in E. coli. or Glu 30 in H. sapiens [47]. More surprisingly, several of these key 
residues were quite distant from the active site, like Tyr 100, Phe 31 and Met 42 in E. 
coli DHFR. It implies that those residues distal from the active site would have been 
positioned in a particular way to maintain the synergy between the structure and 
catalytic efficiency of the enzyme. It suggests that there is a coupled ‘promoting 
motions’ exploit by DHFR to enhance its catalytic rate. Recent NMR relaxation 
studies have elegantly depicted the DHFR catalytic cycle as dynamic energy 
landscape [16, 19, 37]. It suggests that the progression of the enzyme along its 
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reaction coordinate is promoted by a succession of excited and grounding energy 
states induced by the binding or release of the products. It clearly outlines a direct 
correlation between the fluctuations and the catalytic efficiency of the enzyme. Thus 
optimization of the free energy landscape by selection of the substates and pathways 
needed for function is an element of efficient catalysis. If this hypothesis turns out to 
be correct, the effect of a specific inhibitor in the DHFR cycle might also trigger a 
specific effect. It is therefore very tempting to suggest that the preferred fluctuations 
observed along the reaction coordinate discussed earlier could have their respective 
counterpart in presence of inhibitor. The energy landscape of a protein is usually 
depicted as a 3D surface with peak and valleys [322]. We suggest that some of these 
peaks and valleys could be seen as ‘dead end pathways’. In other words, if the 
hierarchy in time and space indicates that slow conformational transitions occurring 
on the timescale of catalytic turnover are facilitated by collective high frequency 
fluctuations, the reduction or modification of these fast motions could also have 
impaired the biological function of proteins. It may explain why transition state 
analogs exert such an unprecedented power on protein function and are used 
successfully in cancer therapy for instance [36]. We could also extend this view as a 
plausible determinant for allosteric regulation of enzymes and signal transduction but 
the correlation is not easy to draw. 
 A number of complementary projects have been also initiated during this PhD. 
The determination of the X-ray structure of the MTX/DHFR complex is one of them. 
This particular work has not been completed, so the discussion is not yet possible 
even if the results are quite promising. To exploit the findings from the dynamic 
study, we though that an unspecific and covalent ligand such as PEG could yield 
original and unexpected results. The basic idea was to replace MTX by PEG 
molecules but the cost of the raw materials (fully deuterated PEG) was out of reach 
for our laboratory so we decide to examine PEG dynamics instead. Chapter 8 gives an 
overview of the PEGylation reaction and sample preparation for neutron scattering 
and SANS. The neutron scattring was carried out in 2007 at the ILL, Grenoble but the 
results have not been processed. As a subsidiary benfit, we also try to determine the 
solution of the PEG-DHFR conjugate using SANS but unfortunately the experiment 
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fails to give the expected results. Last but not least, since neutron scattering is an 
isotope sensitive technique, the need of deuterium labelled proteins is often crucial. 
We have therefore examined the effect of perdeuteration on the temperature 
dependence of the enzyme Bs DHFR in chapter 6. If similar studies have been done 
on the effect of perdeuteration on protein function [180, 207, 214], stability [211], 
and structure [180]. It was original to use the equilibirum model [323] to test the 
interplay between enzyme temperature dependency and perdeuteration. This 
experiment has clearly outlined a decrease in activity, stability when the enzyme was 
perdeuterated. However, this piece of work needs the input of a biophysical method 
to rationalize in terms of structure or energetics these kinetics findings. 
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10. Future directions  
One of the long term goals of this line of research was to highlight the strength of 
neutron scattering in the field of enzymology and catalysis. We show that, DHFR as a 
model system provides a useful tool for the study of fast protein dynamics and the 
effect of ligand binding. However, an obvious missing piece in the present work is a 
description of the other substrate/cofactor combination. It would be clearly 
advantageous to complement our set, with for instance, the natural substrate H2F or 
with other potent inhibitors of DHFR. It well known that bacterial and eucaryotes 
DHFR variants do not respond similarly to anti-folate drugs but the key stones of this 
powerful inhibition are not entirely known [324]. Protein flexibility might be one of 
the milestones of this intricate puzzle. 
Additionally, the binding signature given by the ITC measurement has provided 
some interesting line of evidence about the underlying binding energetics that drive 
the interaction between the enzyme and its stoichoimetric inhibitor. However to fully 
exploit these data, we need a structural input for the reliable interpretations of the 
binding determinants. We have already started the structural determination of the 
complex between the Bs DHFR and the drug MTX using X-ray crystallography. Our 
model is under refinement (Rfact: 22.1%, Rfree : 31% at a resolution of 2.1 Å). In light 
of this evidence, it is interesting to raise the question of drug design. The discovery 
and marketing of drugs is a time and money consuming process for pharmaceutical 
groups. In proteomics, the common strategies are based on the X-ray structures which 
allow the docking of active molecules in the active site of enzymes or binding domain 
of receptors [325, 326]. Nevertheless, through this study and a number or others [327, 
328], it is becoming clear that protein flexibility is a relevant factor in ligand 
recognition, binding or chemical turnover. The implementation of drug design 
strategies must exploit protein flexibility. For instance, Lerner et al employ multiple 
protein structures to incorporate protein flexibility in structure-based drug discovery 
[329]. Their pharmacophore model improves its performance with increased dynamic 
sampling, indicating that including a greater degree of flexibility can enhance the 
quest for potent inhibitors. It emphasizes the growing importance of protein 
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flexibility in the quest of identifying novel inhibitors. It is also important to note that 
distal mutations can impact active site flexibility and protein function [330, 331]. It is 
very tempting to test this hypothesis with PEG molecules and find out whether or not 
protein dynamics, protein function and or protein stability are enhanced or modulated 
by such unspecific and distal ligands. This new field will undoubtedly open new 
strategies in drug design.  
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11. Appendix 
 
Table A. Summary of experimentally determined kcat and kcatD/kcatH in sodium 
phosphate buffer 100 mM pH 8 in H2O 
 
Table B. Summary of experimentally determined kcat and kcatD/kcatH in sodium 
phosphate buffer 100 mM pH 8 in D2O 
 
Enzyme Bs DHFR dBs DHFR  
Temperature 
(K) 
kcat 
(s-1) 
kcat 
(s-1) 
kcatD/kcatH 
298 
303 
308 
313 
318 
323 
328 
333 
338 
343 
348 
353 
358 
13 
21 
33 
51 
78 
117 
173 
254 
367 
526 
747 
1049 
1460 
8 
12 
19 
30 
46 
69 
104 
153 
223 
322 
460 
651 
912 
0.57 
0.57 
0.58 
0.58 
0.59 
0.59 
0.60 
0.60 
0.61 
0.61 
0.62 
0.62 
0.62 
 
Enzyme Bs DHFR dBs DHFR  
Temperature 
(K) 
kcat 
(s-1) 
kcat 
(s-1) 
kcatD/kcatH 
298 
303 
308 
313 
318 
323 
328 
333 
338 
343 
348 
353 
358 
12 
19 
30 
46 
70 
105 
155 
228 
330 
474 
673 
947 
1320 
6 
10 
16 
25 
38 
58 
86 
128 
187 
270 
387 
549 
771 
0.52 
0.53 
0.54 
0.54 
0.55 
0.55 
0.56 
0.56 
0.57 
0.57 
0.58 
0.58 
0.58 
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Abstract 
The aim of this thesis is to investigate the role of fast protein dynamics (pico-
second timescale) in enzyme activity and stability, and specifically to test the 
hypothesis that enzyme activity and stability are inversely related by their internal 
dynamics. 
Activity ∝ Dynamics (flexibility) ∝ 1/Stability 
 
In order to test this hypothesis, the well known anti-cancer drug: methotrexate 
was used as an informative ligand in the network established between these 
properties. A multidisciplinary approach combining neutron scattering, circular 
dichroism, UV absorption, isothermal titration calorimetry and X-ray crystallography 
was undertaken to examine the current paradigm using the enzyme: dihydrofolate 
reductase as a model.  
As inferred by neutron spectroscopy, the binding of MTX influences the 
dynamical behavior of DHFR. Macromolecular dynamics such as the resilience: <k> 
(i.e. structural rigidity) was found to be increased and, inversely, the flexibility 
decreased upon MTX binding. In addition, as revealed by circular dichroism, this 
dynamical dependency upon MTX binding was correlated with an enhanced thermal 
stability. Compared to the free enzyme, the melting temperature was found to be 
increased by 13.8 °C in the presence of MTX. The inhibitory power of MTX was also 
examined by steady state kinetics and isothermal titration calorimetry. The Ki for 
MTX was found to be in the nanomolar range Ki= 10.9 nM. Using isothermal 
titration calorimetry, the binding thermodynamic signature between MTX and DHFR 
was characterized. The binding event was found to be largely favourable (∆Gb=-12.1 
Kcal mol-1), enthalpy driven (∆Hb= -16.8 Kcal mol-1) with an unfavourable entropy 
∆Sb=-15.6 cal K-1mol-1.  
In conclusion, the modulation of the macromolecular dynamics may reflect 
how specific conformations are favoured for subsequent protein function in response 
of the binding of specific ligand and how conformational substates approach to 
protein function. In this context the unprecedented power of transition state analogs 
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such as MTX on protein function might therefore be dependent on fast protein 
dynamics. 
 
Keywords: Incoherent neutron scattering, circular dichroism, isothermal titration 
calorimetry, steady state kinetics, dihydrofolate reductase, methotrexate. 
 
